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“Life is like riding a bicycle. To keep your balance, you must keep moving.” 
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1 
Introduction 
 
 
 
1.1 Feline coronaviruses 
1.1.1 Background 
Two closely related coronaviruses (CoVs) are described in cats: feline infectious peritonitis 
virus (FIPV) and feline enteric coronavirus (FECV). Feline coronaviruses (FCoVs) have a 
worldwide distribution and can infect both domestic and wild feline species. Holzworth was 
the first to introduce feline infectious peritonitis (FIP) as a specific disease entity of cats in the 
early 1960s (Holzworth, 1963). However, the disease was probably observed earlier based on 
a report from 1914, describing a domestic cat with abdominal distention, fever, and ocular 
lesions. In 1966 the infectious nature of FIP was established (Wolfe and Griesemer, 1966). 
Two years later, evidence supporting a viral etiology of the disease was presented and shortly 
after the causative agent was identified as a coronavirus (Ward, 1970; Ward et al., 1968). 
Next, it was discovered that the disease can manifest in an effusive form (“wet FIP”) and a 
non-effusive form (“dry FIP”) (Montali and Strandberg, 1972). FIP was initially considered to 
be a rare and lethal disease manifestation of a single ubiquitous coronavirus (Pedersen, 1976). 
However, this theory was abandoned with the discovery of the second feline coronavirus, 
FECV (Pedersen et al., 1981b). 
Chapter 1 
 
2 
 
1.1.2 Classification, biotypes, serotypes and strains 
Classification   In 1968, the Coronaviridae were recognized as a separate virus family as 
their morphology and intracellular budding site distinguished them from other RNA viruses 
(Siddell et al., 1983). The family of the Coronaviridae, comprising the subfamilies 
Coronavirinae and Torovirinae, is part of the order of the Nidovirales that also includes three 
other families, the Arteriviridae, Roniviridae, and Mesoniviridae. All nidoviruses have a 
positive-sense, single-stranded RNA genome that is transcribed to yield a nested set (nido – 
Latin for ‘nest’) of 3’ co-terminal subgenomic mRNAs. The International Committee on 
Taxonomy of Viruses (ICTV) has recognized four genera within the subfamily of the 
Coronavirinae: Alphacoronavirus, Betacoronavirus, and Gammacoronavirus, which were 
previously referred to as coronavirus groups 1, 2, and 3, and Deltacoronavirus (Adams and 
Carstens, 2012). FCoVs are assigned to the species of the Alphacoronavirus 1 within the 
genera Alphacoronavirus (Table 1.1). Coronaviruses are associated with a wide range of 
diseases, in particular disorders affecting the respiratory and enteric systems, and have been 
isolated from a variety of species.  
Biotypes   From a clinical perspective, it is recognized that FCoV comprises two virulence 
variants, also called biotypes or pathotypes. The avirulent form of FCoV, feline enteric 
coronavirus (FECV), represents the most common biotype in the field and is generally not 
associated with clinical disease. In sharp contrast, infection with the virulent biotype, 
designated feline infectious peritonitis virus (FIPV), manifests as a devastating, highly lethal 
systemic disease named FIP. Conventional wisdom accepts the ‘internal mutation’ theory 
which postulates that FIPV arises by mutation from parental FECV in the individual infected 
host (Poland et al., 1996; Vennema et al., 1998). Although this hypothesis has been widely 
cited, no consensus for the precise nature of the mutation and inducing factors responsible for 
the conversion from FECV to FIPV have been found. The biotype switch has been variably 
ascribed to deletions in the open reading frames (ORFs) 3c, 7a or 7b or to differences in the 
spike (S) protein (Chang et al., 2010; Kennedy et al., 2001; Licitra et al., 2013; Rottier et al., 
2005; Vennema et al., 1998).  
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Table 1.1: Nidovirales taxonomy with species and subspecies in the Alphacoronavirus genus. Adapted from 
(King et al., 2012). 
Order Nidovirales 
 Family Arteriviridae 
 Family Roniviridae 
 Family Mesoniviridae 
 Family Coronaviridae 
o Subfamily Torovirinae 
o Subfamily Coronavirinae 
 Genus Alphacoronavirus 
– Species Alphacoronavirus 1 
 Subspecies Canine coronavirus type I 
 Subspecies Canine coronavirus type II 
 Subspecies Feline coronavirus type I 
 Subspecies Feline coronavirus type II 
 Subspecies Porcine respiratory coronavirus 
 Subspecies Transmissible gastroenteritis virus 
– Species Human coronavirus 229E 
– Species Human coronavirus NL63 
– Species Miniopterus bat coronavirus 1 
– Species Miniopterus bat coronavirus HKU8 
– Species Porcine epidemic diarrhea virus 
– Species Rhinolophus bat coronavirus HKU2 
– Species Scotophilus bat coronavirus 512 
 Genus Betacoronavirus 
 Genus Gammacoronavirus 
 Genus Deltacoronavirus 
 
 
Serotypes   All FCoVs, whether they are FECVs or FIPVs, can be allocated to one of two 
distinct serotypes (I and II) based on virus-neutralization assays using monoclonal antibodies 
(mAbs) raised against the Spike (S) protein. Sera from cats infected with serotype I FCoVs 
can neutralize other serotype I FCoVs but not type II FCoVs, and vice versa (Pedersen et al., 
1984; Shiba et al., 2007). Serotype II FCoVs have arisen from double recombination events 
between FCoV serotype I and canine coronavirus (CCoV). As a result of this genetic 
exchange, serotype II FCoVs acquired the S gene and adjacent regions of CCoV (Fiscus and 
Teramoto, 1987; Herrewegh et al., 1998). Serotype I FECVs/FIPVs predominate throughout 
the world, accounting for 70-95% of the natural FCoV infections (Addie et al., 2003; Benetka 
et al., 2004; Kummrow et al., 2005). Yet, because of the reluctance of serotype I FCoVs to 
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grow in cell culture, most in vitro studies have been conducted on serotype II strains which 
can be readily propagated in vitro. However, this obstacle was recently tackled by the 
establishment of feline intestinal epithelial cell cultures that support the growth of serotype I 
enteric strains. The availability of these susceptible cell lines are a considerable leap forward 
in FCoV research, as they can be used to grow and study enteric FCoVs field strains 
(Desmarets et al., 2013).  
Strains   In addition to the two serotypes, FECVs and FIPVs exist in numerous strains 
defined by distinct single nucleotide polymorphisms (SNPs) and insertion/deletions 
(INDELS). Differences are small between isolates within the same group of cats, seldom 
more than 1-2%, but can be up to 20% between isolates from geographically distinct regions 
(Pedersen, 2009). 
1.1.3 Structural biology 
FCoV particles have a spherical appearance and the diameter averages around 94 nm. Petal-
shaped surface projections (spike proteins) extend a further 20 nm from the surface and give 
the virion the characteristic appearance reminiscent of the solar corona that inspired the name 
of the coronaviruses (Hoshino and Scott, 1980). The nucleocapsid protein (N) packages the 
positive single-stranded RNA genome into a helical nucleocapsid, which in turn is surrounded 
by a phospholipid envelope. The envelope accommodates three viral structural proteins: the 
spike (S) glycoprotein, the membrane (M) protein, and the small envelope (E) protein. 
 
 
 
 
 
 
Figure 1.1: (A) Schematic representation of a feline coronavirus with RNA, envelope (E), membrane (M), spike 
(S) and nucleocapsid (N) proteins. (B) Topology of the three major FCoV structural proteins in the virion 
envelope. Adapted from (Ruch and Machamer, 2012). 
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The genome   Coronaviruses possess an extremely large non-fragmented RNA genome. With 
a length of 29125 nucleotides (nt), excluding the poly adenylated end, the FCoV genome is no 
exception to this (Dye and Siddell, 2005). The genome includes 7 ORFs flanked by a 5’ 
methylated cap and a 3’ poly-A tail. A representation of the FCoV genome is given in Figure 
1.2. The first ORF encodes the polymerase polyprotein (Pol 1a and Pol 1b). The downstream 
ORFs 2, 4, 5, and 6 encode for the structural proteins (spike, membrane, envelope and 
nucleocapsid, respectively). In addition, leaky scanning from two gene clusters (ORF3abc and 
ORF7ab) produce five putative accessory proteins (Schaecher et al., 2007). 
 
 
 
 
Figure 1.2: Schematic overview of genomic organization of feline coronaviruses with a leader sequence, 8 
ORFs and a polyadenylated tail. Each of the ORFS encode one or more proteins depicted below the ORF 
Adapted from (Vermeulen, 2013).  
The polymerase polyprotein   The polymerase gene encompasses two thirds of the genome 
(from the 5’end) and consists of two overlapping open reading frames (ORF1a and 1b) 
connected by a slippery sequence. These ORFs encode the polyproteins pp1a and pp1ab that 
are subsequently cleaved by viral proteases to yield 16 non-structural proteins that function in 
the viral RNA replication/transcription machinery (Ziebuhr et al., 2000). 
The spike or S protein is a heavily N-glycosylated type I membrane protein which occurs in 
a homotrimeric complex. All except a short carboxy-terminal segment of the S molecule 
constitutes the ectodomain. The monomeric S protein has a size between 150 and 200 
kiloDalton (kDa) and contains distinct functional domains near the amino (S1) and carboxy 
(S2) termini. It has been suggested that the S1 subunit forms the globular head while the S2 
subunit constitutes the stalk-like region of the spike (de Groot et al., 1987). The spike 
glycoproteins define the host tropism by mediating coronavirus attachment and virus-induced 
membrane fusion by the S1 and cor S2 part, respectively (Beniac et al., 2006; Beniac et al., 
2007). This fusogenic capacity results in both virus-cell fusion, which results in genome 
release in the cytoplasm, and cell-cell fusion, when being transported to the plasma 
membrane, characterized by syncytium formation (Delmas and Laude, 1990). In addition, 
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these structures play an important role in the induction of neutralizing antibodies and in 
various immune evasion processes (De Groot et al., 1989; Dewerchin et al., 2006). 
The small envelope or E protein (10 kDa) is the least abundant structural protein in the 
virion envelope. This non-glycosylated protein is an integral membrane protein that spans the 
bilayer twice with both termini extending into the virion interior often referred to as 
membrane hairpin topology (Maeda et al., 2001). The E-protein plays a central role in virus 
morphogenesis and assembly (Lim and Liu, 2001). Additionally, it may act as a viroporin, 
inducing the formation of hydrophilic pores in cellular membranes which could facilitate 
virus release from infected cells (Wilson et al., 2004). 
The membrane or M protein (25-30 kDa) is the most abundant envelope protein. This type 
III glycoprotein consist of a triple-spanning transmembrane domain, flanked by a short 
glycosylated amino-terminal ectodomain (outside the virion) and a long carboxyl-terminal 
inner domain (inside of the virion) (Armstrong et al., 1984; Rottier et al., 1986). M protein 
acts as a scaffold protein for virus assembly, through interactions with the other structural 
proteins (Opstelten et al., 1995). They may also be involved in viral entry in 
monocytes/macrophages since neutralizing antibodies against M proteins have been described 
(Kida et al., 2000). Additionally, mAbs against M proteins induce internalization of surface-
expressed M proteins, suggesting that these molecules are also involved in immune evasion 
(Dewerchin et al., 2006). 
The nucleocapsid or N protein is a small, soluble phosphoprotein with a molecular weight 
of 43-50 kDa (Stohlman and Lai, 1979). It packages the viral genomic RNA to form the 
helical nucleocapsid that is incorporated into newly formed virions through interactions 
between the N and M proteins (Narayanan et al., 2000; Parker and Masters, 1990). N protein 
has been shown to function as an RNA chaperone and to facilitate viral RNA synthesis 
(Sawicki et al., 2007; Tahara et al., 1994). Furthermore, the nucleocapsid protein contributes 
to the perturbation of the innate immune response as it was demonstrated to be an interferon 
antagonist (Kopecky-Bromberg et al., 2007; Ye et al., 2007). 
The accessory or group-specific proteins   The viral genome also encodes for group-
specific, most likely non-structural, proteins called accessory proteins. The gene products of 
ORF 3abc and ORF 7ab comprise the putative accessory proteins of FCoV. The biological 
functions of coronavirus accessory proteins are still poorly characterized. It has been shown 
that these proteins are often dispensable for virus replication in vitro. On the other hand, 
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deletion of one or both of these gene clusters results in attenuation of the virus when 
inoculated into the natural hosts (de Haan et al., 2002; Haijema et al., 2004; Ortego et al., 
2003). Additionally, a mutation in 3c, 7a or 7b has been correlated with the development of 
FIPV strains from FECV strains (Kennedy et al., 2001; Vennema et al., 1998). Therefore, it 
has been speculated that these proteins are of key importance for virus–host interactions and 
critically contribute to viral virulence and pathogenesis. The expression and function of 
proteins derived from ORF 3abc are still largely unknown. However, recent studies 
demonstrated that 60-71.4% of FIP isolates, had a truncated 3c protein, while in FECV 
isolates from feces this protein was intact. It was postulated that 3c could be necessary for 
replication in enterocytes but dispensable or even a burden during FIPV infection in 
monocytes which may also explain the restricted horizontal transmission of FIPV (Addie et 
al., 1996; Chang et al., 2010; Pedersen et al., 2012). Most knowledge has been gathered about 
the 7b protein (26,5 kDa), which is a soluble glycoprotein secreted from infected cells that 
might function as a virokine acting as an immune-modulator of host immune responses 
(Herrewegh et al., 1995b; Rottier, 1999). In addition, it was found by our research group that 
deleting ORF 7 from type II FIPV 79-1146 had a negative impact on the replication kinetic in 
feline monocytes. Thus, proteins encoded by ORF 7 play a decisive role in sustaining the 
replication of type II FIPV in its in vivo target cell (Dedeurwaerder et al., 2013a). Recently, it 
was also demonstrated in our laboratory that FIPV 7a protein is a type I interferon (IFN) 
antagonist that protects the virus from the IFN-induced antiviral state. However, IFN-α 
evasion was only possible when ORF3-encoded proteins were present, suggesting that a 
cooperation between the different accessory proteins is essential to completely abolish the 
IFN-mediated immune response (Dedeurwaerder et al., 2013b).  
1.1.4 Pathogenesis and symptoms 
As FIPV is a mutant form of FECV, one cannot understand FIP and FIPV (1.1.4.2) without 
understanding FECV infection (1.1.4.1) (Pedersen et al., 1981b; Poland et al., 1996; Vennema 
et al., 1998).  
1.1.4.1 FECV 
Pathogenesis   The highly contagious FECV spreads primarily via the fecal-oral route, 
although it can also be transmitted by inhalation. Following ingestion, the virus travels 
through the digestive tract, binds and enters the epithelial cells that line the tips of the 
intestinal villi (enterocytes), and due to lytic replication, the infected cells are destructed 
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(Pedersen et al., 1981b). Soon after infection, FECV replication can also be localized at the 
oropharynx (Pedersen, 2009; Vermeulen, 2013). From its initial site of infection, FECV can 
spread through the body via monocyte-associated viraemia and reach different organs 
including mesenteric lymph nodes, spleen, bone marrow, tonsils, thymus and even lungs, 
brain and liver (Gunn-Moore et al., 1998b; Kipar et al., 2010; Meli et al., 2004). Fecal 
shedding of FECV begins within 1 week after initial infection and persists at peak levels for at 
least 2–3 months, followed by an extended period (5–10 months) of lower level viral 
excretion. After primary infection, three excretion patterns are distinguished: self-limiting, 
intermittent and persistent (Foley et al., 1997; Pedersen et al., 2008). Transient salivary 
shedding can also occur in the early phase of infection as result of virus replication in 
oropharyngeal tissue (Vermeulen, 2013). Cats that have recovered from infection can be 
reinfected by the same or a different FECV strain. However, the reinfection appears not to 
increase the chance of biotype switch to FIPV (Addie et al., 2003).  
Recently, an adapted infection model was introduced based on an experimental infection 
study, inoculating three specific pathogen free cats with an infectious field strain FECV-UCD. 
According to this model, FECV infection occurs in three phases. Phase I takes place in the 
naso-oropharyngeal cavity and is the consequence of virus replication in permissive cells at 
this location (most likely cells of the monocytic lineage). Infection of these cells allows FECV 
to escape from immune responses and to spread throughout the body. Phase II starts with the 
gastro-intestinal passage of orally administered virus and represents the infection of 
enterocytes. The infection leads to high fecal shedding and activation of the immune system 
that subsequently contains the infection (2-3 weeks after infection). Phase III is the 
consequence of virus dissemination by the permissive cells in the naso-oropharyngeal cavity 
to the gut (Vermeulen, 2013).  
Symptoms   If a large number of enterocytes are destroyed before immunity takes place, a 
mild to moderate self-limiting diarrhea (and occasionally vomiting) can occur in a proportion 
of cats, especially kittens. Yet, most FECV infections are clinically unapparent (Pedersen et 
al., 1981b). Rarely, the virus may cause severe acute or chronic vomiting and/or diarrhea 
which can be fatal (Kipar et al., 1998b).  
1.1.4.2 FIP and FIPV 
Pathogenesis   According to the widely accepted “internal mutation theory”, the causative 
agent of FIP, FIPV, represents a highly virulent FCoV mutant that arises during an existing 
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infection with the ubiquitous, relatively avirulent FECV (Chang et al., 2010; Pedersen et al., 
1981b; Poland et al., 1996; Vennema et al., 1998). The mutation is more likely to occur 
during primary infection and in kittens, because both conditions lead to a higher level of 
FECV replication and therefore a higher mutation rate. Moreover, kittens have a decreased 
resistance to the mutant virus (Pedersen, 2009; Pedersen et al., 2008). Although there is no 
doubt that FECV and FIPV are genetically distinct to a minor but crucial degree, the precise 
nature of the mutation(s) responsible for the change in disease potential has yet to be 
discovered. Changes in the S gene and the accessory genes 3c, 7a, and 7b have been reported 
to correlate with a biotype switch, but no consensus exists (Kennedy et al., 2001; Rottier et 
al., 2005; Vennema et al., 1998). Irrespective of the viral genetic determinants that account for 
the difference, the acquisition of monocyte/macrophage tropism appears to be an essential 
step in the transformation of an FECV to an FIPV (Rottier et al., 2005; Stoddart and Scott, 
1989). The FIPV is internalized by a clathrin- and caveolae-independent, but dynamin-
dependent endocytosis in macrophage/monocytes (Van Hamme et al., 2008). Mutant viruses 
can proliferate unrestricted within these cells, gain access to the systemic circulation, and 
invade the body. Specific targets are the mesenteric lymph nodes, serosal surfaces of the gut, 
and to a lesser extent the pleura, and the omentum. Some FIPVs even reach leptomengeal 
vessels and venules located in the brain parenchyma and the eyes (Kipar et al., 2005; 
Pedersen, 2009). Although, the parent FECV is more tropic for mature apical epithelium of 
the bowel, PCR results in healthy cats showed that FECVs can also be detected in blood 
monocytes and phagocyte-rich organs during the course of a natural infection (Gunn-Moore et 
al., 1998b; Herrewegh et al., 1995a; Kipar et al., 2010; Meli et al., 2004). Therefore, the 
former view that avirulent FCoV strains remain confined to the digestive tract, while virulent 
strains disseminate to other organs via blood-borne monocytes is too simplistic. The 
difference must rather be a quantitative one. Indeed, when virulent and avirulent strains were 
compared in vitro, the latter infected fewer macrophages and produced lower virus titers than 
the virulent strains. Moreover, the avirulent strains were less able to sustain viral replication 
and to spread to other macrophages (Dewerchin et al., 2005; Stoddart and Scott, 1989). FIPV-
infected circulating monocytes are not only responsible for viral dissemination, but also, in an 
activated state, initiate the development of the typical widespread granulomatous vascular 
lesions (Kipar et al., 2006). The morphological aspects of these FIP lesions have been studied 
in considerable detail and the mechanisms that lead to their development start to unravel. In 
the past, the vasculitis was considered to be induced by a type III hypersensitivity reaction, 
involving the deposition of immune complexes within venules leading to complement 
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activation (Jacobse-Geels et al., 1980, 1982; Pedersen and Boyle, 1980). However, Kipar and 
co-workers demonstrated that the morphology, cellular composition, and distribution of the 
vascular lesions in FIP differs significantly from immune-complex-mediated vascular 
inflammatory processes. Furthermore, the demonstration of FCoV antigen within 
intravascular leukocytes and among cells in the FIP granulomas indicates that the 
granulomatous inflammatory processes are rather attributed to exaggerated activation of 
FCoV-infected circulating monocytes. These activated monocytes adhere to the endothelium 
of small and medium-sized veins. Upon emigration from the vessels, monocytic cells secrete 
matrix metalloproteinases B (MMP9), which is associated with disassembly and destruction 
of the basal lamina of the endothelium (Kipar et al., 2005). The infiltrating, infected 
macrophages tend to congregate around small venules where they continue to replicate virus. 
In response to this virus replication, more monocytes are recruited from the blood and enter 
the target tissues ultimately resulting in the classical lesions of FIP: vasculitis with formation 
of (pyo)granulomas. In addition to virus, inflammatory mediators, such as cytokines, 
leukotrienes, and prostaglandins, are released from infected and dying macrophages (Goitsuka 
et al., 1990; Hasegawa and Hasegawa, 1991; Weiss et al., 1988). These products increase 
vascular permeability and provide additional chemotactic stimuli for neutrophils and 
monocytes. In response to inflammation, these attracted cells release additional mediators and 
cytotoxic substances with enhanced local virus production and increased tissue damage as end 
result. Morphologically, the vascular lesions present as venous and perivenous macrophage-
dominated circular and focal infiltrates with many of the macrophages infected and infection 
restricted to these cells. Neutrophils and T-lymphocytes represent minorities among 
inflammatory cells, and B-lymphocytes have been shown to surround and progressively 
replace macrophages in FIP granulomas (Berg et al., 2005; Kipar et al., 1998a; Kipar et al., 
2005).  
Regardless of viral determinants, the outcome of the infection in an individual cat also 
depends on the immune competence of the animal (de Groot-Mijnes et al., 2005; Kipar et al., 
2006; Pedersen, 1987). Cats that did not develop disease after experimental coronavirus 
infection displayed a greater cell-mediated immune response when compared to those that 
did. In addition, there is ample evidence for an involvement of the immune system in the 
pathogenesis of FIP. Disease progression is accompanied by and presumably the consequence 
of a dramatic dysregulation of the adaptive immune system as evidenced by the common 
occurrence of hypergammaglobulinaemia and of a profound depletion of T-lymphocytes from 
the periphery as well as from lymphoid tissues (Haagmans et al., 1996; Kipar et al., 2001; 
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Paltrinieri et al. 1998; Paltrinieri et al., 2003). Humoral immunity is obviously not protective 
and the pre-existence of antibodies can be rather detrimental (Paltrinieri et al., 1998). FCoV-
seropositive cats that are experimentally infected with FIPV often develop an accelerated, 
fulminating course of the disease compared to seronegative cats (Pedersen and Boyle, 1980; 
Weiss et al., 1980; Weiss and Scott, 1981). This antibody-dependent enhancement of 
infectivity (ADEI) is likely due to opsonisation of the virus by antibodies directed against the 
spike protein, whereby uptake by macrophages via Fc receptor-mediated attachment is 
facilitated (Corapi et al., 1992; Hohdatsu et al., 1991; Olsen et al., 1992). The role of ADEI in 
natural infection is not clear since ADEI only occurs when antibodies are present at 
subneutralizing titers and cats develop FIP on first exposure to FCoV (Addie et al., 1995). 
Moreover, viral proteins are rapidly internalized following exposure to FIPV-specific 
antibodies. This allows the virus to evade antibody-dependent lysis, so the humoral response 
fails to clear FIPV infection (Cornelissen et al., 2007; Dewerchin et al., 2006). Further, 
despite the presence of antibodies and complement, there is no antibody-dependent 
complement mediated lysis of infected monocytes (Cornelissen et al., 2009). The efficacy of 
the primary cell-mediated immune responses most likely determines to what extent the initial 
wave(s) of infection can be contained and hence, may be the decisive factor in disease 
progression (de Groot-Mijnes et al., 2005). If this line of defense fails, FIPV-induced T-cell 
depletion may rapidly lead to a melt-down of the adaptive immune system allowing the virus 
to replicate unchecked. The patterns of expression of various cytokines in the peripheral blood 
monocytes, lymphoid tissue, and ascitis of cats with FIP are being studied extensively. Tumor 
necrosis factor (TNF)-α, interferon (IFN)-γ, interleukin (IL)-6, IL-10, and IL-12 appear to 
play roles in the development of FIP. Increases in IFN and IL-10 may be protective, whereas 
increases in TNF, IL-6, and IL-12 appear to be associated with disease progression (Berg et 
al., 2005; Dean et al., 2003; Gunn-Moore et al., 1998a; Kiss et al., 2004; Takano et al., 2007).  
Symptoms   FIP is a disease with extremely diverse clinical manifestations which reflects the 
variability in the distribution of the hallmark lesions of FIP: vasculitis and granulomas. 
Clinical signs tend to be progressive and ultimately fatal. In general, the disease takes on one 
of two clinical forms: effusive (or “wet”) FIP and non-effusive (or “dry”) FIP, although 
overlap between both forms can occur (Hartmann, 2005; Montali and Strandberg, 1972). 
Effusive disease is more common than non-effusive disease and accounts for around 60-70% 
of the cases (Rohrbach et al., 2001). Whether a cat develops a wet or dry form is thought to 
depend on the strength of the cell mediated immune response (Cornelissen et al., 2007; 
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Pedersen, 1987). Wet forms are presumed to be the consequence of a weak cell-mediated 
immunity combined with a strong humoral response by the host. If a partial cell-mediated 
immune response is mounted, the resulting disease is non-effusive (Pedersen, 2009). In 
addition, a study of Takano et al. revealed that the effusions are also initiated by vascular 
endothelial growt factor (VEGF), specifically produced by FIPV-infected monocytes. In the 
same study a correlation between plasma VEGF levels and the amounts of effusion in cats 
with FIP was demonstrated (Takano et al., 2011a). The earliest signs of overt FIP are 
nonspecific and common to both forms of the disease. These include an intermittent fever 
refractory to antibiotics, lethargy, progressive anorexia, and weight loss (Olsen, 1993). 
However, some patients remain remarkably bright and retain body condition despite the 
presence of severe disease. More specific clinical signs superimpose the vague disease signs 
and depend on the organ distribution of the inflammation and the form of the disease. In 
effusive “wet” FIP, the virus causes vasculitis resulting in the leakage of protein-rich fluid 
from the blood into body cavities. Abdominal fluid, or ascites, is manifested by a non-painful 
distention of the abdomen. If the cat is an intact male, the scrotum may appear enlarged 
(Pedersen, 2009). In cases where effusion is located in the thorax, cats often present with 
dyspnea. As the name already implies, thoracic and abdominal effusions are either absent or 
too scant to be detected in non-effusive “dry FIP”. Instead, larger surface-orientated 
granulomas are found especially in the mesenteric lymph nodes, kidneys, and less commonly 
in the liver, caecum or colon (Harvey et al., 1996). These granulomatous lesions are 
frequently palpable through the body wall or visible on ultrasonography and can give 
symptoms resulting from organ failure. Involvement of the eyes and/or central nervous system 
(CNS) predominates in 60% of the cats with “dry FIP”. Ocular lesions include iritis, uveitis, 
and cuffing of the retinal vasculature (Andrew, 2000; Colitz, 2005). Cats with neurological 
involvement frequently exhibit ataxia, hyperaesthesia, nystagmus, seizures and behavioral 
changes (Foley et al., 1998). Less commonly reported clinical signs of FIP include orchitis, 
skin lesions, and pneumonia (Cannon et al., 2005; Macdonald et al., 2003; Sigurdardottir et 
al., 2001). Under experimental conditions, the incubation period of effusive and non-effusive 
FIP is 2-14 days and several weeks, respectively (Pedersen et al., 1981a). In natural infections 
the actual incubation is unknown, but there is evidence that the infection may smolder in a 
subclinical state for weeks, months, and even years before overt signs are noticed (Pedersen, 
2009). Thereafter, effusive disease tends to have a shorter duration than non-effusive disease 
with most cases of “wet FIP” having a course of only a few weeks. 
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Figure 1.3: Possible clinical features and pathological findings seen during FIP. Enlargement of the abdomen (a) 
due to formation of exudates in the abdominal cavity (b) with formation of multiple small granulomas on the 
intestines (c) observed during the effusive form. Ocular changes (d, e) and formation of larger granulomas on the 
kidney (f) and liver (g) observed during the non-effusive form.  
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1.1.5 Diagnosis 
The ante mortem diagnosis of FIP remains challenging. The wide range of clinical signs 
makes FIP a potential consideration in many different clinical cases and there is no single, 
sensitive, specific, noninvasive diagnostic test currently available to definitively confirm the 
suspicions of FIP (Kipar and Meli, 2014). The present gold standard for a definitive FIP 
diagnosis is the detection of FCoV antigen in macrophages using immunofluorescence (in 
effusion) or immunohistochemistry (in tissue) (Addie et al., 2009; Tammer et al., 1995). The 
histology of lesions is usually pathognomonic and therefore on itself also 100% confirmative 
for FIP (Goodson et al., 2009). Although, positive immunofluorescence staining of 
intracellular FCoV antigen in macrophages of the effusion is 100% predictive of FIP, the 
negative predictive value of the test is only 57% (Hartmann et al., 2003). In addition, 
invasive, expensive methods (e.g., laparotomy or laparoscopy) are usually necessary to obtain 
appropriate tissue samples and it can also give false negative results. Therefore, the ante 
mortem diagnosis of FIP is generally a probability diagnosis based on cumulative odds rather 
than a single, definitive test result. Several parameters including history, clinical signs, 
laboratory changes, and level of antibody titers are combined to establish a presumptive 
diagnosis of FIP (Addie et al., 2009). An algorithm used as guideline in the diagnosis of FIP 
is shown in Figure 1.4. 
1.1.6 Treatment of FIP 
Despite several claims no treatment has proven effective in curing cats of FIP. Treatment can 
be beneficial in early stages; slowing down the disease progression and even producing 
temporary alleviation of clinical signs. Yet, once the disease becomes clinically apparant, it is 
more than 95% fatal at this point (Addie et al., 2004). A number of non-specific treatments 
have been reported for FIP, almost all with insufficient patient numbers, inadequate 
documentation of infection, or lack of essential placebo controls and double blinding 
(Hartmann and Ritz, 2008). As FIP is an inflammatory and immune-augmented disease, 
supportive treatment mainly consists of anti-inflammatory drugs and immunosuppressives, 
such as glucocorticoids or cyclophosphamide. As stated above, they will only delay the 
inevitable but have no curative powers in their own right (Hartmann and Ritz, 2008).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1.4: Algorithm used to facilitate the diagnosis of FIP. Adapted from (Addie, 2011).
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Tumor necrosis factor inhibitors, especially pentoxyfilline, have been anecdotally used to 
combat the vasculitis associated with FIP (Nichols et al., 2001). However, a recent study 
failed to detect an effect of pentoxyfylline on the survival time, the quality of life, or any FIP 
associated clinical or laboratory parameters of FIP cats (Fischer et al., 2011). Certain antiviral 
drugs (e.g. ribavarin) have been tried, and though they inhibited viral replication in the test 
tube, they were not effective in the cat (Weiss et al., 1993; Weiss and Oostrom-Ram, 1989). 
Immunostimulants of several types, including interferon and polyprenyl immunostimulant, 
have also been tried, but again without significant long-term benefit (Ishida et al., 2004; 
Legendre and Bartges, 2009; Ritz et al., 2007). Megadoses of vitamins, and numerous 
nutriceuticals have been advocated as well, but found to be without merit. A wide variety of 
pyridine N-oxide derivates, semisynthetic derivates of glycopeptides, and plant lectins have 
been found to be inhibitory against feline coronavirus in vitro (Balzarini et al., 2006; Keyaerts 
et al., 2007). However, no in vivo studies have been reported to date. In fact, the most 
promising experiments have involved drugs that specifically target certain protein activities of 
FCoVs. These include inhibitors of the viral 3C-like protease and synthetic peptides derived 
from spike proteins that interfere with the fusion of the virus envelope with the cell membrane 
(Kim et al., 2013; Liu et al., 2013). 
1.1.7 Prevention of FIP 
Vaccines   Effective vaccines have been as elusive as effective treatments (Takano et al., 
2014). Most vaccine strategies failed to provide protection or even aggravated the disease. At 
present, the only vaccine commercially available against FIP consist of a temperature-
sensitive mutant of a serotype II FIPV (Primucell-FIP, Pfizer Animal Health). The vaccine is 
administered intranasally and aims at inducing local mucosal immune responses through the 
induction of IgA and systemic cell-mediated immunity (Christianson et al., 1989; Gerber et 
al., 1990). It has proven safe over a long period of use and does not appear to enhance disease. 
However, there is still controversy over the efficacy of this vaccine. Results of experimental 
protection studies have not been consistent, with success rates between 0 and 75%, and the 
results of field studies have been equally contradictionary (Fehr et al., 1997; Gerber et al., 
1990; Reeves et al., 1992). The issues of serotype specificity (i.e., the vaccine contains a 
serotype II strain, while most field isolates are serotype I), interference with maternal Abs, the 
need to withhold vaccination until at least 16 weeks meaning that most kittens of this age in 
endemic situations will already be infected with FCoV and therefore non-responsive, are 
considered as serious limitations and, hence, its applicability remains a matter of dispute 
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(Pedersen, 2009). Haijema reported successful vaccination against a homologous virus 
challenge with a live attenuated serotype II strain with deletion of the accessory gene cluster 
3abc or 7ab (Haijema et al., 2004). However, no follow up research has been reported on this 
vaccine approach. Since 1990, there have been a number of different potential vaccines based 
on recombinant technology described in literature (Klepfer et al., 1995; Vennema et al., 1990; 
Wasmoen et al., 1995). 
Management   It becomes increasingly evident that prevention of FIP should be directed at 
preventing or reducing the prevalence of the underlying FECV infections. This is usually only 
a concern in breeding catteries and rescue shelters. In breeding catteries, two management 
approaches have been advocated: either eradication of infection or taking measures to reduce 
the frequency of the disease. For total elimination of FECV numerous measures have to be 
taken, such as identifying and removing continuous shedders, quarantine of seropositive 
animals until they become seronegative, and strict hygiene precautions to prevent fecal-oral 
transmission. These measures are laborious, time-consuming, costly and must be followed 
rigorously. Furthermore, given the ubiquitous nature of FCoV infections, maintaining a virus-
free colony is extremely challenging. A more practical approach is to eliminate infection in 
kittens born in an FCoV-endemic environment by the isolation of queens and early weaning 
of kittens (Addie and Jarrett, 1990, 1992). However, even the eradication of infection in the 
kittens stays difficult and may compromise their development in other respects. Therefore, it 
may be more appropriate to institute measures to try to minimize the prevalence of this 
infection, and to reduce its impact. The most cost-effective means to control FIP losses are 
six-fold: 1) eliminate over-crowding, and if possible, keep no more than 6 breeding animals; 
2) maintain a larger proportion of older cats; 3) prevent fecal-oral spread by properly 
managing litter boxes, litter replacement, and gross and microscopic spread of litter and litter 
dust; 4) restrict the introduction of new cats and especially limit the continuous presence of 
many kittens; 5) avoid stress and control other kitten hood diseases; and 6) manage genetics 
by excluding toms, and preferably also queens, that have produced kittens that died from FIP, 
from breeding programs (Addie et al., 2009; Pedersen, 2009). 
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1.2 Leukocyte extravasation 
1.2.1 Background 
Leukocyte extravasation entails the migration of leukocytes from the bloodstream into 
perivascular tissue, where they fulfill their task as immune cells. This process involves 
transient adhesion to the vessel endothelium, followed by transmigration through the 
endothelial cell (EC) layer. Over the last decade, a large body of data accumulated that 
established considerable insights into the molecular basis of leukocyte-endothelial 
interactions. The first paragraph (1.2.2) provides a concise review of leukocyte extravasation 
from both a molecular and mechanical point of view. Most of our knowledge comes from 
basic research in humans and mice. However, as feline models are frequently used in 
leukocyte recruitment studies describing the same adhesion molecules, we presume a similar 
molecular biology of leukocyte extravasation in cats (Eppihimer and Schaub, 2001; Hickey et 
al., 1997; Perry and Granger, 1991). The transition of leukocytes from circulating cells to 
tissue-resident cells is strictly orchestrated by a complex process of molecular interactions 
between leukocytes and ECs, and involves radical morphological changes in both cell types. 
The interactions are mediated by the combined action of cellular adhesion receptors and 
leukocyte-activating factors. Special emphasis on the highly specific, regulatory mechanisms 
that control selective leukocyte recruitment is given in part 1.2.3. Leukocyte recruitment is 
essential for immune surveillance and the development of an appropriate inflammatory 
response to injury or infection. However, if the regulatory mechanisms of the inflammatory 
response are altered, the defense attacks of the leukocytes can turn against the organism’s own 
tissue, leading to inflammatory and autoimmune disorders (1.2.4). There is growing optimism 
that our ability to impair leukocyte recruitment might reduce the sequelae associated with 
inflammatory conditions. In part 1.2.5 some of the promising therapeutic approaches are 
summarized.  
1.2.2 The multistep process of leukocyte recruitment 
Leukocyte recruitment is a dynamic process that implies multiple steps including (1.2.2.1) the 
initial selectin-dependent tethering and rolling of leukocytes, (1.2.2.2) the chemokine-induced 
leukocyte activation, (1.2.2.3) the integrin-mediated firm adhesion, (1.2.2.4) the intraluminal 
crawling, and (1.2.2.5) the transendothelial migration of leukocytes (Chavakis et al., 2009). A 
detailed illustration of the leukocyte recruitment cascade is shown in Figure 1.5. 
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Figure 1.5: Schematic overview of the distinct steps that comprise the leukocyte recruitment cascade. Adapted 
from (Rivera-Nieves et al., 2008). 
1.2.2.1 Selectin-dependent tethering and rolling of leukcoytes  
To initiate the inflammatory response, circulating leukocytes have to establish contact with 
the vascular wall, while withstanding shear forces. This already occurs in part as a result of 
physical properties that dictate that the smaller red blood cells (RBCs) move toward the center 
of the bloodstream, whereas the larger white blood cells (WBCs) are displaced toward the 
vessel wall. However, under basal conditions, this propensity of leukocytes to be pushed 
outward is not sufficient to allow the rapidly flowing leukocytes to slow down and interact 
with the vessel wall (Kelly et al., 2007). In fact, the capture of leukocytes requires the local 
generation of mediators and initial activation of endothelium juxtaposed to the inflammatory 
site which enables leukocytes to not only recognize such sites from within the vasculature, but 
also to form contact with the endothelium (Ebnet and Vestweber, 1999). The initial 
interaction or tethering of leukocytes with the endothelium is largely mediated by a class of 
molecules known as selectins. Selectins have been proposed to have rapid bond association 
and dissociation rate constants, facilitating a high frequency of labile and transient tethers 
between leukocytes and the endothelium. In combination with the rapidly flowing 
bloodstream, this momentary loose attachment leads to a rotational movement of leukocytes 
over the endothelial surface in the direction of the shear stress, termed rolling (Sperandio, 
2006; Vestweber and Blanks, 1999). The selectin family comprises of three cell adhesion 
molecules which are type I transmembrane glycoproteins. All three selectins share a similar 
structure containing a calcium-dependent lectin-like binding domain at the amino terminal, an 
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epidermal growth factor (EGF)-like domain, a variable number of short consensus repeats 
(SCRs) similar to those appearing in complement-regulatory proteins, a single-transmembrane 
domain, and a short cytoplasmic tail. The individual members of the selectins are designated 
by the prefixes P (platelet), E (endothelial), and L (leukocyte), according to the cell type in 
which they were originally identified (Kelly et al., 2007; Tedder et al., 1995).  
P-selectin (CD62P) was initially characterized in platelets and was later also detected in 
endothelial cells (ECs). In both cell types, P-selectin is constitutively expressed and stored in 
cytoplasmic granules known as α-granules (in platelets) or Weibel-Palade bodies (WP, in 
endothelium). Cell-surface expression of P-selectin on the endothelium is induced by two 
different mechanisms. Upon endothelial stimulation with inflammatory mediators, such as 
thrombin, histamine, and oxygen-derived free radicals, the WP-bodies are rapidly (within 
minutes) translocated to the cell surface increasing briefly the surface expression of P-
selectin, before returning to basal levels within minutes. After internalization, P-selectin can 
recycle from the endosomes into the storage granules. In addition to this short-lived 
expression, some stimuli, like pro-inflammatory cytokines, can exert transcriptional 
regulation of P-selectin expression responsible for the more prolonged elevation of P-selectin. 
Because of the rapid mobilization of the preformed pool, it is not surprising that P-selectin is 
involved in the very early phases of tethering and rolling (Tedder et al., 1995; Vestweber and 
Blanks, 1999). 
E-selectin (CD62E) was found by a monoclonal antibody approach, when searching for 
cytokine-inducible surface proteins on ECs involved in neutrophil adhesion (Bevilacqua et al., 
1987). Like P-selectin, E-selectin is not expressed on the endothelium under baseline 
conditions. One notable exception are the microvessels in the skin, which express E-selectin 
constitutively, allowing continuous rolling of leukocytes in the dermal vascular bed in order 
to patrol through this tissue located in proximity to the external environment (Sperandio, 
2006). E-selectin is transcriptionally induced on ECs in response to cytokines such as Il-1β, 
TNF-α and by lipopolysaccharide (LPS). Expression of the de novo synthesized protein can 
occur as quickly as 2 h after stimulation, reaching maximal levels at 4-6 h post-stimulus, and 
generally declines again to basal levels within 24 h (Kansas, 1996). In contrast to P-selectin, 
E-selectin is targeted to lysosomes after internalization (Ebnet and Vestweber, 1999). Despite 
delayed expression, the function of E-selectin overlaps with that of P-selectin, temporally 
helping to enhance leukocyte recruitment (Labow et al., 1994). In fact, E-selectin expression 
results in a dramatic decrease in rolling velocity (Kunkel and Ley, 1996). 
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L-selectin (CD62L) was originally discovered as a “lymphocyte homing” molecule, 
mediating lymphocyte recruitment to high endothelial venules (HEV) in lymphoid tissues 
(Gallatin et al., 1983). Later, L-selectin was also found on most other peripheral blood 
leukocytes and was shown to be generally involved in leukocyte entry into sites of 
inflammation. L-selectin is constitutively expressed on myeloid cells and a large subset of 
lymphocytes and can be downregulated at the transcriptional level during lymphocyte 
differentiation from a naïve to memory cell phenotype (Vestweber and Blanks, 1999). The 
function of L-selectin in the initiation of leukocyte-endothelial contact in inflamed areas is 
controlled by the regulated appearance of its ligand(s) (Vestweber and Blanks, 1999). There is 
abundant evidence that L-selectin is rapidly shed from the surface upon cellular activation. 
This proteolytic cleavage of L-selectin from the leukocyte cell surface may be important to 
prevent too strong leukocyte-endothelial interactions. In addition, soluble L-selectin may be 
an important mechanism to prevent leukocyte rolling at sites of subacute inflammation. Taken 
together, it is likely that L-selectin shedding functions as a buffer system, modulating 
leukocyte adhesion to endothelium during inflammation (Ebnet and Vestweber, 1999; Tedder 
et al., 1995).  
The ligands of selectins are composed of a scaffold protein, or perhaps lipid backbone, which 
is modified by certain carbohydrates and in some cases with other posttranslational 
modifications. It is thought that these carrier molecules need to be expressed in the right 
cellular background that provides the necessary repertoire of glycosyltransferases and/or other 
protein-modifying enzymes to confer selectin-binding activity to these molecules (Ebnet and 
Vestweber, 1999). Numerous reports indicate that all selectins bind a sialylated 
tetrasaccharide, sialyl Lewis
x
 (sLex, CD15s, NeuAc,α2,3Galβ1,4(Fuc α1,3)GlcNac) on their 
counter receptor (Sperandio, 2006). Several ligand core proteins that serve as a backbone for 
these carbohydrate side chains have been identified (Figure 1.6).  
P-selectin glycoprotein ligand 1 (PSGL-1) is the best characterized selectin ligand to date. It is 
expressed on myeloid, lymphoid, and dendritic cells and fulfills all criteria of a 
physiologically relevant ligand for P-, E-, and L-selectin (Kansas, 1996). PSGL-1, as almost 
all other glycoprotein ligands of the selectins, is a sialomucin. In addition to carrying the 
correct oligosaccharides, PSGL-1 needs branched carbohydrate side chains. Sulfation of one 
of the tyrosine residues at its N-terminus is also required for its binding to P-selectin and 
probably also to L-selectin, but is not necessary to bind E-selectin (Ramachandran et al., 
1999; Vestweber and Blanks, 1999). As PSGL-1 is also a ligand for L-selectin, and both 
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molecules are found on leukocytes, some investigators have proposed that leukocyte 
recruitment is augmented by L-selectin on flowing leukocytes attaching to already adherent or 
rolling leukocytes expressing PSGL-1. This leukocyte-leukocyte interaction is denoted 
secondary tethering. However, the importance of this phenomenon in vivo remains an area of 
controversy (Kelly et al., 2007; Vestweber and Blanks, 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Selectins and their ligands involved in the first step of leukocyte extravasation. Adapted from 
(Rivera-Nieves et al., 2008). 
The glycoprotein E-selectin ligand-1 (ESL-1) was the first counter receptor for E-selectin to 
be described (Levinovitz et al., 1993). In contrast to the sialomucin-type selectin ligands, 
ESL-1 requires N-linked carbohydrates for binding to E-selectin and only interacts with E-
selectin (Lenter et al., 1994). Unlike PSGL-1 and L-selectin, ESL-1 is not concentrated on the 
tips of microvilli, but rather along the surface of these processes (Ebnet and Vestweber, 
1999). This may suggest that ESL-1 differs in its function from PSGL-1 and L-selectin. While 
the latter two are involved in the initial leukocyte capture, ESL-1 is necessary to convert the 
transient initial tethers into a slower and more stable rolling. In addition, ESL-1 seems to be a 
variant of the tyrosine kinase fibroblast growth factor (FGF) glycoreceptor which could 
convey a receptor function involved in initiating signaling in the bound cells (Steegmaier et 
al., 1995). Recently, CD44 and CD43 have been proposed to be functionally relevant E-
selectin ligands as well (Katayama et al., 2005; Matsumoto et al., 2005). Aside from ESL-1 
and PSGL-1, a third high-affinity ligand for E-selectin is L-selectin itself (Lawrence et al., 
1994).  
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Using antibody-like fusion proteins of L-selectin, heavily glycosylated mucin-like proteins 
have been identified as ligand for L-selectin, including glycosylation-dependent cell adhesion 
molecule-1 (GlyCAM-1), CD34, mucosal vascular addressin cell adhesion molecule-1 
(MAdCAM-1), podocalyxin-like protein, Sgp200, endomucin, and nepmucin. All of them are 
expressed on HEV in lymphatic tissue (Grailer et al., 2009). 
1.2.2.2 The chemokine-induced leukocyte activation 
Selectins initiate, but cannot maintain leukocyte-endothelial interactions with sufficient 
strength to enable transendothelial migration of leukocytes. For complete leukocyte arrest, 
proper activation stimuli are required to transform the shear-sensitive tethering into shear-
resistant firm adhesion to the endothelial surface. Activation with respect to tight adhesion 
includes an increased functional activity of the integrins, spatial redistribution of the integrins, 
and interaction of the cytoplasmic tails of the integrin molecules with cytoskeletal proteins. 
As described above, selectins can be directly involved in the transmission of such activation 
stimuli. However, the primary players in these signal-transducing processes are chemokines 
and their G-protein-coupled receptors (GPCR) on leukocytes. Chemokines are cytokines with 
potent chemotactic activity toward various leukocyte subsets and are generally induced by 
early pro-inflammatory cytokines, including TNF-α, IL-1, or IL-4 (Luster, 1998). The main 
source of chemokines are local tissue cells, infiltrating leukocytes, and, importantly, the 
endothelium itself (Carlos and Harlan, 1994). Chemokines produced within tissues are 
“posted” by ECs through abluminal-to-luminal transcytosis. Chemokines contain binding sites 
for heparan sulfate and glucosaminoglycans (GAG’s), that are abundantly present in the 
glycocalyx, located on the apical surface of ECs. By the immobilization of soluble 
chemokines at the endothelial surface, their appropriate presentation to nearby rolling 
leukocytes could be achieved under flow conditions (Ebnet and Vestweber, 1999; Middleton 
et al., 2002). Chemokines transmit their pro-migratory signals through GPCR located on the 
microvilli of the leukocyte, thereby inducing a wide range of “outside in” signals. This leads 
to integrin activation via “inside-out” signaling, resulting in a greater capacity to adhere to 
their respective ligands (van Buul and Hordijk, 2004). The two major mechanisms regulating 
the adhesive properties of integrins involve changes in their affinity and their avidity. 
Regulation of integrin affinity is mediated by conformational changes in the integrin subunits. 
Regulation of integrin avidity involves spatial redistribution and clustering of integrins on the 
cell surface (Zarbock and Ley, 2008).  
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1.2.2.3 The integrin-mediated firm adhesion  
Following rolling, given the appropriate signals, the low-affinity, selectin-dependent 
interaction is replaced by the high-affinity, integrin-mediated firm adhesion. Integrins are 
fundamental molecules in cell migration as they control both cell-cell and cell-extracellular 
matrix interactions. They comprise a family of 24 heterodimeric receptors, with each integrin 
composed of a non-covalently linked α heavy chain and a β light chain. Integrins have been 
arranged in subfamilies according to the β subunit (Barreiro and Sanchez-Madrid, 2009; 
Mazzone and Ricevuti, 1995). As mentioned above, one of the most important characteristics 
of integrins lies in their ability to dynamically regulate their adherent activity by altering their 
affinity and avidity, regardless of how extensively expressed they are on the membrane 
(Hynes, 2002). The regulation of integrin affinity for their respective ligands is mediated by 
conformational changes induced by separation of the cytoplasmic tails of the integrin α and β-
subunits. This separation is mediated by inside-out integrin signaling (Chavakis et al., 2009). 
Recent observations predict the existence of at least 3 different conformational states: (i) bent 
conformation with low affinity, (ii) extended conformation with intermediate affinity, and (iii) 
extended conformation with high affinity (Beglova et al., 2002; Nishida et al., 2006). 
Circulating leukocytes maintain their integrins in an inactive or low-affinity state to avoid 
nonspecific contact with uninflamed vascular walls. When they arrive at the inflammatory 
focus, the chemokine-induced activation mediates a reversible change of the conformation of 
the integrins from the inactive, bent form to the extended form with intermediate affinity. This 
event prepares the integrin for binding to its endothelial ligand. The integrin undergoes a 
subsequent conformational change after binding to the ligand (outside-in signaling), 
culminating in the complete activation of the integrin (Barreiro and Sanchez-Madrid, 2009). 
This signaling following integrin ligation is transduced through the cytoplasmic tails of the 
integrins and mediates the stabilization of the initial adhesion. This pathway, also designated 
as ligand-induced post-adhesion strengthening, is relevant for sustained adhesion of 
leukocytes onto the vascular endothelium and resistance to shear stress (Ley and Zarbock, 
2006). The main component of integrin avidity regulation is based on the post-ligand binding 
interaction of the integrin with the cytoskeleton. Lateral mobility leads to an accumulation of 
integrins in areas where ligands are available, a process called “clustering”, which regulates 
cell avidity for surface-presented ligands (Chavakis et al., 2009). 
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Figure 1.7: Integrins and their ligands involved in firm leukocyte adhesion. Adapted from (von Andrian and 
Mackay, 2000). 
The most relevant integrins for leukocyte adhesion to the endothelium are members of the β2 
subfamily, particularly lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18 or 
αLβ2), that is expressed on virtually all immune cells, and macrophage-1 antigen (mac-1, 
CD11b/CD18 or αMβ2), predominantly found on myeloid cells. The other important integrin 
needed for adhesion to endothelium is the α4-integrin, which associate with β1-integrin to 
form very late antigen-4 (VLA-4, CD49d/CD29 or α4β1), expressed by most mononuclear 
cells, or with β7-integrin to form α4β7, found primarily on lymphocytes homing to intestinal 
tissues (Elangbam et al., 1997; Mazzone and Ricevuti, 1995). Most of the ligands for 
leukocyte integrins are transmembrane proteins that belong to the immunoglobulin supergene 
family (Figure 1.7). Members of the Ig supergene family share structural and genetic features 
with immunoglobulin molecules, and each contains at least one immunoglobulin domain. 
Four members of this family expressed by ECs are involved in leukocyte firm adhesion: 
Intercellular Adhesion Molecule-1 (ICAM-1, CD54), Intercellular Adhesion Molecule 
(ICAM-2, CD102), vascular cell adhesion molecule-1 (VCAM-1, CD106), and the mucosal 
vascular addressin cell adhesion molecule-1 (MadCAM-1) (Carlos and Harlan, 1994). 
Endothelial ligands for LFA-1 include ICAM-1 and ICAM-2. Both are expressed 
constitutively at low levels, but only ICAM-1 is significantly upregulated following 
inflammatory stimulation. Mac-1 also binds ICAM-1, although this integrin is a fairly 
promiscuous molecule capable of binding fibronectin, fibrinogen, and complement fragments 
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(Diamond et al., 1993). VCAM-1 is the main ligand for VLA-4 and also binds weakly to 
α4β7. VCAM-1 is not constitutively expressed in most tissues, but is upregulated through de 
novo synthesis after cytokine stimulation (Beekhuizen and van Furth, 1993). The α4β7 
integrin, apart from interacting with VCAM-1 and fibronectin, specifically recognizes 
MadCAM-1, which is restricted to ECs of the intestinal mucosa and gut-associated lymphoid 
tissues (GALT) (Berlin et al., 1993; Briskin et al., 1997).  
1.2.2.4 Intraluminal crawling  
After firm adhesion to the endothelium, leukocytes move slowly over the luminal surface 
until they reach an area appropriate for transmigration. This process, designated as crawling 
or locomotion, requires reversible adhesion, rearrangement of the actin cytoskeleton, and 
chemotaxis toward inflammatory stimuli (Schenkel et al., 2004). As described above, the 
binding of integrins to their ligands induces outside-in signaling with a concomitant activation 
of multiple signaling cascades in the leukocytes. This outside-in signaling is translated by the 
leukocyte into cell polarization and forward movement. This movement is generally assumed 
to be driven by the combination of protrusion at the leading edge of the cell and contraction at 
the back, which allows displacement of the cell body (Vicente-Manzanares and Sanchez-
Madrid, 2004). In addition, to move forward, cells have to form new adhesion sites and break-
down old ones, both in the protruding and in the retracting part of the cell. This turnover of 
focal adhesions is very complex and involves the cyclic modulation of receptor affinity of the 
β2-integrins LFA-1 and Mac-1 for their endothelial ligand ICAM-1 (Phillipson et al., 2006). 
1.2.2.5 Transendothelial migration  
In the final stage of extravasation, the leukocyte squeezes (in an amoeboid fashion) between 
the tightly apposed ECs with minimal disruption of the vascular lining. During this process, 
called transendothelial migration or diapedesis, the endothelial cell-to-cell junctions represent 
the major barrier for the passing leukocytes. The main constituent of the specific structures 
that connect ECs are adherens junctions and tight junctions. These endothelial junctions are 
only partially dismantled during transmigration, so that the leukocyte membrane and the 
endothelium remain in close contact and vascular integrity is maintained throughout the 
process. When diapedesis is completed, the endothelial membrane reseals its links instantly 
(Barreiro and Sanchez-Madrid, 2009; Muller, 2003). Different molecules that are 
concentrated at the lateral borders of ECs govern this step in leukocyte migration and are 
depicted in Figure 1.8.  
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Figure 1.8: Cell adhesion molecules at the endothelial-cell borders that govern transendothelial leukocyte 
migration. Adapted from (Strell and Entschladen, 2008). 
En route to perivascular tissues, transmigrating leukocytes encounter the subendothelial 
basement membrane (BM) which is a complex, organized extracellular matrix (ECM) 
comprised of several collagenous and non-collagenous components. Infiltrating leukocytes 
utilize enzymes, known as matrix metalloproteinases (MMPs) to make selective clips in the 
ECM components and to traverse the BM (Madri and Graesser, 2000). The signals that 
regulate expression of MMPs in leukocytes are largely unknown. It is possible that signals 
mediated by the engagement of leukocyte adhesion receptors during the initial stages of 
transendothelial cell migration may lead to secretion or activation of MMPs in the migrating 
cells. Once through the blood vessel wall, the leukocytes encounter chemokines, in 
immobilized or soluble form, in the ECM giving them cues to migrate further into the 
extravascular space (Middleton et al., 2002).  
1.2.3 Regulation and selectivity of leukocyte recruitment 
Leukocyte extravasation is regulated by exquisite mechanisms of selective leukocyte-EC 
recognition, which displays extraordinary specificity in relation to the inflammatory stimulus, 
the stage of the inflammatory response, and the tissue site or organ involved. Examples 
include the almost exclusive infiltration of eosinophils at extravascular sites of allergic 
reactions, the specific temporal pattern in inflammation of early emigration of neutrophils 
versus late accumulation of mononuclear leukocytes, and the tissue-selective interaction of 
lymphocyte subsets with HEVs in organized lymphoid tissues (Carlos and Harlan, 1994). As 
individual adhesion molecules often participate in multiple leukocyte-EC interactions, the 
selective recruitment of leukocyte subtypes cannot be explained by a simple lock-and-key 
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model. More likely, additional levels of control are required to produce selective recruitment 
of blood-borne immune cells in vivo. A model of leukocyte-EC recognition has been proposed 
that provide sufficient combinatorial diversity to allow the fine tuning and selectivity of the 
inflammatory response. There are 3 key components in this model : (1) primary adhesion 
molecules (selectins) and their multiple carbohydrate ligands, (2) a plethora of activating 
factors (cytokines and chemoattractants), and (3) activation-dependent adhesion molecules 
(integrins) and their Ig-like ligands (Butcher, 1991). The differential regulation mechanisms 
for leukocyte-endothelial interactions are listed beneath.  
1. Regulation of leukocyte emigration by differential intravascular shear stress 
Leukocyte adhesion is substantially determined by the shear stress imposed on leukocytes 
by the blood flow. This explains, in part, why leukocyte extravasation occurs mainly 
through post-capillary venules, where shear forces are greatly reduced. The local 
vasodilatation at the onset of inflammation causes a further slowing of blood flow 
contributing to increased leukocyte infiltration (Schleiffenbaum and Fehr, 1996).  
2. Differential expression of adhesion molecules 
a. Maturation-associated changes in leukocyte adhesion molecule expression pattern 
The pattern of adhesion molecule expression changes with maturation of leukocytes. 
Typically, mature cells express lower densities of L-selectin (CD62L), the homing 
receptor for secondary lymphoid organs, and higher densities of LFA-1 (CD11a), the 
molecule associated with trafficking to non-lymphoid reservoir sites (Shephard, 2003). 
b. Differential tissue expression of endothelial adhesion molecules 
The restricted expression of some endothelial adhesion molecules (e.g. GlyCAM-1 and 
MAdCAM-1 on HEV in lymph nodes and in GALT, respectively) favors the recruitment 
of specific leukocyte subclasses that bear the appropriate counter receptors (Grailer et al., 
2009).  
c. Stimulus-specific changes in the pattern of endothelial adhesion molecule expression 
The expression of a specific combination of endothelial adhesion molecules that 
preferentially bind a certain leukocyte subclass, is a possible mechanism to account for 
selective leukocyte recruitment. As the adhesion molecule expression pattern is 
constrained by a certain degree of stimulus-specificity, it is suggested that cytokine-
specific modulation of the transcription and expression of adhesion molecules confer 
leukocyte selectivity (Schleiffenbaum and Fehr, 1996).  
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3. Posttranslational quantitative changes in the expression of adhesion molecules 
a. Cell surface upregulation of adhesion molecules from intracellular stores 
Some adhesion molecules are constitutively synthesized and stored in cytoplasmic 
granules. In response to the right stimulus, this preformed pools of adhesion molecules 
can be rapidly (within minutes) mobilized to the cell surface resulting in increased 
expression independent of de novo mRNA or protein synthesis (Carlos and Harlan, 1994). 
b. Cell surface losses caused by adhesion receptor shedding or internalization 
A number of adhesion processes appear to be regulated by rapid reduction in surface 
expression of adhesion molecules. This downregulation of surface expression can be 
achieved by proteolytic shedding or alternatively by internalization via endocytosis of the 
adhesion molecules (Ebnet and Vestweber, 1999; Tedder et al., 1995).  
4. Inhibition of adhesion molecule-ligand interactions by circulating adhesion molecules 
Shed soluble adhesion molecules in the peripheral blood seem to be still functional and 
may therefore interfere with leukocyte binding to the endothelium (Pigott et al., 1992; 
Schleiffenbaum et al., 1992).  
5. Posttranslational modifications in the glycosylation of adhesion molecules 
Modifications in the glycosylation pattern of some adhesion molecules have been 
implicated to regulate the leukocyte-endothelial interaction. In addition, despite the 
abundant endothelial expression throughout the body of some adhesion molecules, 
leukocyte recruitment is restricted because of site-specific glycosylation patterns 
(Baumhueter et al., 1994; Shimizu and Shaw, 1993). 
6. Activation and deactivation of adhesion molecules (inside-out signaling) 
Instead of the relative levels of cell surface expression, it is proposed that the activation 
state of some adhesion molecules, particularly integrins, is more important. This is the 
place where chemoattractants are believed to play an import role in shaping the cellular 
mix of the inflammatory infiltrate. Because chemoattractants display some degree of 
cellular specificity, adhesion molecule activation may be another major tool of the 
immune system for directing leukocyte traffic in an orderly fashion. A further degree of 
complexity is added by the fact that cytokines and chemoattractants as well as their 
respective receptors and antagonists are also differentially regulated (Carlos and Harlan, 
1994; Schleiffenbaum and Fehr, 1996).  
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7. Cellular activation through adhesion molecules (outside-in signaling) 
Because cells must detach during directional migration, other events, such as regulation of 
function and redistribution of adhesion molecules on the cell surface, also occur as a result 
of leukocyte binding (Bochner, 2000).  
Table 1.2 summarizes the regulation mechanisms of the different cell adhesion molecules. 
The regulation involves both quantitative changes in expression and qualitative changes in 
avidity. For the endothelial adhesion molecules quantitative alterations in surface expression 
predominate. In contrast, leukocyte adhesion molecules are regulated primarily by qualitative 
changes in receptor avidity (Carlos and Harlan, 1994).  
Table 1.2: Differential regulation of cell adhesion molecules involved in leukocyte-endothelial interactions. 
Adapted from (Schleiffenbaum and Fehr, 1996).  
Adhesion molecule Regulatory principles 
  
Selectins 
 P-selectin (CD62-P) Upregulation from granules, de novo synthesis,  
 
internalization 
E-selectin (CD62-E) De novo synthesis, internalization, shedding 
L-selectin (CD62-L) Constitutive expression, activation, shedding, inhibitor 
  
Integrins 
 LFA-1 (CD11a/CD18) Constitutive expression, activation 
Mac-1 (CD11b/CD18) Activation, upregulation from granules 
VLA-4 (CD49d/CD29) Constitutive expression, activation 
  
Immunoglobulin supergene family 
 ICAM-1 (CD54) Constitutive expression, de novo synthesis,  
 
shedding, glycosylation ? 
ICAM-2 (CD102) Constitutive expression 
VCAM-1 (CD106) De novo synthesis, shedding 
PECAM-1 (CD31) Constitutive expression 
  
Sialomucins 
 PSGL-1 Glycosylation ? 
GlyCAM-1 Tissue specific, constitutive expression, shedding,  
 
glycosylation ? 
MAdCAM-1 Tissue specific, constitutive expression, glycosylation ? 
CD34 Glycosylation ? 
   
Regulation of adhesion molecule expression during differentiation/maturation or in response to long-term 
stimulation is not included.  
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1.2.4 Role of adhesion molecules in inflammatory and autoimmune 
 disorders 
An effective host response to infection or tissue damage requires local accumulation of 
leukocytes. Leukocyte adhesion to the vessel wall, a key step in this process, is a highly 
regulated process with a limited number of decision points along every step of the adhesion 
cascade. Expression of specific combinations of adhesion molecules on leukocyte 
subpopulations determines their capacity to reach specific tissues where cognate endothelial 
ligands show restricted expression. This results in an orderly recruitment that begins and 
terminates physiological inflammatory responses. Although inflammation can occur with 
minimal damage to the vessel wall and surrounding tissues, control mechanisms sometimes 
appear to fail and the inflammatory response itself becomes a significant clinical problem. 
Under these conditions, continuous dysregulated production of pro-inflammatory cytokines 
results in inappropriately increased adhesion molecules expression, which subsequently 
favors adhesiveness over tissue specificity, resulting in failure of termination of the 
inflammatory response and perpetuation of dysregulated leukocyte recruitment. Therefore, 
chronic inflammation can result in substantial tissue damage or initiate processes leading to 
excessive fibrous repair. A substantial number of studies demonstrate that adhesion molecule 
expression is induced or upregulated on either peripheral blood leukocytes or infiltrating 
leukocytes and endothelium in areas of vascular inflammation in a wide variety of 
inflammatory diseases in human (Bevilacqua et al., 1994; Rivera-Nieves et al., 2008). Table 
1.3 presents a brief overview of the elevated expression of endothelial adhesion molecules 
and the corresponding infiltrating leukocyte subtypes in several human disorders in which 
leukocyte extravasation is an integral part of the immunopathology.  
 
 
 
 
 
 
 
 
 
 
Chapter 1 
 
32 
 
Table 1.3: Adhesion molecules in human inflammatory and autoimmune diseases (Bevilacqua et al., 1994).  
Inflammatory Disease Adhesion molecule(s) Leukocyte infiltrate 
Atherosclerosis E-selectin, ICAM-1, VCAM-1 T-cell, monocyte 
Ischemia and reperfusion injury P-selectin, E-selectin, ICAM-1 Neutrophil 
Acute respiratory distress 
syndrome 
P-selectin, E-selectin, ICAM-1 Neutrophil 
Asthma E-selectin, ICAM-1, VCAM-1 Eosinophil, T cell, monocyte, 
basophil 
Glomerulonephritis ICAM-1, VCAM-1 Monocyte, T cell, neutrophil 
Inflammatory bowel disease E-selectin, ICAM-1, VCAM-1 Monocyte, neutrophil, T cell, 
eosinophil 
Rheumatoid arthritis E-selectin, ICAM-1, VCAM-1 Monocyte, neutrophil 
Diabetes mellitis type II E-selectin, ICAM-1 Monocyte, neutrophil 
Psoriasis E-selectin, ICAM-1 T-cell, neutrophil 
Multiple sclerosis ICAM-1, VCAM-1 T-cell, monocyte 
Graft rejection E-selectin, ICAM-1, VCAM-1 T-cell 
Graft versus host disease E-selectin, ICAM-1, VCAM-1 T-cell, monocyte, neutrophil 
 
1.2.5 Anti-adhesion therapy 
Because of the importance of detrimental inflammatory responses in numerous diseases in 
humans and animals, anti-inflammatory agents like corticosteroids and non-steroidal anti-
inflammatory drugs are extensively used. However, anti-inflammatory drugs often have 
limited efficacy and severe side-effects. In search for more selective but still potent blockers 
of the inflammatory response, direct inhibition of leukocyte adhesion to the endothelial lining 
and recruitment to extravascular tissue has attracted increasing interest. The step-by-step 
paradigm of leukocyte recruitment implies that blockade of any of the involved steps should 
interrupt the extravasation process and prevent leukocyte trafficking. Accordingly, 
pharmacological interference with the function of adhesion molecules, the key molecules 
involved in leukocyte recruitment, presents promising strategies for therapeutic intervention 
in inflammatory disorders. Table 1.4 gives an overview of anti-adhesion therapies in 
preclinical and clinical phases that strive to break the path of the multistep recruitment 
cascade (Lefer, 2000; Rivera-Nieves et al., 2008; Simmons, 2005; Szekanecz and Koch, 2004; 
Ulbrich et al., 2003). 
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Table 1.4: Anti-adhesion therapies (Simmons, 2005; Szekanecz and Koch, 2004). 
Target structure Tool Mechanism 
   
Selectins and ligands 
 Selectins Soluble sLex-mimetics Competive glycomimetic Pan-selectin inhibitor  
Selectins Soluble analog of PSGL-1 Competive glycomimetic Pan-selectin inhibitor  
Selectins Heparin oligosaccharrides L- and P-selectin antagonist 
P-selectin Neutralizing mAb against CD62-P P-selectin antagonist 
E-selectin Neutralizing mAb against CD62-E E-selectin antagonist 
L-selectin Neutralizing mAb against CD62-L L-selectin antagonist 
Selectin ligands Inhibitor of α-1-3-FT Glycosylation modifier :  
  
inhibtion of the generation of sLex 
Selectin ligands 
Structural derivates of 
Galβ1,3GlcNAc  Competitive, glycometabolic inhibitor:  
 
or Galβ1,4GlcNAc decoys that compete as substrate for FT  
PSGL-1 Neutralizing mAb against PSGL-1 PSGL-1 antagonist 
   
Integrins 
  β2 integrins Neutralizing mAb against CD18 β2 integrins antagonist 
αL integrin Neutralizing mAb against CD11a αL integrin antagonist 
α4 integrins Neutralizing mAb against CD49d α4 integrins antagonist 
VLA-4 Peptide derivate that contains the  ligand-mimetic competitive  
 
 binding sequences in VCAM-1 α4β1 integrin antagonist 
α4 integrins Small peptide that binds α4 integrins Allosteric α4 integrin antagonist 
LFA-1 Small peptide that binds LFA-1 Allosteric αLβ2 integrin antagonist 
   
Ig supergene family 
  ICAM-1 Antisense oligodeoxynucleotide ICAM-1 anatgonist 
ICAM-1 Neutralizing mAb against CD54 ICAM-1 anatgonist 
PECAM-1 Neutralizing mAb against CD31 PECAM-1 antagonist 
   
Chemokines 
  MCP-1 peptide chemokine antagonist 
Groα peptide chemokine antagonist 
   
Chemokine receptors 
 CXCR3, CCR5 Small peptide Inhibition of chemokine induced  
  
integrin activation 
CCR5 Vaccinia viral vector Adenoviral-mediated delivery of a viral  
  
 protein that blocks CC-chemokines 
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2 
Aims 
Feline infectious peritonitis (FIP) is an important disease of domestic and wild felids, 
triggered by infection with the virulent variant of feline coronaviruses (FCoVs), feline 
infectious peritonitis virus (FIPV). With mortality approaching 100%, FIP accounts for the 
majority of infectious disease-related deaths in young cats. At present, there is no effective 
way to prevent the infection or treat the disease and no diagnostic protocol exists that can 
discriminate avirulent from virulent FCoV strains. Furthermore, despite many attempts of the 
scientific community to explain the pathogenesis, FIP remains an enigmatic disease. 
The pathology of FIP is characterized by multifocal granulomatous vascular lesions in several 
vital organs, often with accumulation of exudates in body cavities. Morphologically, the 
vasculitis manifests as venous and perivenous macrophage-dominated circular leukocyte 
infiltrates. Although it is now widely accepted that exaggerated leukocyte extravasation elicit 
the inflammation typically associated with FIP lesions, relatively few studies have been aimed 
at elucidating this key pathogenic event. Therefore, the general goal of this doctoral research 
was to establish a better understanding of the leukocyte interaction with vascular endothelial 
cells (ECs) during the course of FIPV infection. More insights in this process are not only 
essential to further resolve the FIP pathogenesis, but provide valuable information that could 
assist in the development of more accurate diagnostic methods and could promote the design 
of novel therapeutic tools. 
A prerequisite for circulating leukocytes to cross the endothelium and gain access to the 
surrounding tissue is the adhesion of these cells to vascular endothelial cells. This involves the 
stepwise interaction between adhesion molecules on the surface of leukocytes and their 
corresponding receptors on the luminal surface of the endothelium. Given the large number of 
leukocytes in FIP lesions, we hypothesized that FIPV infection could alter the expression of 
adhesion molecules on leukocytes and endothelial cells (ECs). This might favor leukocyte-
Aims 
 
48 
 
endothelial adherence and subsequent migration, thereby inducing endothelial cell damage 
and contributing to the pathogenesis of FIP. Despite their critical role in the pathological 
outcome of FIP, the expression of adhesion molecules and their endothelial ligands during 
FIPV infections remains largely undescribed. Hence, the first purpose of this doctoral 
research was to analyze the activation status of peripheral blood leukocytes from FIP patients 
(Chapter 3.1) and to describe the vascular FIP lesions regarding the expression of the 
endothelial ligands (Chapter 3.2).  
In the second part, we aimed to unravel the pathogenic mechanism underlying the endothelial 
activation in FIP lesions. For this purpose, we first needed to set up a representative in vitro 
model of feline venous ECs (Chapter 4.1). As monocytes are the target cells of FIPV 
replication, we finally examined in this novel EC line if FIPV can provoke EC activation by 
an indirect route, in which inflammatory factors released from virus-infected monocytes act as 
key intermediates (Chapter 4.2).  
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3 
Expression of leukocyte-endothelial 
adhesion molecules in FIP 
 
Summary  
This chapter bundles the research results, addressing the first aim of the thesis; assessment of 
the expression and distribution of leukocyte adhesion molecules and their counter receptors, 
the endothelial adhesion molecules, during FIPV infection. Chapter 3.1
1
 presents the results of 
a comparative analysis on the quantitative expression of adhesion molecules on the main 
peripheral leukocyte population between healthy controls and FIP cats. In chapter 3.2
2
 it was 
determined wheter endothelial cells in FIP patients are activated to increase their adhesiveness 
to leukocytes, as reflected by elevated surface expression of endothelial adhesion molecules.  
 
 
 
 
 
1
 Adapted from: Olyslaegers, D.A., Dedeurwaerder, A., Desmarets, L.M., Vermeulen, B.L., Dewerchin, H.L., 
Nauwynck, H.J., 2013. Altered expression of adhesion molecules on peripheral blood leukocytes in feline 
infectious peritonitis. Veterinary microbiology 166(3-4):438-49  
2
 Adapted from: Olyslaegers, D.A., Dedeurwaerder, A., Desmarets, L.M., Dewerchin, H.L., Nauwynck H.J., 
2014. Local upregulation of endothelial cell adhesion molecules characterizes the granulomatous lesions in 
feline infectious peritonitis. Submitted to Veterinary microbiology. 
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3.1 Altered expression of adhesion molecules on peripheral blood 
leukocytes in feline infectious peritonitis 
3.1.1  Summary 
Feline infectious peritonitis (FIP) is a fatal, coronavirus-induced systemic disease in domestic 
and wild felids. The pathology associated with FIP (multifocal granulomatous vasculitis) is 
considered to be elicited by exaggerated activation and subsequent extravasation of 
leukocytes. As changes in the expression of adhesion molecules on circulating leukocytes 
precede their margination and emigration, we reasoned that the expression of leukocyte 
adhesion molecules may be altered in FIP. In the present study, the expression of principal 
adhesion molecules involved in leukocyte transmigration (CD15s, CD11a, CD11b, CD18, 
CD49d and CD54) on peripheral blood leukocytes from cats with naturally occurring FIP 
(n=15) and controls (n=12) was quantified by flow cytometry using a formaldehyde-based 
rapid leukocyte preparation technique. T- and B-lymphocytes from FIP patients exhibit higher 
expression of both subunits (CD11a and CD18) composing the β2 integrin lymphocyte 
function-associated antigen (LFA)-1. In addition, the expression of the α4 subunit (CD49d) of 
the β1 integrin very late antigen (VLA)-4 was elevated on B-lymphocytes from FIP patients. 
The expression of CD11b and CD18, that combine to form the β2 integrin macrophage-1 
antigen (Mac-1), was elevated on monocytes, whereas the density of CD49d was reduced on 
this population in FIP. Granulocytes of FIP cats displayed an increased expression of the α 
chain of Mac-1 (CD11b). These observations suggest that leukocytes from FIP patients show 
signs of systemic activation causing them to extravasate into surrounding tissues and 
ultimately contribute to pyogranuloma formation seen in FIP.  
3.1.2 Introduction 
Feline infectious peritonitis, first described in 1963, is a highly fatal, progressive, and 
immunopathological disease of domestic and wild Felidae (Holzworth, 1963). FIP occurs 
worldwide and is currently one of the leading infectious causes of death in cats. The causative 
agent of FIP, feline coronavirus (FCoV), is ubiquitous in virtually all cat populations, with 
seropositivity of up to 90% depending on environment and geographical area. From the 
seropostive cats, 5 to 12% eventually develop FIP (Addie and Jarrett, 1992). FCoV is an 
enveloped, single-stranded, positive-sense RNA virus belonging to the family Coronaviridae 
within the order of the Nidovirales (Gorbalenya et al., 2006). FCoVs are classified into two 
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serotypes (I and II) according to the amino acid sequence of the spike protein (Herrewegh et 
al., 1998). In addition, each serotype can be further divided into two distinctly different 
pathotypes, based on their pathogenicity in cats. The most common pathotype in the field, 
feline enteric coronavirus (FECV), causes a mild, often unapparent enteric infection. In sharp 
contrast, infection with the virulent pathotype, designated feline infectious peritonitis virus 
(FIPV), manifests as a devastating, highly lethal systemic disease called FIP (Pedersen, 1987). 
FIP is characterized by fibrinous to granulomatous serositis, often with protein-rich effusions 
in body cavities, and (pyo)granulomatous inflammatory lesions in various organs (Weiss and 
Scott, 1981a, b). In the heterogeneous and sometimes confusing histopathological picture of 
FIP one distinct feature stands out: the multifocal granulomatous vasculitis, restricted to small 
and medium-sized veins. Morphologically, the vasculitis is typified by a venous and 
perivenous circular cell infiltrate dominated by monocytes/macrophages intermingled with a 
few neutrophils and lymphocytes (Kipar et al., 1998). The vasculitis has previously been 
regarded to be induced by a type III hypersensitivity reaction, involving the deposition of 
immune complexes within venules leading to complement activation (Jacobse-Geels et 
al.,1982; Pedersen and Boyle, 1980). However, Kipar and co-workers demonstrated that the 
morphology, cellular composition, and distribution of the vascular lesions in FIP differs 
significantly from immune-complex-mediated vascular inflammatory processes. Furthermore, 
the demonstration of FCoV antigen within intravascular leukocytes and among cells in the 
FIP granulomas indicates that the phlebitis is initiated by activated and FCoV-infected 
circulating monocytes. Excessive numbers of activated monocytes will emigrate out of the 
blood circulation and accumulate perivenously. The exaggerated extravasation is associated 
with an enhanced local release of matrix metalloproteinases B (MMP 9) leading to endothelial 
barrier dysfunction (Kipar et al., 2005). Considering the importance of leukocyte 
extravasation in the pathogenesis of FIP, comparatively few studies have been aimed at 
investigating this key pathogenic event. A crucial step in the process of leukocyte recruitment 
into the parenchyma is the adherence of circulating leukocytes to vascular endothelial cells 
(EC), which is facilitated by adhesion molecules expressed on the surface of participating 
cells. Based on their biochemical properties and molecular structure, these adhesion 
molecules have been grouped into three gene families: the selectins, the integrins, and the 
immunoglobulin (Ig) supergene family (Carlos and Harlan, 1994). The initial adhesive 
interaction involves the participation of endothelial selectins that bind with sialyl lewis X 
(sLex, CD15s) carbohydrate moieties, which can be found on the terminal domains of 
glycoproteins expressed on the leukocyte surface. Because of its relative low affinity nature, 
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this binding results under hydrodynamic shear flow in leukocyte rolling along the vessel wall. 
The transiently bound leukocytes are subsequently activated on encountering immobilized 
chemokines at the endothelial surface. This activation step enables the strengthening of the 
adhesive forces and leukocytes become firmly attached to the endothelium. This firm 
adhesion is achieved by the interplay between integrins and Ig supergene family receptors 
(Ebnet and Vestweber, 1999). The integrins are heterodimer glycoproteins consisting of two 
non-covalently associated dissimilar proteins designated α and ß chain. The integrins are 
divided into different groups dependent on the common ß chain. The ß2 (CD18) subunit 
combines with αL (CD11a) subunit to build lymphocyte function-associated antigen (LFA)-1 
or with αM (CD11b) to form macrophage-1 antigen (Mac-1). They are responsible for 
interactions with intercellular adhesion molecule (ICAM)-1 (CD54), present constitutively on 
EC and markedly induced during inflammation. The ß1 integrins named very late antigen 
(VLA) share a common ß1 (CD29) chain that can be linked with a number of α chains. The 
VLA-4 receptor contains α4 subunit (CD49d) and is one of the ß1 integrins responsible for 
leukocyte extravasation due to its interaction with vascular cell adhesion molecule (VCAM)-1 
present on activated endothelium. Both ICAM-1 and VCAM-1 belong to the Ig supergene 
family and are built of several immunoglobulin domains (Barreiro and Sanchez-Madrid, 
2009; Carlos and Harlan, 1994).   
Given the large number of leukocytes in FIP lesions, we hypothesized that FIPV infection 
could alter the expression of adhesion molecules on leukocytes. This might favor leukocyte-
endothelial adherence and subsequent migration, thereby inducing endothelial cell damage 
and contributing to the pathogenesis of FIP. Despite their critical role in the pathological 
outcome, the expression of adhesion molecules on peripheral leukocytes during FIPV 
infection remains mainly undescribed. Identification of adhesion molecules with altered 
expression in FIP will not only provide invaluable insights to further elucidate the 
pathogenesis but this essential data can also assist in the development of more accurate 
diagnostic methods.  
Therefore, the aim of  the present study was to quantify the expression of adhesion molecules 
on the main peripheral leukocyte populations in FIP patients and healthy controls by flow 
cytometry using the formaldehyde-based rapid leukocyte preparation technique (Hamblin et 
al., 1992). With a panel of thoroughly validated monoclonal antibodies, the main adhesion 
molecules associated with leukocyte transendothelial migration were studied: CD15s, CD11a, 
CD11b, CD18, CD49d and CD54.  
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3.1.3 Material and methods 
3.1.3.1  Patients and controls 
Fifteen cats, naturally infected with FCoV and clinically strongly suspected of FIP  (based on 
cat profile, clinical signs and blood and/or exudate examination) were included in this study. 
The characteristics and pathological findings of these cats are listed in Table 3.1.1. In all 
cases, the presumptive diagnosis of FIP was confirmed by post-mortem examinations that 
comprised necroscopy, histology and immunohistochemistry for FCoV-antigens. Patients 
were not receiving corticosteroids or other immunosuppressive therapy. Serology for feline 
immunodeficiency virus (FIV) and for feline leukaemia virus (FeLV) was performed using a 
commercially available ELISA kit (Witness® FeLV-FIV, Synbiotics Corporation, San Diego, 
CA, USA) according to the procedure advised by the manufacturer. All cats were confirmed 
not to be infected with FIV and FeLV.  
Table 3.1.1: Characteristics and pathological findings of the FIP cats enclosed in this study.  
 
M = male; F = female; mo = month; y = year; M = mesentery; I = intestines; Li = liver; S = spleen; U = urinary 
bladder; K = kidney; P = pleura; Pe = peritoneum; Lu = lungs; D = diaphragm; St = stomac 
- exudate not present 
a
 immunoperoxidase monolayer assay (IPMA) antibody titer 
 
 Breed Sex Age FCoV antibody titer
a 
Clinical Lesions 
    Serum Exudate form  
1 Scottisch fold M 5 mo ≥ 12800 6400 effusive M, I 
2 Domestic shorthair F 3 mo 3200 1600 effusive I, Li, S, U 
3 Domestic shorthair F 2 y ≥ 12800 ≥ 12800 effusive I 
4 Burmese M 2.5 mo ≥ 12800 - non-effusive I, K, P 
5 British shorthair M 6 y ≥ 12800 ≥ 12800 effusive M, I, U 
6 Domestic shorthair F 6 mo ≥ 12800 ≥ 12800 effusive M, I 
7 Domestic shorthair M 4 mo 1600 1600 effusive M, I 
8 British shorthair F 8 mo ≥ 12800 ≥ 12800 effusive I, K, Pe 
9 British shorthair M 6 mo ≥ 12800 ≥ 12800 effusive M, I 
10 Norwegian forest cat M 3 y ≥ 12800 ≥ 12800 effusive M, I, K, U, Lu, P 
11 Domestic shorthair F 1 y 6400 3200 effusive I, Pe, D 
12 Sacred birman M 1 y ≥ 12800 - non-effusive K, Li, Lu 
13 Domestic shorthair M 5 mo ≥ 12800 ≥ 12800 effusive I, S, M, Li, St 
14 Domestic shorthair M 2 y ≥ 12800 ≥ 12800 effusive Lu, S, Li, U, D, K, I 
15 Domestic shorthair F 6 mo 6400 6400 effusive S, I, M, Li, D 
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A control group of twelve specific pathogen free (SPF) cats of a non-specific breed (age 
between 1 and 3 years) were permanently kept at the animal facility of the faculty of 
veterinary medicine of Ghent University. At the time of sampling, these cats were clinically 
healthy and did not show any hematological or biochemical abnormalities attributed to FIP or 
any other infectious disease. Because client-owned FIP cats were used on the basis of 
availability, and SPF cats, currently present in the animal facility, were enclosed as controls, it 
was not possible to match controls one-to-one to cases based on age or other factors.  
The study and its methodology were approved by the ethical committee of the Faculty of 
Veterinary Medicine, Ghent University (application EC2012/043) and informed consent was 
obtained from the owners of all patients. 
3.1.3.2 Preparation of leukocytes 
Peripheral blood leukocytes from patients and controls were prepared for labeling and flow 
cytometry by the formaldehyde-based rapid leukocyte preparation technique. Peripheral blood 
(10 ml) was sampled from the external jugular vein into heparin (Leo, Zaventem, Belgium) at 
a final concentration of 10 U/ml. The fresh blood was mixed, within 5 min, with an equal 
volume of prewarmed (37°C) 0.4% paraformaldehyde (PF) in phosphate buffered saline 
(PBS) and incubated for 4 min at 37°C. An excess (20ml) of warmed (37°C) lysing buffer pH 
7.4 (0.83% ammonium chloride/0.01 M Tris) was then added and incubated at 37°C until the 
erythrocytes were lysed (5 min). Cells were sedimented by centrifugation at 200 x g for 5 min 
at room temperature and the supernatant was discarded. The leukocyte-rich pellet was washed 
twice with PBS and finally the leukocytes were resuspended in 2ml PBS, and stored at 4°C 
until labeling the next day. 
3.1.3.3 Cell labeling 
To prevent non-specific binding, 2.5x10
7
 leukocytes were first pre-incubated with PBS 
containing 1% bovine serum albumin (BSA) (Sigma-Aldrich GmbH, Steinheim, Germany) 
and 10% normal goat serum (NGS) for 30 min at 37°C. Thereafter, cells were washed with 
PBS and incubated with saturating amounts of monoclonal antibodies (mAbs) against the 
different adhesion molecules (CD15s, CD11a, CD11b, CD18, CD49d, or  CD54; Table 3.1.2) 
in separate tubes for 1h at 37°C. After a washing step, Alexa fluor 647-conjugated goat anti-
mouse IgG1 or IgM Abs (Molecular Probes, Eugene, Oregon, USA) were added and 
incubation was carried out for 1 h at 37°C. Next, the residual free binding sites of the 
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secondary Abs were saturated by adding an excess of non-specific subclass matched Abs 
raised in the same species as the primary Abs against the adhesion molecules (mouse IgG1 or 
IgM) for 30 min at 37°C. In the second stage of the staining procedure, the samples were 
divided over three additional tubes to define the different leukocyte subsets within each 
adhesion molecule. T-cells were identified by anti-CD3 mAbs (Nishimura et al., 2004), 
visualized with the fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG3 Abs 
(Molecular probes). Anti-CD21 mAbs prelabeled with Alexa fluor 488-conjugated Fab 
fragments (Zenon mouse IgG1, labeling kit, Invitrogen, Carlsbad, USA) was used as marker 
for B-cells. A double staining with anti-CD13 and anti-granulocytes (VMRD Inc., Pullman, 
WA, USA), preconjugated with Zenon Alexa Fluor 488 or R-phycoerythrin (PE) Mouse IgG1 
labeling kits (Invitrogen) respectively, was performed to distinguish the monocytes (only 
CD13 positive) and the granulocytes (double positive). Isotype controls for each antibody, 
prepared with subclass matched irrelevant mAbs, were run in parallel to identify non-specific 
background fluorescence. The mAbs with human or dog as target species either reacted with 
cat according to the manufacturer (CD11b, CD18 and CD21) or had previously been shown to 
cross-react with feline leukocytes (CD11a and CD49d) (Kaname et al., 2002). For mAbs 
raised against human antigens with unknown feline cross-reactivity (CD15s and CD54), the 
tissue distribution and fluorescence patterns of the antigens recognized by these mAbs were 
determined in the cat and were almost identical to those of humans indicating that the mAbs 
recognized the cat homologues of the human antigens. The optimal dilution of each Ab was 
determined prior to experiments and the same batches of Ab were used throughout the study. 
For details on antibodies see Table 3.1.2. Labeled leukocytes were resuspended in 500µl of 
1% PF in PBS and left overnight in the dark at 4°C before flow cytometric analysis. 
3.1.3.4 Flow cytometry 
Flow cytometry was performed using a FACSCanto flow cytometer equipped with 
FACSDiva software (BD Biosciences, Mountain View, California, USA). The instrument was 
calibrated before each experiment with the same lot of fluorescence reference beads (rainbow 
calibration particles (8 peaks), BD Biosciences) to ensure that relative fluorescence values 
were comparable between runs. For each sample, a minimum of 10.000 events was acquired 
within the leukocyte gate. Forward and side scatter (FSC and SSC) were collected on a linear 
scale, while fluorescence was measured using a five decade logarithmic scale. Gates were set 
to isolate singlet events from debris and aggregates. Next, leukocyte subpopulations were 
carefully delineated according to their light scatter characteristics and cell marker expression 
Chapter 3.1 
56 
 
(Fig. 2). The mean fluorescence intensity (MFI) in arbitrary units (linear conversion of log10 
fluorescence) was used as a relative indicator of the surface density of each adhesion 
molecule on the respective leukocyte population. These values were corrected by subtracting 
control fluorescence of the same subpopulation in which primary mAbs were substituted by 
irrelevant isotype matched mAbs. For unimodally distributed markers, results were expressed 
as MFI of the whole leukocyte subpopulation. For bimodally distributed markers, the results 
were described in two ways: the proportion (%) of brightly positive cells within each 
subpopulation, and next the MFI of the brightly (+) subset. The spectral overlap of Alexa 
Fluor 488- and PE-labeled antibodies was corrected using electronic compensation. To 
examine whether differences in expression were attributed to differences in cell size the FSC 
measurements on the different cell populations of the patients were compared with those of 
the controls.  
Table 3.1.2: Monoclonal antibodies used for surface molecule labeling. 
Antibody Ligand Comments Target 
species 
Isotype Source 
CSLEX1 CD15s Specific for the α2-3 sialosylated form 
of lacto-N-fucopentaose III 
Human IgM,κ BD Biosciencesa 
25.3 CD11a Recognizes structural epitope on αL-
chain of LFA-1 
Human IgG1 Beckman Coulter
b
 
CA16.3E10 CD11b Recognizes structural epitope on αM-
chain of Mac-1 
Dog IgG1 Serotec
c
 
CA1.4E9 CD18 Recognizes structural epitope on 
common β2-chain of integrins 
Dog IgG1 Serotec 
HP2/1 CD49d Recognizes structural epitope on α4 
chain of VLA-4 
Human IgG1 Serotec 
RR1/1 CD54 Recognizes ICAM-1 Human IgG1 Santa Cruz  
Biotechnology, Inc.
d
 
NZM1 CD3 Recognizes the epsilon chain of feline 
CD3  
Cat IgG1 Y. Nishimura
e
 
CA2.1D6 CD21 Recognizes complement receptor 2 
expressed by B-cells 
Dog IgG1 Serotec 
25-2B CD13 Recognizes aminopeptidase N present 
on cells of the myeloid lineage 
Cat IgG1 VMRD
f
 
CL35A undetermined Granulocyt marker Cat IgG1 VMRD 
  
a 
BD Biosciences, CA, USA. 
d 
Santa Cruz Biotechnology Inc., CA, USA. 
b 
Beckman Coulter, Roissy, France.
  e 
Yorihiro Nishimura, University of Tokyo, Japan. 
c 
Serotec, Oxford, UK. 
f 
VMRD, Pulman, USA. 
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3.1.3.5 Statistic analysis 
The results were summarized and analyzed using non-parametric methods, since the 
distribution of data was non-Gaussian. The receptor density, expressed as MFI, was presented 
as median value, 25
th
 to 75
th
 percentile, and range. The significance of differences between 
FIP patients and controls was calculated with the Mann-Whitney U-test (two-tailed). 
Correlations were calculated using Spearman’s rank test. P values equal or lower than 0.05 
were considered to be statistically significant. All statistical analyses were performed using 
SPSS 19.0 (SPSS Inc., Chicago, IL, USA). 
3.1.4 Results 
3.1.4.1 Leukocyte preparation technique and flow cytometric analysis 
Peripheral blood leukocytes from patients and controls were prepared for antibody labeling 
and flow cytometry by the formaldehyde-based leukocyte preparation technique. 
Representative light scattergrams of peripheral blood leukocytes from healthy subjects and 
FIP cats obtained with this technique are shown (Figure 3.1.1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.1: Light scattergrams of peripheral blood leukocytes. Peripheral blood leukocytes from controls (A) 
and FIP patients (B) were prepared for flow cytometry by the formaldehyde-based rapid leukocyte preparation 
technique. The FSC/SSC profiles acquired with this technique differ considerably between the two groups. 
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Striking differences in FSC/SSC profiles of leukocytes from healthy and FIP cats were noted. 
The technique applied on blood of healthy subjects permitted to clearly define lymphocytes, 
monocytes and granulocytes based on their intrinsic forward and sideward light scattering 
characteristics. In contrast, these main leukocyte populations could not be identified simply 
by their FSC and SSC properties in FIP samples because of a considerable overlap between 
granulocytes and monocytes.  Furthermore, a substantial diminution of the lymphocyte count 
in FIP cats made it difficult to separate this population from cell debris.  
Since gating of leukocyte populations based on physical characteristics could not be applied 
on FIP samples and to discriminate between B- and T-lymphocytes within the lymphocyte 
gate, specific cell markers were used to identify the different subpopulations in leukocytes 
from controls and patients. One colour staining with anti-CD3 (T-lymphocytes) and anti-
CD21 (B-lymphocytes) plotted against SSC and two colour dot plots with anti-CD13 and 
anti-granulocytes (monocytes and granulocytes) are shown in Figure 3.1.2.  
Finally, it was ascertained that the leukocyte preparation technique only rendered surface 
antigens and not intracellular antigens accessible for antibodies. The processing did not 
permeabilise leukocyte membranes, as evidenced by our failure to stain cells with antibodies 
to the cytoplasmic antigen vimentin (data not shown).  
 
 
 
 
 
 
 
 
Figure 3.1.2: Identification of the leukocyte subpopulations. T-lymphocytes (A), B-lymphocytes (B), monocytes 
(C) and granulocytes (D) were carefully gated according to their intrinsic light scatter characteristics and 
expression of specific cell markers. Dot plots from peripheral blood leukocytes from healthy controls. 
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3.1.4.2 Expression patterns of adhesion molecules 
The following distribution patterns of adhesion molecules were observed in healthy cats as 
well as in FIP cats by histogram analysis: Within the CD21
+
 leukocyte subpopulation (B-
cells), each adhesion molecule showed a unimodal fluorescence distribution, indicating that 
adhesion molecules were expressed by all (CD11a, CD18 and CD49d) or none (CD15s, 
CD11b and CD54) of the B-lymphocytes. On T-lymphocytes the same distribution of 
adhesion molecules was seen as on B-lymphocytes, except the VLA-4 expression (CD49d) on 
T-lymphocytes was characterized by a clear bimodal distribution containing a negative and a 
positive subset. The expression profiles of adhesion molecules on granulocytes and 
monocytes were similar to each other. The entire granulocyte and monocyte population was 
brightly positive for CD11a, CD11b and CD18 and dimly positive for CD54, presenting as a 
unimodal distribution of fluorescence intensities. By contrast, the histogram of CD15s on both 
populations showed a bimodal distribution. CD49d expression on both monocytes and 
granulocytes revealed a unimodal peak. However, monocytes expressed a moderate to high 
level of this molecule, whereas granulocytes expressed only little surface VLA-4. 
Representative histograms of adhesion molecules with a unimodal or bimodal expression 
pattern are shown in Figure 3.1.3. 
 
 
 
 
 
 
Figure 3.1.3: Expression patterns of adhesion molecules. Representative histograms of adhesion molecules on 
leukocytes from healthy controls plotting logarithm of fluorescence intensity per cell against cell number results 
in either unimodal (A and B) or bimodal distribution (C and D) patterns. On B-lymphocytes, CD11a (A) and 
CD11b (B) expression, display a unimodal fluorescence distribution, but CD11a is expressed by all the cells 
whereas CD11b expression is absent on the entire population. CD49d (C) and CD15s (D) are only expressed by 
a proportion of the T-lymphocyte and granulocyte population, respectively, and histograms demonstrate a typical 
bimodal fluorescence distribution. Open histograms illustrate the binding of the irrelevant, isotype-matched 
mAbs. Full histograms represent the binding of the relevant mAbs.  
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3.1.4.3 Expression level and distribution of adhesion molecules in FIP compared with 
 controls 
The surface expression of adhesion molecules was compared between FIP cats (n=15) and 
healthy controls (n=12) using the logarithmic MFI parameter of the entire leukocyte 
subpopulation (unimodally distributed molecules) or of only the brightly positive subset 
(bimodally distributed molecules). In addition, the proportion of brightly positive cells within 
each subpopulation was compared between patients and controls for adhesion molecules with 
a bimodal distribution.  
sLex expression   No significant differences were observed in the level of sLex (CD15s) 
expression on any leukocyte population from patients compared with controls (Figure 3.1.4). 
However, the high degree of intersubject variability in expression of sLex on all the leukocyte 
populations in both FIPV-infected and uninfected groups was noteworthy. The proportion of 
the monocyte and granulocyte population brightly expressing sLex also varied greatly among 
individuals and there were no significant differences in the percentages of cells expressing the 
molecule when patients and controls were compared.  
 
 
 
 
 
 
 
 
Figure 3.1.4: Expression level and distribution of sLex on leukocyte subpopulations from controls and FIP 
patients. sLex (CD15s) expression shows an unimodal distribution on B-and T-lymphocytes and a bimodal 
distribution on granulocytes and monocytes by histogram analysis. Expression level (A) was expressed as MFI 
of the whole leukocyte population (unimodal) or of the brightly positive subset (bimodal). Distribution (B) of 
sLex on granulocytes and monocytes was assessed by percentage CD15s-positive cells within the respective 
subpopulation. 
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Integrin expression   Figure 3.1.5 shows the expression of the β1 and β2 integrins on the 
peripheral blood leukocytes from healthy controls compared with FIP cats. 
Figure 3.1.5: Expression levels of integrins on leukocyte subpopulations from controls and FIP patients. 
Expression of integrins are unimodally distributed on all the leukocyte subpopulations. Expression level of 
CD49d (A), CD11a (B), CD11b (C) and CD18 (D) was compared between controls and FIP patients using the 
logarithmic MFI parameter of the entire leukocyte subpopulation.  
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Granulocytes expressed low levels of the β1 integrin VLA-4 (CD49d/CD29) and these levels 
were not significantly different between patients and controls. On the contrary, lymphocytes 
and monocytes displayed moderate to high expression levels of CD49d. Significant 
differences in MFI associated with CD49d-expression on B-lymphocytes and monocytes were 
detected in the FIP cats compared with the control cats. The relative number (%) of CD49d-
positive T-lymphocytes appeared comparable between FIP cats (75.7±11.6%) and healthy 
controls (83.3 ± 4.8%). 
The expression of the β2 integrins LFA-1 and Mac-1 was increased on leukocytes from FIP 
patients. More specific, the CD11a (αL-chain of LFA-1) expression on FIP lymphocytes (B- 
and T-cells) was significantly higher than that of the controls. Granulocytes and monocytes 
from FIP patients expressed significantly higher density of the CD11b (αM-chain of Mac-1) 
molecule. The expression of CD18 (common β2-chain) was upregulated on all leukocyte 
populations in the patient group although the difference did not achieve significance for the 
granulocyte population.  
The possibility that the observed differences in fluorescence were due to a difference in size 
between the cells of the patient and control group was explored by comparing the mean 
forward scatters. There were no substantial differences in the mean forward scatters of B-
lymphocytes, T-lymphocytes, granulocytes and monocytes showing that the differences in the 
MFIs were not attributable to differences in size between both groups. 
ICAM-1 expression   MFI values for ICAM-1 (CD54) expression were not significantly 
different between patients and controls for any leukocyte population (Figure 3.1.6). The 
expression of ICAM-1 was found to be extremely variable on monocytes and granulocytes 
from FIP cats. 
3.1.4.4 Clinical correlation 
Correlations between adhesion molecule expression on the different leukocyte populations 
and some aspects of the disease were sought using Spearman’s rank coefficient. The immune 
and disease status of the patients was defined by various laboratory data (lymphocyte count  
and neutrophil count (relative and absolute numbers) and blood albumin). A significant 
correlation was found for CD18 expression on B-lymphocytes and albumin level (Spearmann 
coefficient = -0.7273; P= 0.0144).  
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3.1.5 Discussion 
FIP pathology is typically characterized by widespread granulomatous vascular lesions. It is 
accepted today that the inflammatory reaction in FIP lesions is initiated by excessive 
leukocyte migration from the bloodstream into surrounding tissues (Kipar et al., 2005). To 
date, adhesion molecules, which play a major role in leukocyte extravasation, have not been 
well characterized in FIP. To the best of our knowledge, this is the first comparative analysis 
of the quantitative expression of leukocyte adhesion molecules between normal and FIP cats 
using a whole blood flow cytometric assay. Currently, researchers are well aware that the 
expression of function-associated antigens, like adhesion molecules, can be rapidly and 
artefactually modulated if cells are activated in vitro. This activation can readily occur during 
conventional cell preparation and labeling procedures (Forsyth and Levinsky, 1990; Macey et 
al., 1995). To overcome these problems and to minimize ex vivo alterations, we have 
successfully applied the formaldehyde-based rapid leukocyte preparation technique, 
previously designed to prepare human leukocytes for this purpose (Hamblin et al., 1992). In 
addition, it is well known that excessive formaldehyde fixation can cause permeation of the 
cell membrane (Macey and McCathy, 1993). This would implicate that not only adhesion 
molecules expressed at the membrane surface but also intracellular storage pools of adhesion 
molecules become accessible for antibodies. Therefore it was first ascertained that the 
technique conserved the plasma membrane integrity, evidenced by a lack of cell staining with 
antibodies to the cytoplasmic antigen vimentin.  
Figure 3.1.6: Expression level of ICAM-1 on 
leukocyte subpopulations from controls and FIP 
patients. Expression of ICAM-1 (CD54) is unimodally 
distributed on all the leukocyte population. Expression 
level of CD54 was compared between controls and 
FIP patients using the logarithmic MFI parameter of 
the entire leukocyte subpopulation.  
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Taken together, except for any possible changes due to the process of venipuncture itself, we 
believe that our findings represent the true state of the adhesion molecules on the surface of 
leukocytes from the circulating pools.  
Patients included in our study were selected with great care in an attempt to avoid potential 
confounding factors. Since glucocorticoids have been reported to affect the production of 
various cytokines, which in turn can affect the expression of adhesion molecules, it was 
verified that FIP cats had not received any glucocorticoid or other immunosuppressive 
therapy (Torsteinsdottir et al., 1999). In addition, as the exact influence of other pathogens on 
adhesion molecule expression is unknown, it was confirmed that FIP patients were not 
affected by intercurrent infections with FeLV or FIV.  
Adhesion molecules coordinate the various phases of leukocyte adherence to endothelium in a 
stepwise fashion through a regulated mechanism of ligand binding. The present study aimed 
to assess the expression of principal adhesion molecules involved in the leukocyte-
endothelium interaction. We have demonstrated that the majority of adhesion molecules 
displayed a unimodal fluorescence distribution. Therefore changes in expression level (MFI), 
rather than distribution (% positive cells), appear to be an appropriate tool to determine 
whether there are alterations of expression associated with FIPV infection. The first step of 
extravasation, the characteristic leukocyte rolling phenomenon, is mediated by endothelial 
selectins that recognize sLex carbohydrate moieties on the terminal domains of glycoproteins 
on the leukocyte surface. Our results show considerable intersubject variation in the 
expression of sLex on all leukocyte populations. This wide biological range of sLex 
expression levels was not only seen in the patient group but also in the control group that was 
considered to be a relatively homogeneous group of young adult SPF cats. These findings are 
consistent with a study of Rebuck and Finn demonstrating that there is inherent variability in 
the expression of adhesion molecules (especially L-selectin) on granulocytes between and 
within healthy humans (Rebuck and Finn, 1994). The second step in the adherence cascade 
involves firm attachment of leukocytes on the endothelium and is largely mediated by the 
interaction between integrins and members of the Ig supergene family. LFA-1 and Mac-1 are 
β2-integrins that promote the tight adherence of leukocytes to the endothelial ligand ICAM-1. 
LFA-1 is found on all leukocytes, whereas Mac-1 is only present on myeloid cells. In this 
study we demonstrate that granulocytes and monocytes of FIP cats display significantly more 
Mac-1 and circulating lymphocytes express higher densities of LFA-1 than control subjects. 
Increase in integrin expression is regulated by at least two mechanisms and can occur rapidly 
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within minutes or gradually over a time course of 12 to 72 hours. The rapid alterations are 
achieved by their mobilization from intracellular storage pools to the cell surface. In 
circulating granulocytes and monocytes, but not in lymphocytes, significant amounts of Mac-
1 (CD11b/CD18) are stored in intracellular vesicles, which upon cell activation are 
translocated within minutes to the membrane surface (Mazzone and Ricevuti, 1995). This 
undoubtedly allows the rapid and prompt responsiveness of these cells during the 
development of the inflammatory process and might explain their predominance in 
inflammatory infiltrates in FIP (Takano et al., 2009a). In addition to these rapid changes in 
cell-surface expression, quantitative alteration in integrin receptors can occur with longer 
stimulation (hours to days) and involves de novo integrin subunit synthesis. Lymphocyte 
adhesion relies greatly on LFA-1 (CD11a/CD18). Since little or no CD11a/CD18 is stored 
intracellularly, upregulation of these adhesion molecules depends on this second mechanism, 
which is a substantially slower process (Mazzone and Ricevuti, 1995). These factors may 
underline the relatively slow lymphocyte responsiveness to activation, which in turn may be 
reflected in their later accumulation during the development of FIP lesions (Kipar et al., 
1998). Consistent with their original name (“very late antigens”), most leukocyte β1 integrins 
increase their expression gradually after several days of activation. VLA-4 is unique among 
β1 integrins in its ability to bind, in addition to matrix proteins, the endothelial ligand VCAM-
1. The latter is a member of the Ig supergene family that resides on cytokine-activated 
endothelium (Carlos and Harlan, 1994). Our results show that feline neutrophils, like their 
human counterparts, express relative low levels of VLA-4 confirming the prevailing view that 
VLA-4 plays a relatively minor role in neutrophil adhesion. In contrast, monocytes and 
lymphocytes express moderate to high levels of VLA-4  and its interaction with VCAM-1 has 
been proposed as an alternative emigration pathway for these cells. In our study, an increased 
expression of the α4 subunit (CD49d) of VLA-4 on B-lymphocytes from FIP patients was 
demonstrated. This is consistent with the immuno-histochemical findings of Kipar et al. and 
Berg et al., who both examined the cellular composition of FIP lesions. They showed that in 
lesions without extended necrosis, B-cells and plasma-cells progressively infiltrate 
granulomas, hence replacing macrophages and forming a broad outer rim (Berg et al., 2005; 
Kipar et al., 1998). Since VLA-4 is critically involved in monocyte interaction with the 
endothelium, it was of interest that, despite this cell type predominates in FIP granuloma’s, 
the expression levels of CD49d were significantly lower on monocytes from FIP patients 
compared with healthy controls. Meerschaert and Furie showed that monocyte adhesion on 
human EC monolayers  was only inhibited completely when EC were preincubated with a 
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combination of mAbs against the β2 integrins and VLA-4 (Meerschaert and Furie, 1995). 
These in vitro observations suggest that CD11/CD18 and VLA-4 represent alternative 
pathways for the transendothelial migration of monocytes. Given that the availability of at 
least one of these pathways is sufficient to support normal levels of migration, together with 
our findings, makes us assume that monocyte extravasation in FIP largely depends on β2 
integrin-ICAM-1 interaction. ICAM-1 is a member of the Ig supergene family member that is 
not only expressed on endothelial cells, but also on lymphocytes and 
monocytes/macrophages. It is well known that homotypic and heterotypic lymphocyte 
adhesion, mediated by interaction of ICAM-1 and CD11a,b/CD18, facilitates lymphocyte 
functions including antigen recognition, lymphocyte co-stimulation and cytotoxicity. In 
addition, ICAM-1 has been shown to play an essential role in monocyte-lymphocyte 
communication (Hubbard and Rothlein, 2000). In view of the central role of ICAM-1 in the 
immune response, we explored the expression of this molecule in FIP. No differences were 
noted in the expression of ICAM-1 on lymphocytes and monocytes between patients and 
healthy controls. To date, published data on ICAM-1 expression on granulocytes is limited. 
Most recently, it was reported that human neutrophils do express ICAM-1 and it is 
upregulated by in vitro stimulation with endotoxin and tumor necrosis factor (TNF)-α. It was 
further speculated that upregulation of ICAM-1 may allow neutrophils to assist each other in 
reaching the final destination through their increased ‘stickiness’ via CD11a,b/CD18-ICAM-1 
interaction (Wang et al., 1997). Our flow cytometric analyses with the anti-CD54 monoclonal 
antibody demonstrated that feline granulocytes express moderate amounts of ICAM-1. The 
expression on granulocytes in the FIP group was characterized by a high variability between 
patients that might be responsible for the lack of significant difference with the control group. 
This variability might correlate with the stage of disease. However, this hypothesis could not 
be thoroughly assessed since in spontaneously occurring FIP it is not possible to determine 
the moment of infection nor to have an exhaustive follow-up, because cats were euthanatized 
just after blood sampling.  
Higher expression of adhesion molecules in patients is consistent with the general activation 
of peripheral leukocytes. However, this study has not determined the mechanisms underlying 
the altered expression. Since only a small proportion of circulating monocytes are infected 
with FIPV, together with the findings that granulocytes and lymphocytes, which are not 
susceptible to FIPV infection, show similar expression changes than monocytes indicates that 
a direct effect of viral infection itself does not account for the observed alterations. It seems 
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more likely that indirect effects, such as complex changes in the cytokine milieu associated 
with advancing FIP disease are causing these altered cell surface molecule density. A variety 
of cytokines has been shown to influence adhesion molecules expression. Mainly tumor 
necrosis factor TNF-α, interleukine (IL)-1, and interferon (IFN)-γ have been implicated in the 
upregulation of integrins. Studies of cats with FIP have shown that cytokine expression is 
markedly altered as compared to healthy animals. Specifically it has been noted that the 
expression of the pro-inflammatory cytokines TNF-α, IL-1 and IL-6 are significantly 
increased in FIP, which very likely accounts for the activation of leukocytes in the circulation 
(Goitsuka et al., 1990; Kiss et al., 2004; Takano et al., 2009b). An additional or alternative 
explanation for our findings may be a difference in relative immaturity of leukocytes in FIP 
cats. The rate of migration of cells from the bone marrow through the blood to tissues is likely 
to be faster in FIP patients than in normal cats, resulting in the accumulation of less mature 
cells in the circulation. FIP hematology is often characterized by a neutrophilia accompanied 
with an increased count of left shifted or less mature (“band”) neutrophils,  providing 
evidence for an increased recruitment from the bone marrow. Differences in integrin 
expression are known to occur during leukocyte differentiation and altered surface levels may 
therefore reflect a different maturational level of cells in patients compared with controls 
(Elghetany, 2002; Kansas et al., 1990). Changes in the composition of FIP peripheral 
lymphocytes may also underlie the increased level of CD11a/CD18 expression we have seen 
on these cells. It has been shown that T-lymphocytes undergo phenotypic changes upon 
encountering specific antigens and this conversion from naïve to memory type involves 
increase of the level of expression of adhesion molecules (Sanders et al., 1988).  
Whether the observed changes in cell adhesion molecule expression have functional 
consequences which contribute to the disease process can only be speculated. Whilst 
quantitative changes in expression have been associated with increased adhesion in vitro, it is 
recognized that adhesion in vivo can also occur without an increase in the level of surface 
expression. In fact, a body of data confirms that the regulation of the integrin-mediated 
adherence seems to be more complex than a pure quantitative change in expression of these 
molecules on the cell surface. It appears that under steady-state conditions integrin molecules 
on the cell surface are in a relatively low functional active state and upon activation of the 
leukocytes these molecules convert to an active state resulting in a higher affinity for their 
respective ligands. These qualitative changes are believed to be at least equally important than 
quantative changes for in vivo activity of many adhesion molecules (Arnaout, 1990). We 
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examined only the level of surface expression of adhesion molecules and the affinity state of 
these molecules was not determined. However, since their key role in leukocyte adherence, 
increase of the number of adhesion molecules expressed on the cell surface may predispose 
leukocytes to increased adhesion. Because adherence is generally accepted as being a rate-
limiting step for transmigration to occur, relatively high adherence is followed by relatively 
high transmigration. Adherent and diapedesing leukocytes may release proteases, toxic 
oxygen metabolites and vasoactive substances, together leading to endothelial injury with 
subsequent loss of vascular integrity, edema and tissue injury contributing to the hallmark 
lesions of FIP.  
The recruitment of the characteristic leukocyte infiltrate in FIP is regulated by the expression 
of leukocyte adhesion molecules in conjunction with the reciprocal expression of their counter 
receptors on the vascular endothelium. Given that the site and disease specificity is believed 
to be related to endothelial expression of a combination of vascular adhesion molecules it 
would be of great value to assess the expression and distribution of these cytokine-inducible 
endothelial ligands at sites of FIP lesions in the future.  
In summary, we have demonstrated that leukocytes from FIP cats show signs of activation in 
the peripheral circulation concerning adhesion. It is very likely that the priming of the blood 
leukocytes in FIP is one of the mechanisms behind the excessive recruitment and 
accumulation of immune cells resulting in granuloma formation and ultimately contributing 
indisputable to the pathogenesis of FIP disease. Our findings may provide reliable laboratory 
markers to support the ante mortem diagnosis of FIP which at present is still challenging. 
However, larger studies, including other pathological conditions, are warranted to evaluate the 
discriminating power of these parameters for FIP. In addition, detailed understanding of 
leukocyte interaction with vascular endothelial cells in FIP offers invaluable insights that 
could promote the development of novel therapeutic tools to interfere with leukocyte 
recruitment and subsequently limit tissue injury. 
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3.2 Local upregulation of endothelial cell adhesion molecules 
 characterizes the  granulomatous lesions in feline infectious peritonitis 
3.2.1  Summary 
Feline infectious peritonitis (FIP) is a fatal, coronavirus-induced systemic disease in cats, 
characterized by multifocal granulomatous vasculitis. Although the underlying cause of  FIP 
remains largely unknown, the disturbed interaction of leukocytes with endothelial cells (ECs)  
has been proposed to play a central role in the pathogenesis. Adhesion molecules on the 
surface of leukocytes and their corresponding receptors on endothelium are pivotal for 
adhesion of leukocytes to ECs. In our previous report, significant differences were detected in 
expression of adhesion molecules between leukocytes from healthy controls and FIP cats. 
There are no studies examining the expression of endothelial cell adhesion molecules in FIP, 
although it can be postulated that they play an important role in the pathogenesis. Hence, the 
purpose of this investigation was to determine whether ECs in FIP patients are activated to 
increase their adhesiveness to leukocytes, as reflected by elevated surface expression of 
adhesion molecules. Endothelial cell expression of P-selectin, E-selectin, intercellular 
adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1 was 
quantitated immunohistochemically in specimens from FIP cats and compared with that of 
healthy subjects. The surface expression of all endothelial cell adhesion molecules was 
elevated in FIP patients versus healthy controls. Further comparison between the expression 
of the vessel-associated adhesion molecules in FIP lesions and in adjacent, unaffected tissues, 
showed that this upregulation was limited to the vessels involved in granulomas. Locally 
activated ECs in association with primed leukocytes explain the perpetuated, upregulated 
influx of leukocytes, promoting vasculopathy and ultimately contributing to tissue damage, as 
seen in FIP. 
3.2.2 Introduction 
Feline coronavirus (FCoV) is an important pathogen of wild and domestic cats with a 
worldwide distribution. Infection with FCoV can have distinct clinical outcomes from a mild 
or apparently symptomless enteritis to a lethal, systemic disease called feline infectious 
peritonitis (FIP) (Pedersen, 1987). FIP is accompanied by fibrinous to granulomatous 
inflammation of serosal membranes and disseminated granulomas in numerous organs, 
frequently with accumulation of exudates in body cavities (Weiss and Scott, 1981a, b). The 
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histologic picture of FIP lesions is characterized by extensive infiltration of leukocytes into 
the parenchyma, particular in areas around small venules (Kipar et al., 2005). A prerequisite 
for circulating leukocytes to cross the endothelium and gain access to the surrounding tissue is 
the adhesion of these cells to vascular endothelial cells. Studies have uncovered this process 
as a well-regulated cascade of events, with each step controlled by partially constitutive, 
partially dynamically regulated complementary adhesion molecules expressed on the surface 
of both participating cells. Based on their biochemical properties and molecular structure, the 
adhesion molecules have been grouped into at least three families: the selectins, the integrins, 
and the immunoglobulin (Ig) supergene family (Carlos and Harlan, 1994). Members of the 
selectin family, P-selectin (CD62P) and E-selectin (CD62E), are selectively expressed on 
activated endothelial cells. Their lectin domain interacts with leukocyte ligands bearing sialyl 
lewis X (sLex, CD15s)-related determinants, initiating reversible leukocyte tethering and 
rolling under conditions of flow (Vestweber and Blanks, 1999). Subsequent firm cell arrest 
and final transmigration are mediated by proteins of the Ig supergene family, expressed on the 
endothelium, and their counter structures on leukocytes, the integrins. Intercellular adhesion 
molecule-1 (ICAM-1, CD54), ligand for the β2 integrins lymphocyt function-associated 
antigen-1 (LFA-1, CD11a/CD18) and macrophage-1 antigen (Mac-1, CD11b/CD18), is 
constitutively expressed on endothelial cells at low levels, but is upregulated following 
inflammatory stimulation. Vascular cell adhesion molecule (VCAM-1, CD106), the ligand for 
the β1 integrin very late antigen-4 (VLA-4, CD49d/CD29), is only expressed on activated 
endothelium (Carlos and Harlan, 1994; Ebnet and Vestweber, 1999, Barreiro and Sanchez-
Madrid, 2009).  
A previous study conducted in our laboratory demonstrated significant alterations in adhesion 
molecule expression on peripheral blood leukocytes from FIP patients, reflecting their 
activated state that predispose them to extravasate (Olyslaegers et al., 2013). Since leukocyte 
recruitment is regulated by the expression of leukocyte adhesion molecules in conjunction 
with the reciprocal expression of their counter receptors on the vascular endothelium, it would 
be of great value to assess the expression and distribution of these cytokine-inducible 
endothelial ligands in FIP. Accordingly, this study was designed to quantify and compare the 
in situ expression of P-selectin, E-selectin, ICAM-1, and VCAM-1 on ECs at sites of FIP 
lesions versus normal tissue, using immunohistochemistry. As FIP lesions are commonly 
found in the renal cortex and the serosae of the small intestines, these tissues were selected for 
sampling (Kipar et al., 2005; Pedersen, 2009). In addition, we tested whether EC activation 
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occurs locally or systemically by comparing affected and non-affected tissues from FIP 
patients.  
Data obtained from this study will have important implications for a better understanding of 
the leukocyte-dependent vascular injury in FIP and may help designing rational therapeutic 
blocking strategies that may improve the health status of FIP affected cats.  
3.2.3 Material and methods 
3.2.3.1  Patients and controls 
Fourteen cats, feline leukemia virus (FeLV)- and feline immunodeficiency virus (FIV)-
negative,  presenting clinical signs consistent with FIP were referred from private clinicians. 
In all cases, the presumptive diagnosis of FIP was confirmed by post-mortem examinations. 
As control animals, eight healthy, conventionally housed, FeLV- and FIV-negative cats, that 
had to be euthanized for health-unrelated problems, were selected. The characteristics of the 
cats, sampled organs and the pathological findings are reported in Table 3.2.1. Details of 
therapies received at the time of investigation were recorded and subjects given any form of 
immunoregulatory drugs were excluded. The study and its methodology were approved by the 
ethical committee of the Faculty of Veterinary Medicine, Ghent University (application 
EC2012/043) and informed consent was obtained from the owners of all patients. 
3.2.3.2  Specimens 
Tissues were collected immediately after euthanasia, carefully embedded in methocel, snap 
frozen in liquid nitrogen and stored at -70° C. Kidneys and small intestines from FIP cats 
were sampled at regions with macroscopic signs of FIP lesions and at unaffected sites. 
Control specimens were taken from kidney and intestinal wall from healthy cats in equivalent 
areas, being the outer renal cortex where the Venae Capsulares are situated and the intestinal 
serosae. 
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Table 3.2.1: Characteristics and pathological findings of cats enclosed in this study. The upper part shows the 
healthy cats (HC), whereas the lower part shows the cats with FIP. 
Cat Breed Age Sex Pathologic form Lesions Sampled organs 
HC1 Domestic shorthair 2 y F N.A. N.A. K, I 
HC2 Domestic shorthair 1 y M N.A. N.A. K, I 
HC3 Domestic shorthair 3 y M N.A. N.A. K, I 
HC4 Domestic shorthair 5 mo F N.A. N.A. K, I 
HC5 Domestic shorthair 9 mo M N.A. N.A. K, I 
HC6 Domestic shorthair 5 y M N.A. N.A. K, I 
HC7 Domestic shorthair 1 y F N.A. N.A. K, I 
HC8 Domestic shorthair 8 mo F N.A. N.A. K, I 
FIP1 British shorthair 8 mo F effusive  K, I, Pe K, I 
FIP2 Sacred birman 1 y M non-effusive K, Li, Lu K 
FIP3 Burmese 17 mo M non-effusive K, I, P K, I 
FIP4 Oriental shorthair 8 mo F non-effusive K K 
FIP5 Domestic shorthair 5 mo F non-effusive S, K K 
FIP6 Domestic shorthair 2 y M effusive  lu, S, Li, U, D, K, I K, I 
FIP7 Domestic shorthair 3 Y M effusive  K, Lu K 
FIP8 Norwegian forest cat 3 y M effusive  M, K, I, U, Lu, P K, I 
FIP9 Oriental shorthair 4 mo M effusive  M, I,  I 
FIP10 Scottisch fold 5 mo M effusive  M, I I 
FIP11 Domestic shorthair 5 y F effusive  Pe, K, I, Li, Lu K, I 
FIP12 Domestic shorthair 5 mo M effusive  I, Li I 
FIP13 Domestic shorthair 2 y F effusive  I I 
FIP14 Domestic shorthair 4 mo M effusive  M, I,  I 
 
M = male; F = female; mo = month; y = year; M = mesentery; K = kidney; I = intestines; Li = liver; S = spleen; 
U = urinary bladder; P = pleura; Pe = peritoneum; Lu = lungs; D = diaphragm; St = stomac 
3.2.3.3  Immunohistochemistry 
Frozen sections of 10 µm were prepared with a cryostat (Leica Microsystems, Germany) and 
fixed for 10 min in 4% PF. Incubation steps were performed in a moist chamber at 37°C for 1 
h (unless otherwise mentioned), and each step was followed by two washings in PBS. To 
block non-specific binding, slides were first incubated with 10% NGS in PBS for 30 min. 
Sections were then incubated with one of the primary monoclonal antibodies (mAbs): P-
selectin, E-selectin, VCAM-1 (Clones Psel.KO.2.7, CL2/6, STA, respectively; AbD Serotec, 
Raleigh, USA), and ICAM-1 (Clone RR1/1; Santa cruz biotechnology, Santa Cruz, USA). 
Although the primary mAbs have human as target species, they were proven to react with cat 
by the manufacturer (P-selectin) or by the comparison of the tissue distribution and 
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fluorescence patterns of the antigens between feline and human tissues (E-selectin and 
VCAM-1). Next, sections were incubated with the secondary antibody, Texas Red-conjugated 
goat anti-mouse IgG (Molecular Probes, Eugene, Oregon). Tissue sections were then 
permeabilized with 0.1% Triton X-100 (Sigma-Aldrich, St. Louis, USA) for 2 min. Sections 
were further blocked with an avidin-biotin blocking kit (Vector Laboratories, Burlingame, 
USA), according to the manufacturer’s instructions. FCoV-infected cells were visualized by 
overlaying the sections with biotinylated mAb against the FCoV nucleocapsid (N)-protein 
(10A12, produced and characterized in our laboratory), followed by exposure to streptavidin 
conjugated to Alexa Fluor® 405 dye (Molecular Probes). Finally, blood vessels were 
identified by staining for von Willebrand factor (vWF), using fluorescein isothiocyanate 
(FITC)-labeled sheep polyclonal anti-human vWF Abs (AHP062F; AbD Serotec). 
Afterwards, slides were mounted in glycerin/PBS (0.9 : 0.1, v/v) with 2.5% 1,4-diazabicyclo 
(2,2,2) octane (Janssen Chimica, Beerse, Belgium). Specificity of Ab binding was assessed by 
substituting the primary mAbs with isotype-matched irrelevant mAbs. 
3.2.3.4 Quantitative evaluation and statistics 
Images were acquired with a confocal microscopy (Leica Microsystems) using fixed settings 
for excitation and detection. In FIP cats, images were recorded at the sites of the granuloma’s  
(three images) and in adjacent regions of the granuloma’s (three images), based on FCoV 
expression. For the healthy controls, three images were recorded in the same anatomical 
region as the FIP cats. Quantitative analysis of fluorescent signals associated with adhesion 
molecule expression was carried out using the NIH Image J software program (National 
Institutes of Health, Bethesda, USA). In brief, the original multi-color image was split into 
single color channels and the endothelium (vWF positive) was outlined on the green digital 
image, using a freehand selection tool. This defined area was copied to the red digital image 
(adhesion molecule expression) and the mean brightness value of this selection, expressed in 
arbitrary units, was used as indicator of red fluorescence intensity. The measurements were 
performed only on the vessels in the image that were cut in cross-section to reduce the impact 
of apparent lack of immunostaining due to tangential or oblique planes of section across the 
endothelium. The average staining intensity was calculated from the three images acquired 
from one cryosection and normalized with the average of three independent background 
values on the same slide. Results were expressed as mean expression with standard deviation 
(SD). Comparisons of staining intensity of each individual adhesion molecule between 
different groups were made using nonparametric methods. The Mann-Whitney U-test was 
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used to make the comparison between FIP and healthy cats, whereas the Wilcoxon matched-
pairs signed rank test was applied to compare expression in unaffected and affected tissues 
within a FIP patient with the level of significance less than 0.05. Graphs and statistical 
analyses were created with Graph Pad Prism 5.0 (GraphPad Software, San Diego, USA). 
3.2.4 Results 
3.2.4.1 P-selectin expression (Figure 3.2.3 A) 
Compared with healthy controls, we found a significant increase of endothelial expression of 
P-selectin in the renal cortex (at site of lesions) of FIP patients. This upregulation was limited 
to the vessels involved in the granulomatous lesions, as demonstrated by the comparison 
between unaffected and affected regions (Figure 3.2.1 A-E-I). No significant differences were 
observed in the level of P-selectin expression between intestinal vessels from healthy cats 
compared with FIP cats at sites of the granulomas. In addition, P-selectin displayed no 
significant difference in expression level between tissues involved in FIP lesions and adjacent, 
uninvolved regions (Figure 3.2.2 A-E-I). The overall higher degree of P-selectin expression in 
biopsies from intestines compared with that in kidneys was noteworthy. 
3.2.4.2 E-selectin expression (Figure 3.2.3 B) 
Endothelium in tissues collected from kidneys and intestines from healthy cats expressed low 
levels of E-selectin. The expression of this adhesion molecule was significantly increased in 
FIP. However, this upregulation was restricted to the blood vessels where extravasation of 
FIP-infected cells had occurred (Figure 3.2.1 B-F-J, 3.2.2 B-F-J).  
3.2.4.3 ICAM-1 expression (Figure 3.2.3 C) 
Compared with healthy controls, affected vessels in kidneys and intestines from FIP patients 
showed a significant increase in expression of ICAM-1.  Within the patient group, comparison 
between unaffected and affected regions showed that in both organs this molecule was 
selectively upregulated at sites of vascular lesions (Figure 3.2.1 C-G-K, 3.2.2 C-G-K).  
3.2.4.4 VCAM-1 expression (Figure 3.2.3 D) 
The expression of VCAM-1 in FIP lesions in kidneys and intestines was higher than that in 
healthy control organs, although the difference only achieved significance for the intestines. 
However, the difference in VCAM-1 expression between endothelial cells in infected and 
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non-infected, bordering renal tissues did reach the 5% significance level. Although not 
significantly, there was also a trend toward higher endothelial expression of VCAM-1 in 
intestinal pyogranuloma’s compared with the unaffected, neighboring intestinal wall (Figure 
3.2.1 D-H-L, 3.2.2 D-H-L). 
3.2.5 Discussion 
A patho-anatomical hallmark of FIP is the infiltration of large numbers of leukocytes into the 
parenchyma, causing functional impairment of the affected organs. Decisive for the invasion 
of tissues by inflammatory cells is their transmigration across the endothelium. This leukocyte 
recruitment is known to be a multi-step process, that for the most part is staged at the vascular 
level. Leukocytes first roll and subsequently adhere firmly to the endothelial membrane, 
before they ultimately emigrate from the vascular lumen. These events are orchestrated by the 
engagement of increasingly well-defined ligand pairs (Carlos and Harlan, 1994). In previous 
work, we demonstrated a systemic activation of peripheral leukocytes in FIP, as reflected by 
their higher surface expression of adhesion molecules (Olyslaegers et al., 2013). Despite the 
general activation of circulating leukocytes, FIP lesions are typically restricted to small and 
medium-sized veins and are predominantly distributed in selected organs, such as kidneys and 
the intestines (Kipar et al., 2005; Pedersen, 2009). Given the strategic location of the 
endothelium, at the interface between circulating leukocytes and extravascular tissue, we 
reasoned that a contained upregulation of vascular adhesion molecules could be responsible 
for the localized recruitment and retention of the FIP infiltrates that typify this disease. 
Immunohistochemical stainings of samples from kidneys and intestines from healthy cats 
revealed minimal expression of P-selectin, E-selectin, ICAM-1, and VCAM-1, whereas the 
surface expression of these molecules was significantly upregulated on ECs in FIP-infected 
tissues. As the analyzed molecules mediate the arrest of circulating leukocytes on the 
endothelium and thereby facilitate their influx in tissues, our results provide further support 
for a prominent role of leukocyte extravasation in the initiation of FIP lesions. Further 
comparison between the expression of  the vessel-associated adhesion molecules in FIP 
lesions and in neighboring, unaffected tissues, showed that this upregulation is limited to the 
vessels involved in the pyogranulomas. Notwithstanding the systemic activation of leukocytes 
in FIP, this restricted upregulation of the endothelial ligands regulates local leukocyte 
trafficking and might explain the refined location of FIP lesions. 
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Figure 3.2.1: Expression of the endothelial adhesion molecules in renal vessels. Cryosections of samples from 
the renal cortex from healthy cats (A-D), FIP cats at unaffected sites (E-H), and FIP cats at affected sites (I-L) 
were immunohistochemically stained with mAbs against P-selectin, E-selectin, ICAM-1 or VCAM-1 (red) 
together with the endothelial marker vWF (green) and infection (blue) as described in MATERIAL AND 
METHODS. Scale bar, 75 µm.  
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Figure 3.2.2: Expression of the endothelial adhesion molecules in intestinal vessels. Cryosections of samples 
from the small intestines from healthy cats (A-D), FIP cats at unaffected sites (E-H), and FIP cats at affected 
sites (I-L) were immunohistochemically stained with mAbs against P-selectin, E-selectin, ICAM-1 or VCAM-1 
(red ,) together with the endothelial marker vWF (green) and infection (blue) as described in MATERIAL AND 
METHODS. Scale bar, 75 µm. 
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Figure 3.2.3: Expression level of the endothelial adhesion molecules in renal and intestinal vessels from controls 
and FIP patients. Endothelial expression of P-selectin (A), E-selectin (B), ICAM-1 (C), and VCAM-1 (D) in the 
kidney and intestines was quantitated immunohistochemically as described in MATERIAL AND METHODS. 
Expression levels were compared between healthy controls and affected vessels in FIP cats and within FIP cats 
between tissues affected by FIP lesions and neighboring, unaffected tissues.  
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It is now well recognized that the expression of endothelial adhesion molecules are 
dynamically regulated by inflammatory mediators (Carlos and Harlan, 1994). Therefore, the 
local upregulation of P-selectin, E-selectin, ICAM-1, and VCAM-1 in FIP lesions indicates 
prior exposure of the endothelium to pro-inflammatory chemokines or cytokines. As it has 
been shown that FIPV-infected monocytes release TNF-α and IL-1β, two key cytokines 
involved in endothelial cell activation, they may be involved in the pathomechanism of FIP 
(Kipar et al., 2005; Regan et al., 2009). It is conceivable that local cytokine production of 
infected monocytes is responsible for elevated expression of adhesion molecules on ECs and 
therefore inducing an augmented local influx of activated leukocytes. Diapedesing leukocytes 
release proteases, toxic oxygen metabolites, and vasoactive substances, together leading to 
endothelial injury with subsequent loss of vascular integrity, initiating the hallmark lesions of 
FIP. Finally, once they have emigrated, leukocyte infiltrates remain secreting inflammatory 
mediators inducing persistent endothelial activation and therefore promoting continuous 
leukocyte recruitment, leading to tissue injury and eventually organ failure.  
Following pro-inflammatory stimulation of the endothelium, there are variable expression 
kinetics of the different inducible adhesion molecules. P-selectin and E-selectin are operative 
in early stages of leukocyte-endothelial attachment and therefore have been regarded as being 
expressed in early and active states of inflammation (Ebnet and Vestweber, 1999). ICAM-1 
and VCAM-1 expression, on the other hand, are thought to characterize later phases of 
inflammation (Elangbam et al., 1997). Therefore, the expression level of the different 
endothelial adhesion molecules can be correlated with the age of the lesions. In addition, 
considering that ICAM-1 is a specific counter receptor for the β2-integrins LFA-1 and Mac-1 
and that VCAM-1 is a ligand for the β1-integrin VLA-4, our findings proved that both β1- and 
β2-pathways are important for the transendothelial leukocyte migration in FIP (Kelly et al., 
2007).  
To explain the overall higher P-selectin expression in intestinal vessels compared with vessels 
in the renal cortex different hypotheses can be formulated. A mouse model of inflammation 
demonstrated that a significant amount of P-selectin can be expressed under basal conditions. 
This constitutive P-selectin expression in mouse showed profound regional differences in 
tissue distribution. Organs that are constantly exposed to external inflammatory stimuli, such 
as the small intestines, exhibited a significant level of basal P-selectin expression (Eppihimer 
et al., 1996). It is possible that the discrepancy in P-selectin expression in our study can be 
explained as well by the regional heterogeneity of constitutive P-selectin in feline tissues. The 
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high expression of P-selectin may also be attributed to the presence of preformed storage 
pools of this adhesion molecules within granular structures (Weibel-Palade bodies) in ECs. 
After endothelial activation, rapid (within minutes) increase in P-selectin expression involves 
translocation of the preformed pools  to the endothelial surface, whereas the expression of the 
other adhesion molecules is linked to de novo protein synthesis and therefore requires several 
hours (Ebnet and Vestweber, 1999).  Although samples were collected immediately after 
death of the animal, a notable period of time elapsed from the euthanasia until the snap-freeze 
of the specimens. How tissues react on a molecular basis during this period of interrupted 
blood supply is not known, but it cannot be excluded that inflammatory reactions are 
stimulated. Among all organs, the metabolically active intestines are probably the most 
sensitive to ischemic injury (Mallick et al., 2004). Therefore, the high P-selectin expression in 
the intestinal vasculature may also reflect the rapid mobilization of preformed adhesion 
molecules elicited by the ischemic period during sampling.    
One final point deserves some attention. Corticosteroids are potent inhibitors of the nuclear 
transcription factor-κB (NF-κB) activity (Auphan et al., 1995). NF-κB controls many genes 
involved in inflammation, including the cytokine-induced endothelial expression of the P-
selectin, E-selectin, ICAM-1, and VCAM-1 (Manning et al., 1995). Therefore, it was verified 
that patients and controls included in our study had not received any corticosteroids or other 
immunosuppressive therapy. In addition, as the effect of other systemic viral infections on 
adhesion molecules expression is unknown, only cats that were negative for  FIV and FeLV 
were enclosed.  
In summary, we have shown that the surface expression of four distinct endothelial cell 
adhesion molecules, P-selectin, E-selectin, ICAM-1, and VCAM-1, is upregulated in the 
granulomatous vascular lesions in FIP. These data substantiate the hypothesis that local 
upregulation of vascular adhesion molecules constitutes an essential prerequisite for the 
recruitment of the characteristic leukocyte infiltrate in FIP. With leukocyte-endothelial 
interactions being intimately linked to the pathogenesis of FIP, the identification of the 
dominant adhesion molecules may form the basis of new, pathogenesis-directed, therapeutic 
approaches for FIP. 
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4 
The pathogenic mechanism underlying the 
endothelial activation in FIP lesions  
 
Summary  
This chapter deals with the elucidation of the pathogenic mechanism underlying the 
endothelial activation in FIP lesions. For this purpose the set up of a representative in vitro 
model system was required. Therefore, in chapter 4.1
1
 two novel immortalized feline 
endothelial cell lines were generated and extensively characterized to validate their 
endothelial specific phenotype and functionality. In the second part, chapter 4.2
2
, in vitro 
experiments were performed with the established feline venous EC line to unravel the 
interaction between the FIPV-infected monocyte and the endothelium.  
 
 
 
 
1
 Adapted from: Olyslaegers, D.A., Desmarets, L.M., Dedeurwaerder, A., Dewerchin, H.L., Nauwynck, H.J., 
2013. Generation and characterization of feline arterial and venous endothelial cell lines for the study of the 
vascular endothelium. BMC Vet Res 9, 170.  
2
 Adapted from: Olyslaegers, D.A., Dedeurwaerder, A., Desmarets, L.M., Dewerchin, H.L., Nauwynck H.J., 
2014. Pro-inflammatory mediators produced by feline infectious peritonitis virus (FIPV)-infected monocytes, 
enhance surface expression of endothelial adhesion molecules and promote adherence of uninfected monocytes 
to feline venous endothelial cells. Submitted to Journal of general virology. 
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4.1 Generation and characterization of feline arterial and venous 
endothelial cell lines for the study of the vascular endothelium  
4.1.1  Summary 
The in vitro culture of endothelial cells (ECs) is an indispensable tool for studying the role of 
the endothelium in physical and pathological conditions. Primary ECs, however, have a 
restricted proliferative lifespan which hampers their use in long-term studies. The need for 
standardized experimental conditions to obtain relevant and reproducible results has increased 
the demand for well-characterized, continuous EC lines that retain the phenotypic and 
functional characteristics of their non-transformed counterparts. In this study, we describe the 
immortalization of primary feline ECs from aorta and vena cava through the successive 
introduction of simian virus 40 large T (SV40LT) antigen and the catalytic subunit of human 
telomerase (hTERT). In contrast to the parental ECs, the transformed cells were able to 
proliferate continuously in culture. Established cell lines exhibited several inherent 
endothelial properties, including typical cobblestone morphology, binding of endothelial cell-
specific lectins and internalization of acetylated low-density lipoprotein. In addition, the 
immortalization did not affect the functional phenotype as demonstrated by their capacity to 
rapidly form cord-like structures on matrigel and to express cell adhesion molecules following 
cytokine stimulation. The ability to immortalize feline ECs, and the fact that these cells 
maintain the EC phenotype will enable a greater understanding of fundamental mechanisms 
of EC biology and endothelial-related diseases. Furthermore, the use of cell lines is an 
effective implementation of the 3-R principles formulated by Russel and Burch in 1959. 
4.1.2 Introduction 
Endothelial cells line the inner surface of blood vessels. In this strategic position, they play a 
key role in a large number of important physiological processes, such as regulation of 
vascular tone and blood flow, fluid and solute exchange, haemostasis and coagulation, 
inflammatory responses and angiogenesis. Furthermore, the endothelium is actively involved 
in a wide variety of pathological processes, including tumor invasion, atherosclerosis, 
arthritis, thrombosis, and vasculitis (Cines et al., 1998; Sumpio et al., 2002). In order to 
investigate the role of ECs in these events, it has been proven valuable to optimize techniques 
to isolate, culture and characterize these cells in vitro. Substantial data supports a central role 
of endothelial dysfunction and/or injury in the pathogenesis of many diseases in cats, 
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including feline infectious peritonitis (FIP), feline immunodeficiency virus (FIV) and several 
neoplasms (Steffan et al., 1994; Steffan et al., 1996; Takano et al., 2011b). In addition, 
numerous interests have arisen in feline endothelial cell cultures as they provide 
representative in vitro systems for the study of several vascular disorders in human, such as 
myocardial ischemia and reperfusion injury (Weyrich et al., 1995). On top, FIV infection in 
cats represents a well-established animal model in the study of human immunodeficiency 
virus (HIV)-1 infection. The availability of feline endothelial cell cultures would therefore 
offer an important asset to gain further understanding in endothelial-related diseases in cats 
and to address questions related to vascular pathophysiology in humans through the use of 
feline models (Fletcher et al., 2006). 
In the past, ECs were considered to be a homogeneous cell population that functions merely 
as a passive physical barrier between blood and tissue. The last decades, it became 
increasingly apparent that ECs display significant heterogeneity in phenotype, function, 
antigenic composition and biological behavior depending on the vascular system they 
originate from. Differences not only exist between macro- and microvascular ECs, but arterial 
and venous ECs also differ intrinsically (Thorin and Shreeve, 1998). Therefore, when 
studying the biological characteristics of a disease, it is desirable to use ECs isolated from 
vessels of the appropriate size and functionality, that originate from the proper anatomical 
compartment.  
Freshly isolated cells are well differentiated and provide cultures that have characteristics 
very close to the tissue of origin. Therefore, much of the knowledge on properties and 
functions of the vascular endothelium has been obtained from primary EC cultures. However, 
the use of primary ECs presents various disadvantages. They frequently require special 
culture substrata, growth factors, cofactors and high serum concentrations. Furthermore, like 
most somatic cells, ECs undergo only a predetermined and finite number of cell divisions in 
culture. Thereafter, cells enter an irreversible proliferation arrested state, referred to as 
replicative senescence and finally die (Campisi, 1997). Because of this limited lifespan of 
primary cells, researchers frequently need to re-establish fresh cultures. The isolation of ECs 
often implies labor intensive procedures with varying success and reproducibility. Moreover, 
the behavior of cells may differ considerably from batch to batch due to their multidonor 
origin, what questions the comparison of experimental results obtained with different EC 
isolates. The above limitations of primary cells and the need for consistent material 
throughout long-term studies, have increased the demand for continuously growing 
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(immortalized), well-characterized EC lines stably presenting endothelial properties. Efforts 
to extend the in vitro lifespan of cells have frequently focused on their transformation with 
viral oncogenes from DNA tumor viruses. The common mode of action of these viral 
oncoproteins is to bind and inactivate the protein products of the cell cycle regulatory genes 
p53 and retinoblastoma (Rb), allowing cells to overcome senescence signals and to continue 
proliferation (Lin and Simmons, 1991; Resnicksilverman et al., 1991). Of this type, 
overexpression of the gene for Simian Virus 40 large T antigen has been the most widely 
applied technique to bypass replicative senescence. Nonetheless, in most reports the 
additional lifespan of the post-senescent cell lines expressing SV40LT is still restricted by 
another barrier called crisis. The onset of crisis typically coincides with critically short 
telomeres accompanied by chromosomal instability and widespread apoptosis (Macera-Bloch 
et al., 2002). Therefore, ectopic expression of the human telomerase reverse transcriptase 
(hTERT) gene, being the catalytic component of telomerase, has been proposed as an 
alternative method to hurdle replicative senescence. Cells with reconstituted telomerase 
activity maintain sufficient telomere lengths that allow cells to not only circumvent replicative 
senescence, but escape from crisis and become truly immortal (Colgin and Reddel, 1999). 
Nevertheless, immortalization of cells by induction of telomerase activity alone is still 
controversial and several cell types even seem refractory to the hTERT immortalization 
protocol (Yeager and Reddel, 1999). Meanwhile, coexpression of hTERT and a viral 
oncogene, like SV40LT antigen, has proven to be effective and efficient to immortalize a 
number of cell types including endothelial cells (Bian et al., 2005; Darimont et al., 2002). 
Besides, cell lines transformed with an oncogene/hTERT combination have significantly more 
genomic stability than cell lines immortalized with an oncogene alone (Darimont et al., 2002).  
A diverse range of gene delivery systems have been developed to insert genetic material into 
cells. Since efficient non-viral transfection of primary cells is still a challenge, gene transfer 
into primary cells is restricted to the use of viral vectors. A variety of recombinant viral 
vectors have been tailored to their specific applications. Recently, the lentiviral vector system 
has gained popularity as it can actively pass through the nuclear membrane enabling the 
transduction of not only dividing but also non-dividing cells. In addition, lentiviral vectors 
will integrate into the host cell genome, giving rise to permanent and stable gene expression 
(Vannucci et al., 2013). These properties make this vector the most suitable vehicle for 
transducing the feline EC cultures with the immortalization genes. 
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The present work details the successful isolation and culture of ECs from feline aorta and 
vena cava, using relatively straightforward techniques. Next, considering above mentioned 
immortalization paradigms, immortalized EC lines were established by transducing these 
primary EC cultures with a combination of SV40LT antigen and hTERT using lentiviral-
based vectors. Finally, cell lines were extensively characterized and compared with their non-
transformed counterparts for the expression of critical phenotypic EC markers. In addition, 
the response of the immortalized EC lines to known inflammatory stimuli and their capacity 
to form tube-like capillary structures on matrigel was assessed to demonstrate a differentiated 
functional state similar to their parental cells. Well-characterized feline endothelial cell lines 
with a known and constant functional profile can facilitate studies to investigate the role of 
ECs in vascular physiology and pathology in cats and humans. 
4.1.3  Material and methods 
4.1.3.1 Primary EC cultures 
Aorta   Endothelial cells were directly isolated after euthanasia of the cat with an overdose of 
20% SodiumPentobarbital (1 ml/1.5 kg; Kela Laboratories, Hoogstraten, Belgium). After 
opening  the chest and the abdomen, a blunt needle was inserted in the aorta ascendens and 
immobilized with a hemostatic clamp. A small incision was made in the aorta wall just before 
it branches into the iliac arteries. After rinsing with phosphate buffered saline (PBS; Vel 
chemicals, UCB, Brussels, Belgium) to remove any residual blood, a blunt needle was placed 
in the latter incision and secured by a hemostatic clamp. Important branches of the aorta were 
pinched off. Prewarmed enzyme mixture of 0.1% type I collagenase (Invitrogen, Paisley, UK) 
and 0.12% dispase (Sigma-Aldrich, St. Louis, MO, USA) in Dulbecco's Modified Eagle's 
Medium  (DMEM; Gibco BRL, Merelbeke, Belgium), was infused into the vessel. During 
enzyme incubation, the vessel was gently ‘massaged’ to facilitate EC detachment. After 10 
min of incubation, the enzyme solution, containing the ECs, was flushed from the aorta by 
perfusion with DMEM (37°C) from one syringe through the vessel into the other syringe. The 
incubation and perfusion steps were repeated four times with introduction of fresh enzyme 
solution each time. The effluent was collected in chilled centrifuge tubes containing fetal calf 
serum (FCS; Gibco BRL). The cells were sedimented at 200 x g at 4°C for 10 min. The 
supernatant was discarded and the pellet washed 2 times with cold DMEM. The final pellet 
was resuspended in endothelial growth medium and plated onto 0.5% gelatin-coated culture 
dishes (Nunc A/S, Roskilde, Denmark). Endothelial growth medium consisted of DMEM 
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supplemented with 10% FCS, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.1 mg/ml 
gentamycin, 1 mM sodium pyrovate, 1% non-essential amino acids 100x (Gibco BRL), 50 
µg/ml endothelial cell growth supplement (ECGS; Biomedical Technologies Inc., Stoughton, 
MA, USA) and 10 U/ml heparin (Leo, Zaventem, Belgium). Cultures were maintained at 
37°C in a humidified incubator with 5% CO2. The medium was changed within 24 h of initial 
plating, thereafter at 48-72 h intervals. 
Vena cava   Immediately after euthanasia the vena cava inferior was aseptically removed 
from the cats’ abdominal cavity and transferred to a petri dish. Periadventitial fat and 
connective tissue was carefully stripped by blunt dissection. One end of the vein was 
cannulated with a blunt needle, secured by a hemostatic clamp. After rinsing with PBS the 
other end of the vessel was clamped, using a hemostat. The segment was filled with 
prewarmed collagenase/dispase (0.1%/0.12%) solution until there was moderate distention of 
the vessel. After an incubation time of 20 min, the occluding hemostatic clamp was opened. A 
fresh cut was made to remove the crushed part of the vessel. The endothelial cells, liberated 
by the enzymes, were obtained by flushing the vessel with DMEM (37°C). The effluent was 
collected into sterile syringes and transferred into chilled centrifuge tubes with FCS. Cells 
were pelleted by centrifugation at 200 x g at 4°C for 10 min. After 2 additional washes with 
cold DMEM, the pellet was resuspended in endothelial growth medium, plated on 0.5% 
gelatin-coated plastic ware and incubated at 37°C in a 5% CO2-air atmosphere. After 
overnight incubation, cell debris and non-adherent cells were washed away with prewarmed 
DMEM and fresh medium was added. Thereafter, cells were refed every 2-3 days.  
4.1.3.2 Immortalization of endothelial cells 
Cell lines were created by sequentially introducing the simian virus 40 large T antigen 
followed by human telomerase reverse transcriptase into primary EC cultures. Midconfluent, 
proliferating primary cultures were first exposed to the recombinant lentiviral vector 
containing the sequence encoding the SV40LT transforming protein (Applied Biological 
Materials Inc., Richmond, BC, Canada) in the presence of polybrene (8 µg/ml, Applied 
Biological Materials Inc.). To avoid cytotoxicity, the viral supernatant was diluted after 30 
min with heparin free EC growth medium (1:1) and further incubated overnight. The medium 
was replaced by fresh complete growth medium the next day and then every second day until 
cells reached confluence. After 3 passages, the polyclonal populations of SV40LT expressing 
cells, overcoming senescence, were infected with recombinant lentiviral vector carrying the 
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hTERT gene (Applied Biological Materials Inc.), as described above. This vector also 
contains the puromycin resistance gene as a selection marker. At 72 h post-transduction, cells 
were incubated in their regular growth medium containing puromycin (10µg/ml; Applied 
Biological Materials Inc.) to select for stable hTERT transduced cells. Selection was carried 
out until the cultures were devoid of nonresistant cells (< 14 days) and surviving cells were 
further expanded in standard medium and routinely passaged at a 1:3 split ratio using 10% 
trypsin (Sigma-Aldrich)/ 1% versene (Vel chemicals) in PBS. 
4.1.3.3 Characterization of primary endothelial cells and EC lines 
Endothelial cells isolated from aorta and vena cava and the immortalized ECs established 
from these primary cultures were characterized in a number of ways. Cell characterization 
studies of the immortalized ECs were carried out with early-passage cells (P6-P10) and 
repeated with cells at a higher passage number (P28-P31) to ensure the stability of the 
endothelial traits.  
4.1.3.3.1 Morphology 
Cultures were examined daily by inverted light microscopy and photographed in phase-
contrast (IX50; Olympus, Tokyo, Japan). 
4.1.3.3.2 Cell characterization by immunofluorescence  
von Willebrand’s Factor (vWF) immunofluorescence   The presence of vWF was 
determined by direct immunofluorescence using fluorescein isothiocyanate (FITC)-labeled 
sheep polyclonal anti- human vWF antibodies (AHP062F; AbD Serotec, Raleigh, NC). ECs 
were seeded on glass coverslips and allowed to attach and grow overnight. After removal of 
the medium, cells were fixed with 4% paraformaldehyde (PF) for 10 min at room temperature 
(RT). Following 2 washes in PBS, the cells were permeabilized with 0.1% Triton X-100 
(Sigma-Aldrich) for 2 min at RT. After being rinsed twice in PBS, cells were incubated with a 
1:50 dilution of the polyclonal antibody at 37°C for 1 h. Cells were washed twice with PBS, 
and the nuclei were counterstained with Hoechst 33342 (Molecular Probes, Eugene, Oregon, 
USA) for 10 min at 37°C. After an additional wash in PBS the coverslips were inverted over a 
drop of glycerin/PBS (0.9 : 0.1, v/v) with 2.5 % 1,4-diazabicyclo(2,2,2) octane (Janssen 
Chimica, Beerse, Belgium) and analysed using confocal microscopy (Leica Microsystems 
DMRBE, Wetzlar, Germany).  
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Ulex europaeus agglutinin-1 (UEA-1) expression   The presence of UEA-1 binding antigen 
was evaluated on endothelial cells grown on coverslips. PF (4%)-fixed cells were incubated 
with biotin-labeled UEA-1 lectin (Sigma-Aldrich) at a concentration of 500 µg/ml for 1 h at 
37°C. After 2 rinses with PBS the lectin was revealed by subsequent incubation with 
streptavidin-Texas Red (1:100; Molecular Probes) for 1 h at 37°C. Cells were washed with 
PBS, and the cell nuclei were stained with Hoechst for 10 min at 37°C. After final rinses with 
PBS, coverslips were mounted in glycerin/PBS (0.9 : 0.1, v/v) with 2.5 % 1,4-diazabicyclo 
(2,2,2) octane and examined for fluorescence with a confocal microscope. To exclude false 
positives produced by nonspecific binding of the secondary antibody, controls lacking the 
lectin were included.  
Uptake of acetylated low-density lipoprotein (Ac-LDL)   The presence of scavenger 
receptors for acetylated low density lipoprotein on EC was detected using 1,1-diocatadecyl-
3,3,3’,3’-tetramethyl-indocarbocyanine perchlorate Ac-LDL (DiI-Ac-LDL; Biomedical 
Technologies Inc.). Near confluent EC cultures grown on coverslips were incubated with 10 
µg/ml DiI-Ac-LDL in complete growth medium for 4 h in a humified 5% CO2/air incubator at 
37°C. After the incubation period, cells were rinsed 3 times with probe free medium and fixed 
with paraformaldehyde (4%) for 10 min at RT. Nuclei were stained with Hoechst 33342 (10 
min, RT). Coverslips were mounted in glycerin/PBS (0.9 : 0.1, v/v) with 2.5 % 1,4-
diazabicyclo(2,2,2) octane and DiI-Ac-LDL uptake was visualized with a confocal 
microscope.  
Expression of cytoskeletal proteins   To assess the expression of the different cytoskeletal 
proteins, immunostainings were performed against vimentin, desmin, and alpha smooth 
muscle actin (SMA). Cells were fixed with 4% PF in PBS for 10 min at RT followed by 
permeabilization with 0,1% Triton X-100 for 2 min at RT. Cells were incubated with the 
appropriate primary antibody dilutions containing 10% normal goat serum (NGS) for 1 h at 
37°C. Primary monoclonal antibodies were anti-vimentin (Clone V9; 1:100; Lab Vision 
Corporation, Fremont, CA, USA), anti-desmin (Clone DE-R-11; 1:100; Dako, Glostrup, 
Denmark) and anti-SMA (Clone 1A4; 1:100; Dako) and were proven to be cross-reactive with 
the feline homologues. After 2 washes in PBS, Texas Red-conjugated goat anti-mouse IgG 
(1:100; Molecular Probes) was added for 1 h at 37°C to detect the binding of the primary 
antibodies. Nuclei were stained with Hoechst 33342 for 10 min at RT. The coverslips were 
washed 2 times in PBS, mounted and examined for fluorescence. Negative controls, where the 
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primary antibodies were substituted with isotype matched irrelevant monoclonal antibodies at 
equivalent concentration, were routinely performed. 
Immunodetection of SV40LT antigen and hTERT in EC lines   Immortalized ECs were 
analyzed for the co-expression of hTERT and SV40L T antigen by indirect 
immunofluorescence. Cells grown on glass coverslips were fixed with 4% PF and 
permeabilized with 0.1% Triton X-100.  Cells were first incubated with polyclonal rabbit 
antibodies against hTERT (Applied Biological Materials Inc.) containing 10% NGS for 1 h at 
37°C. Binding of the primary antibodies was revealed by subsequent incubation with FITC-
conjugated goat anti-rabbit IgG antibodies (Molecular Probes) for 1 h at 37°C. Next, cells 
were incubated with monoclonal antibodies specific for SV40LT antigen (Applied Biological 
Materials Inc.) containing 10% NGS, followed by goat anti-mouse-Alexa fluor 594-labeled 
antibodies (Molecular Probes), each for 1 h at 37°C. Nuclei were stained and coverslips 
mounted as described above.  
4.1.3.3.3 Capillary-like tube formation assay on matrigel 
Matrigel (BD biosciences, Bedford, MA, USA) was allowed to thaw on ice overnight. 
Prechilled 24-well culture dishes were coated on ice with 300 µl matrigel per well. Gels were 
allowed to solidify for 30 min at 37°C. Endothelial cells were trypsinized and 10
5
 cells, 
resuspended in 500 µl endothelial growth medium, were plated onto these gels. The plates 
were returned to the incubator and incubated for 24 h. Morphological changes were 
periodically monitored and photographed using  an inverted phase-contrast microscope.  
4.1.3.3.4 Quantification of cell adhesion molecule expression in response to tumor  
  necrosis factor-alpha (TNF-α)  
An enzyme-linked immunosorbent assay (ELISA) was used to quantify changes in surface 
expression of the endothelial cell adhesion molecules E-selectin, intercellular adhesion 
molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in response to TNF-
α. Homogenous EC monolayers, and therefore single-cell suspensions as starting material, are 
necessary to obtain accurate results with this test. Since the isolation of primary ECs resulted 
in cell clusters, which was necessary for sufficient outgrowth of the isolated cells, and 
subpassage of the primary cultures was difficult (aortic ECs) or even impossible (venous 
ECs), the ELISA was only performed on the immortalized ECs. Immortalized ECs were 
seeded in normal growth medium on gelatin-coated 96-well plates (BD biosciences) at a 
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density of 5000 cells/well. At 3 days post confluence, cultures were incubated for 6 h (E-
selectin) or 12 h (ICAM-1 and VCAM-1) with fresh growth medium supplemented with 
increasing concentrations of recombinant feline TNF-α (0.01, 0.1, 1, and 10 ng/ml; R&D 
Systems, Minneapolis, MN, USA) or vehicle control (PBS plus 0.5% bovine serum albumin; 
Sigma-Aldrich). After stimulation, cells were gently washed once with DMEM and incubated 
with monoclonal antibodies to ICAM-1 (Clone RR1/1; 1:200; santa cruz biotechnology, Santa 
Cruz, CA, USA ), E-selectin (Clone CL2/6; 1:200; Abd serotec) and VCAM-1 (Clone STA; 
1:200; Abd serotec) for 1.5 h on ice. After washing 3 times with DMEM, the EC monolayers 
were fixed with 1% PF for 5 min at RT. After three additional washes with PBS, cells were 
exposed to the secondary antibody, horseradish peroxidase-conjugated goat anti-mouse IgG 
(1:2000; Molecular Probes) for 1 h at RT. Finally, cells were triple washed with PBS 
containing 0.05% Tween 20 (Sigma-Aldrich) and binding of antibody was detected by the 
addition of 50 µl tetramethylbenzidine substrate solution (R&D systems). After exactly 15 
min, the color reaction was stopped by the addition of 50 µl of 1M H2SO4 and the optic 
density (OD) was measured at 450 nm using an ELISA reader (Thermo LabSystems, Beverly, 
MA, USA). Cells stained with isotype matched irrelevant monoclonal antibodies were used as 
background wells. All data points were performed in triplicate and results were expressed as 
mean with standard deviation (SD). 
4.1.3.4 Statistic analysis 
The significance of differences in surface expression of cell adhesion molecules between 
vehicle control and TNF-α treatment at graded doses was calculated with the Mann-Whitney 
U-test (two-tailed). P values equal or lower than 0.05 were considered to be statistically 
significant. All statistical analyses were performed using Graph Pad Prism 5.0 (GraphPad 
Software, San Diego, CA, USA). 
4.1.4 Results 
4.1.4.1 Cell morphology and growth characteristics 
Aorta   At the completion of the primary isolation, aggregates of 20-50 aortic ECs could be 
seen floating in the medium. Cells attached to tissue culture plates within 24 h. After another 
day, marked proliferation began as daughter cells dispersed from one another, indicating their 
amoeboid activity. At confluence, a tightly packed monolayer of slightly elongated cells with 
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some overlapping of adjacent cells was evident (Figure 4.1.1 A). Cells could be propagated 
for one, sometimes two, passages before reaching a state of replicative senescence. 
Following the  transduction of the primary ECs with the SV40LT antigen, there was a 2-week 
period of dramatically decreasing cell viability, followed by the emergence of viable colonies. 
The frequency of clone formation approximated 5x10
-5
 and these clones of fast growing cells 
were further expanded before hTERT transduction. Transformed aortic ECs divided faster and 
were able to grow in medium with a low concentration of FCS (0.5%) and without growth 
factors (heparin and ECGS) that does not support growth of non-transformed cells. Their 
morphology was essentially indistinguishable from that of primary endothelial cells. 
However, in sparse cultures they formed networks, as demonstrated in Figure 4.1.1 B, and 
when allowed to become hyperconfluent, cells were capable of growing to a higher density 
and appeared smaller under these conditions. Transformed aortic cells have been passaged 
over 64 times over the span of 10 months without any change in morphology or growth 
characteristics. 
 
Figure 4.1.1: Morphologic features of primary ECs and EC lines in culture demonstrated by phase contrast 
microscopy. At confluence, primary aortic ECs show an elongated phenotype with no strict contact inhibition 
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(A). Immortalized aortic ECs form networks in sparse culture (B). Confluent monolayers of primary venous ECs 
(C) and immortalized venous ECs (D) demonstrate a characteristic cobblestone-like appearance. Scale bar, 100 
µm. 
Vena cava   Liberated cell clusters from the vena cava, each containing 3 to 7 ECs, adhered 
within 24 h. Cells grew outward from the colonies by migration and proliferation. During this 
stage cells assumed an elongated morphology but formed a contact-inhibited cobblestone-like 
monolayer of polygonal cells at confluence (Figure 4.1.1 C). By the first subculture, cells 
already demonstrated apparent senescence, characterized by slow growth, cellular 
enlargement and multinucleation.  
Three attempts of transduction of independently derived primary venous ECs were necessary 
to generate SV40LT positive clones and the frequency of emergence of the transformed 
clones was in the order of 1-3x10
-6
. In contrast to the parental cells, a substrate of gelatin and 
the presence of high serum concentration and growth factors were not essential for the cell 
attachment and growth of the SV40LT/hTERT expressing cells. The cell line formed a 
monolayer of density-inhibited cells with a cobblestone-like morphology, comparable to their 
primary counterparts (Figure 4.1.1 D). Cells have been maintained in culture for more than 11 
months (53 passages) without any signs of senescence and with preserved characteristics.  
4.1.4.2 Cell characterization by immunofluorescence  
von Willebrand Factor   Cells from primary EC cultures were strongly labeled with 
antiserum against the von Willebrand factor. At high magnification, small fluorescently 
labeled vesicles in a distribution consistent with that of Weibel-Palade (WP) bodies were 
evident (Figure 4.1.2 A and C). Subcultures of non-transformed ECs were only weakly 
positive for vWF and did not contain WP bodies (data not shown). The production of vWF 
was completely extinguished in transformed cells (Figure 4.1.2 B and D). 
Ulex europaeus agglutinin-1   Endothelial cells were stained with lectin, a plant agglutinin 
derived from Ulex europaeus that recognize α-L-fucose-containing glycoproteins present on 
the surface of ECs. A cell membrane-associated staining pattern was clearly evident in 
primary ECs derived from aorta and vena cava (Figure 4.1.2 E and G). A similar positive 
staining was observed in the transformed counterparts (Figure 4.1.2 F and H). 
Uptake of acetylated low-density lipoprotein   Primary ECs and EC lines were evaluated 
for their ability to metabolize Ac-LDL, a function mediated by specific receptors found on 
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ECs and macrophages. Following 4 h incubation with DiI-Ac-LDL-supplemented media, a 
marked accumulation of the fluorescent lipoprotein was observed in all cultures of non-
transformed (Figure 4.1.2 I and K) and transformed cells (Figure 4.1.2 J and L). The dot-like 
fluorescence appeared throughout the cell cytoplasm but was especially concentrated in the 
perinuclear region of the cells. 
Expression of cytoskeletal proteins   To assess the intermediate filament protein profile, 
vimentin and desmin expression was detected by immunocytochemistry. The expression of 
the myofilament, smooth muscle alpha actin, was also examined. Vimentin was expressed 
abundantly and homogenously in the primary and SV40LT/hTERT expressing EC cultures, 
indicating their mesenchymal origin. Cultures lacked desmin and SMA expression, thereby 
excluding the possibility of smooth muscle cell and/or pericyte contamination.  
 
Figure 4.1.2: Characterization of cultured primary ECs and EC lines. Representative examples of 
immunofluorescence stainings of endothelial cell specific markers. Primary ECs (A and C) demonstrate an 
intense perinuclear granular immunofluorescence for vWF, whereas the transformed counterparts (B and D) 
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completely lack vWF expression. Both non-transformed and transformed ECs (E-H) react with UEA-1 lectins, as 
a membrane-associated staining pattern was evident. Primary (I and K) and immortalized (J and L) ECs 
incorporate DiI-Ac-LDL to the same extent, resulting in an intense punctuate fluorescence with predominantly a 
perinuclear distribution. 
Expression of SV40LT antigen and hTERT in EC lines   The success of transformation of 
primary EC cultures to continuous EC lines was confirmed by immunocytochemical staining 
against the two transduced immortalization genes. EC lines were uniformly positive to nuclear 
SV40LT antigen and cytoplasmic hTERT (Figure 4.1.3).   
 
Figure 4.1.3: Immunodetection of SV40LT antigen and hTERT in EC lines. Aortic EC line (A) and venous EC 
line (B) were uniformly positive to nuclear SV40LT antigen (red) and cytoplasmic hTERT (green). Scale bar, 25 
µm. 
4.1.4.3 Capillary-like tube formation on matrigel  
Endothelial cells cultured on an appropriate extracellular matrix, such as matrigel, are capable 
of orienting into capillary-like structures, reminiscent of blood vessel angiogenesis in vivo. To 
evaluate whether transformed ECs retained the capacity to exhibit this endothelial function, 
cells were plated onto matrigel and the extent of tubulogenesis was assessed by light 
microscopic examination at different times after plating. Both EC lines were able to 
demonstrate an angiogenic response. Cells attached rapidly and immediately began to 
elongate and to align themselves into cellular arrays. The onset of tubule-like structure 
formation could be visualized as early as 1 h after plating, with more complex formation and 
extensive branching over the next hours. After 3 to 4 h of initial seeding the immortalized ECs 
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had formed an interconnected network of anastomosing cells that by low power light 
microscopy had a honeycomb appearance. This tubule network only remained stable for 10 to 
12 h after which it disintegrated. Although tube formation of immortalized ECs paralleled that 
of non-immortalized ECs, there were notable differences in both the time course and the 
composition of tube formation. Tubulogenesis of primary ECs was less rapid with elongated 
processes only observed 3 to 4 h after initial seeding and tube-like structure formation 
apparent after 6 to 8 h. Yet, the netlike structures in the non-transformed EC cultures 
maintained for more than 18 h. Tubules eventually retracted and at 24 h cells had clumped 
into a mass. Primary ECs also mainly exhibited single-cell processes (Figure 4.1.4 A and 4B), 
whereas immortalized ECs predominantly reorganized into thicker and multicellular cords 
(Figure 4.1.4 C and D). 
 
Figure 4.1.4: Capillary-like tube formation on matrigel of primary ECs and EC lines. Phase-contrast images 
showing angiogenic response of primary (A) and immortalized (C) aortic ECs and primary (B) and immortalized 
(D) venous ECs, 8 h after plating cells on 24-well plated precoated with matrigel at a density of 10
5
 cells/well. 
Primary ECs (A-B) mainly exhibited single-cell processes, whereas immortalized ECs (C-D) predominantly 
reorganized into thicker, multicellular cords. Scale bar, 100 µm. 
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4.1.4.4 Surface expression of cell adhesion molecules in response to TNF-α  
To estimate the immunologic activity of the transformed ECs, the surface expression of E-
selectin, ICAM-1 and VCAM-1 in response to TNF-α was examined using a cell-based 
ELISA (Figure 4.1.5). E-selectin was not expressed on unstimulated arterial nor venous 
transformed ECs, as similar OD-values were obtained when the primary antibody was 
substituted with an isotype matched irrelevant monoclonal antibody (data not shown). Upon 
EC activation, E-selectin was induced in a dose-dependent manner on both cell lines. Over a 
period of 6 h, TNF-α (10 ng/ml) caused 1.7 and 2.4-fold increases in surface expression 
compared with basal expression on arterial and venous ECs, respectively. We observed a 
complete loss of both constitutive and inducible expression of ICAM-1 on both cell lines. 
ELISA analysis of resting immortalized venous ECs demonstrated a negligible basal 
expression of VCAM-1 and this expression was threefold upregulated after a stimulation 
period of 12 h with TNF-α (10 ng/ml). In contrast, immortalized aortic ECs showed a high 
basal expression of VCAM-1 that was almost two times higher than the maximum de novo 
expression on venous ECs. In addition, the VCAM-1 expression on the aortic ECs was not 
further increased when exposed to TNF-α.  
 
Figure 4.1.5: Surface expression of cell adhesion molecules on EC lines in response to TNF-α. Immortalized 
aortic (A) or venous (B) endothelial cells were incubated for 6 h (E-selectin) or 12 h (ICAM-1 and VCAM-1) 
with either vehicle control or TNF-α at indicated doses. Surface expression was measured by ELISA as 
described in materials and methods. OD450, absorbance units at 450nm. Bars show means with SD from 3 
separate experiments. * Significantly different from control expression, P < 0.05. 
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4.1.5 Discussion 
Endothelial cells are active participants in a wide variety of physiological and pathological 
processes. The ability to isolate and culture ECs has added tremendously to our understanding 
regarding their importance in these processes. Here, we have described in detail reliable and 
relatively simple protocols for the isolation and culture of ECs from feline aorta and vena 
cava. Yet, as described by many others, the use of these primary ECs in cell culture 
technology is confined by their inherently short replicative life span, their fastidious culture 
requirements and their lot-to-lot variability. These limitations have prompted us to undertake 
the immortalization of these primary cells to generate cell lines that provide a consistent 
model system for the study of the vascular endothelium. In this study, we have established 
two novel immortalized feline endothelial cell lines that retained much of the phenotypic 
characteristics of normal ECs and the capacity to recapitulate endothelial functions. To the 
best of our knowledge, this is the first report on the transformation of feline ECs by sequential 
lentiviral transduction with SV40LT and hTERT genes. Primary ECs were first successfully 
transduced with SV40LT allowing cells to proliferate for many population doublings (PDs) 
beyond the point at which original cells become senescent. The ability of this viral oncogene 
to extend the cellular lifespan has been attributed to its competence to abrogate the function of 
the cell cycle regulators p53 and pRb. This permits cells to escape the first mortality 
checkpoint known as “replicative senescence”. However, cells that bypass senescence in this 
way, are still subjected to telomeric shortening and eventually succumb at a second mortality 
checkpoint referred to as “crisis” (Macera-Bloch et al., 2002). Studies have demonstrated that 
in a number of cell types, crisis can be circumvented by restoring telomerase activity 
(Halvorsen et al., 1999; Zhu et al., 1999). According to the telomere hypothesis, telomeric 
repeat DNA at the ends of chromosomes shorten with each cell division in the absence of 
telomerase activity. Once telomeres have shortened below a preset length, cells activate 
mechanisms that irreversibly arrest the cell cycle leading to cellular senescence. Telomerase, 
silenced in most somatic cells, is a ribonuclear protein complex that has a catalytic subunit 
with reverse transcriptase activity (hTERT) which synthesizes and maintains the telomeres 
(Blackburn, 1991; Greenwood and Lansdorp, 2003). Besides, several studies provide 
evidence for an additional protective function of telomerase by physical capping of the 
chromosome ends. This proposed “capping” function prevents cells from inducing a 
senescence checkpoint by protecting telomeres from recognition as damaged DNA even when 
they remain short (Chan and Blackburn, 2002; Zhu et al., 1999). Ectopic expression of 
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hTERT restores telomerase activity giving cells a truly unlimited proliferative potential. 
Although reconstitution of telomerase activity alone is sufficient to confer immortality on 
many primary cells, in our hands the hTERT-mediated transformation did not render the 
feline primary ECs immortalized (data not shown). On the other hand, the association of 
SV40LT and hTERT gene expression was effective to drive these cells continuously through 
the cell cycle. This reinforces the observation of others that additional changes, such as 
inactivation of pRb and p53, are a pre-requisite for hTERT-induced immortalization (Kiyono 
et al., 1998; O'Hare et al., 2001). The feline EC lines have been cultured for more than 50 
passages and none of them show signs of growth arrest or cell death. On top, transformation 
of the EC isolates released the cells from their requirements for pre-formed extracellular 
matrices, exogenous growth factors and high serum concentrations. These data clearly 
demonstrate that the feline ECs are immortalized and can serve as continuously renewable 
cell lines that can be cultured in simple growth medium. Nevertheless, viral oncoproteins have 
pleiotropic effects on cell physiology and can confer altered geno- and phenotype to the 
immortalized cells (Fanning, 1992). Therefore, before utilizing the EC lines as substitutes for 
primary ECs in vitro, it remained to be demonstrated that the immortalized cells retained 
much of the normal physiology of ECs. For this end, phenotypical and functional assays were 
carried out to directly compare the transformed cells with their parental cells. Since no single 
endothelial characteristic is sufficient to confirm endothelial identity, the best means of 
characterizing endothelial cultures is to examine a series of properties and then to make an 
assessment. Characteristic, although not definitive, endothelial features include morphology, 
vWF expression, strong uptake of DiI-Ac-LDL and staining with UEA-1 lectins (Hewett and 
Murray, 1993). Feline EC lines were practically similar to the primary cells in terms of 
morphological appearance, possession of scavenger receptors class A (DiI-Ac-LDL 
endocytosis), and presence of α-L-fucosyl containing glycoproteins on the surface (UEA-1 
binding). Yet, we failed to detect the presence of vWF antigen in the two continuous EC lines, 
whereas the original EC cultures were strongly labeled with antiserum against this 
glycoprotein. Since viral oncoproteins induce chromosomal aberrations in the host cell, it is 
possible that a highly differentiated function, as the production of vWF, is abolished by the 
immortalization procedure. However, as reported by Müller et al., the limitation of a 
monolayer cell culture, deprived of essential physiological factors such as shear stress or the 
presence of other cell types, must be taken into consideration as an alternative, more likely 
explanation (Muller et al., 2002). Indeed, it is known that vWF synthesis is controlled at the 
transcriptional level in response to the tissue microenvironment (Zanetta et al., 2000). The 
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observation that the non-transformed ECs lose their ability to express significant levels of this 
molecule after already the first passage also supports this idea. 
To constitute a relevant model for addressing specific issues of endothelial cell biology, the 
model system must not only closely resemble the phenotype of the original primary cells but 
also exhibit specific EC functions. Therefore, two typical endothelial functions, capillary-like 
tube formation on matrigel and the ability to mobilize adhesion molecules in response to a  
pro-inflammatory stimulus, were used to confirm functionality. ECs are the primary cells 
involved in the formation of new blood vessels or angiogenesis and this can be mimicked in 
vitro by culturing cells on matrigel (Arnaoutova et al., 2009). Non-transformed ECs, placed 
on matrigel, formed branching tube-like structures within 24 h. Despite transformation that 
has conferred on the EC lines, they also clearly responded to this extracellular matrix message 
as they were capable of generating vascular-like channels on matrigel within 12 h.  
Endothelial cells are key regulators of the inflammatory response by controlling leukocyte 
recruitment. Cytokines and other inflammatory mediators induce cell adhesion molecules on 
the surface of ECs which allow leukocytes to recognize sites of inflammation and bind the 
blood vessel wall (Barreiro and Sanchez-Madrid, 2009). We examined the capacity of the 
immortalized ECs to upregulate the expression of cell adhesion molecules E-selectin, ICAM-
1 and VCAM-1 following their stimulation with pro-inflammatory stimuli. TNF-α was used 
because it is a potent stimulator for E-selectin, ICAM-1 and VCAM-1 expression and it is 
produced during many inflammatory processes (Zelova and Hosek, 2013). TNF-α could elicit 
the characteristic upregulation of E-selectin and VCAM-1 on venous immortalized ECs in a 
dose-dependent manner. These results demonstrate that the venous EC line retained its typical 
response to pro-inflammatory stimulation. Aortic immortalized ECs behaved functionally in a 
manner similar to the venous ECs with respect to the cytokine-inducible expression of E-
selectin. However, the aortic EC line exhibited a high constitutive surface expression of 
VCAM-1 that was not further induced upon activation. These differences may reflect the 
heterogeneity of ECs arising from different vascular compartments, as high VCAM-1 
expression on arterial ECs may be pivotal to leukocyte recruitment in regions subjected to 
major hemodynamic stress. However, differences may also be imposed by the 
immortalization procedure. Both cell lines showed a complete loss of both constitutive as 
inducible ICAM-1 expression. In further attempts to induce ICAM-1 expression, shorter (4 h) 
and longer (48 h) time periods of TNF-α (10 ng/ml) treatment and interleukine- 1 (IL-1; 10 
ng/ml) and lipopolysaccharide (LPS; 1 µg/ml) stimulation were tested. No ICAM-1 
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expression was noted 4 h or 48 h after TNF-α treatment. Treatments with IL-1β and LPS for 
12 h failed to induce ICAM-1 expression on both EC lines (data not shown). The absence of 
ICAM-1 expression on the continuous EC lines cannot be explained by a TNF-α-receptor 
defect as this stimulus elicited enhanced expression of E-selectin and VCAM-1. As it was not 
possible to perform the assay with primary ECs, we cannot exclude that non-transformed 
feline ECs in culture lack ICAM-1 expression as well.  
All these data collectively support that the EC lines retained nearly all phenotypic and 
functional characteristics of endothelial cells as defined by essentially and commonly 
accepted criteria. 
In summary, we have described in detail the methodology for the successful isolation and 
culture of feline endothelial cells from aorta and vena cava. By ectopic expression of SV40LT 
and hTERT we have generated EC lines from these primary EC cultures. The induced 
transformation preserved most of the features of vascular endothelium. The ready availability 
of well-characterized feline EC lines opens the door for detailed in vitro studies and will allow 
the dissection of fundamental mechanisms of endothelial bioactivity and endothelial-related 
diseases in cats and humans. 
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4.2 Pro-inflammatory mediators produced by feline infectious peritonitis 
 virus  (FIPV)-infected monocytes, enhance surface expression of 
 endothelial adhesion molecules and promote adherence of  uninfected 
 monocytes to feline venous endothelial cells  
4.2.1  Summary 
The pathology of cats that have succumbed to feline infectious peritonitis (FIP) is 
characterized by multifocal granulomatous vasculitis. The pathogenic mechanism underlying 
these lesions is not fully understood, but a local virus-induced dysfunction of endothelial cells 
(ECs) likely governs disease progression. In this study, we showed that feline venous ECs 
become activated when exposed to supernatant from feline infectious peritonitis virus (FIPV)-
infected monocytes, as indicated by enhanced adhesion molecule expression. Active viral 
replication seemed required to induce the EC-stimulating activity in monocytes. Adhesion 
assays demonstrated an increased adhesion of naïve monocytes to ECs treated with 
supernatant from FIPV-infected monocytes. Taken together, our results strongly indicate that 
FIPV can modulate EC function by an indirect route, in which pro-inflammatory factors 
released from virus-infected monocytes act as key intermediates. FIP patient’s sera did not 
display an EC activating effect, suggesting a local action of the mediators only at the sites of 
vasculitis.  
4.2.2  Introduction 
Feline infectious peritonitis (FIP) is a highly lethal, immunopathological disease in cats 
caused by the virulent variant of feline coronaviruses (FCoVs), feline infectious peritonitis 
virus (FIPV) (Pedersen, 1987). Vascular leakage and infiltration of large numbers of 
leukocytes into tissues characterize the pathology and suggest that leukocyte extravasation is 
one of the main pathophysiological events during FIPV-infection (Kipar et al., 2005). This 
movement of inflammatory cells from the blood into surrounding tissues has been described 
as a complex sequence of adhesion and signaling events between leukocytes and endothelial 
cells (ECs). The upregulation of several adhesion molecules on ECs is a prerequisite for stable 
leukocyte-endothelial cell adhesion that necessarily precedes leukocyte diapedesis (van Buul 
and Hordijk, 2004). There are several families of adhesion molecules that are expressed on 
the endothelial cell surface either constitutively or following activation. Whereas P-selectin 
and E-selectin account for leukocyte rolling along the inner surface of the vessel wall, 
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intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 
mediate subsequent firm leukocyte attachment and migration (Barreiro and Sanchez-Madrid, 
2009; Carlos and Harlan, 1994). Local upregulation of vessel-associated adhesion molecules 
in FIP lesions has been previously demonstrated by our team (Olyslaegers et al., 2014). 
However, the underlying pathogenic mechanism of the endothelial activation remains poorly 
understood. In vivo, endothelial cells are refractory to FIPV infection (Hayashi et al., 1977). 
Therefore, we hypothesized that FIPV mediates EC activation via an indirect route. As 
monocytes are the target cells of FIPV replication, it seems likely that they act as a central 
processor of inflammation by releasing cytokines. These pro-inflammatory molecules may 
further activate downstream the endothelial cells.  
In this work, we evaluated in an in vitro model of feline venous ECs, the ability of FIPV-
infected monocytes to generate soluble mediators which activate ECs, as reflected by 
enhanced surface expression of adhesion molecules. In addition, we analyzed whether the 
alteration in adhesion molecule expression also permitted an enhanced endothelial binding of 
uninfected monocytes. Finally, we examined if inflammatory mediators present in FIP 
patient’s sera could also induce EC activation.  
4.2.3  Material and methods 
4.2.3.1 Isolation of blood monocytes 
Purpose-bred FCoV-, FeLV- and FIV-negative cats, permanently kept at the animal facility of 
the faculty of veterinary medicine of Ghent University, were used as blood donors. 
Mononuclear cells were separated by density gradient centrifugation on Ficoll Paque, as 
described previously (Dewerchin et al., 2005). Briefly, heparinized (15 U/ml; Leo, Zaventem, 
Belgium) blood collected from the vena jugularis was mixed 1:1 with cold PBS, layered onto 
Ficoll-Paque (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom), and 
centrifuged at room temperature. The cell layer at the interface, consisting mainly of 
peripheral blood mononuclear cells (PBMC), was collected and a lysis step was performed to 
remove residual red blood cells.  
For virus inoculation, monocytes from three different blood donors were seeded in 24-well 
tissue culture plates at a concentration of 4 x 10
5
/ml monocytes in RPMI 1640 medium 
(Invitrogen) containing 10% fetal calf serum (FCS, Greiner Bio-one, Kremsmuenster, 
Germany), 100 U/ml penicillin, 0.1 mg/ml
 
streptomycin, 0.1 mg/ml gentamycin, 10 U/ml 
heparin, 1 mM sodium pyruvate and 1% non-essential amino-acids (100×) (Invitrogen). After 
The interaction between the FIPV-infected monocyte and the endothelium 
 
109 
 
overnight incubation, non-adherent cells were removed by washing the dishes twice with 
RPMI 1640. As previously determined in our laboratory, the adherent cells typically consisted 
of 86±7 % monocytes (Dewerchin et al., 2005). 
For adhesion assays, monocytes from one donor that was different from the donors for viral 
infection, were immediately separated from the Ficoll-purified PBMC fraction by positive 
magnetic activated cell sorting (MACS; Miltenyi-Biotec, Bergisch Gladbach, Germany) using 
the monocyte marker DH59B (VMRD Inc., Pullman, WA, USA) and anti-mouse IgG 
microbeads, together with LS separation columns (Miltenyi-Biotec). After this procedure, the 
resulting cell population was represented by > 95% monocytes, as assessed by flow 
cytometry.  
4.2.3.2 Virus and mode of infection 
The serotype ІІ FIPV strain 79–1146, passaged on Crandell Rees feline kidney (CrFK) cells 
and kindly provided by Dr. Egberink (Utrecht University, The Netherlands), was used. For 
UV-inactivation, a thin layer of viral suspension was exposed to short-wave UV light for 10 
min. Inactivation of virus infectivity was verified by plaque assay on CRFKs.  
At 56 h post-seeding, monocytes were mock-infected or inoculated at a multiplicity of 
infection (m.o.i.) of 1 with both replication-competent FIPV and UV-inactivated FIPV. After 
1 h incubation at 37°C, the inoculums were removed, and cells were washed twice with RPMI 
and further incubated with fresh media. Monocyte supernatant was collected at 48 h post 
inoculation (hpi) and centrifuged to remove any cellular debris. In order to inactivate present 
virus, supernatants were irradiated with UV prior to their storage at -70°C. At 48 hpi, 
4.9±0.6% of the monocytes were infected with the replication-competent FIPV, as assessed 
by immunocytochemistry using mAb against the FCoV N-protein. 
4.2.3.3 Serum samples 
Sera were obtained from healthy conventional cats (n=8) and from FIP patients (n=7) by 
centrifugation of coagulated blood for 10 min at 1500 x g, aliquoted, and stored at -70°C. 
Before use, sera were heat inactivated (56°C, 30 min). 
4.2.3.4 Feline venous endothelial cells 
Two feline endothelial cell line were previously generated in our laboratory by simian virus 
40 (SV40) T-antigen- and human Telomerase Reverse Transcriptase (hTERT)-induced 
immortalization of primary venous and arterial ECs. As the venous immortalized ECs were 
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proven to retain their typical immunological activity, these cells were selected to investigate 
the leukocyte-endothelium interaction in FIP. The venous endothelial cell line was propagated 
as previously described (Olyslaegers et al., 2013b).  
4.2.3.6 Adhesion molecule expression assay 
Surface expression of endothelial adhesion molecules was determined using an enzyme-
linked immunosorbent assay (ELISA), as previously described (Olyslaegers et al., 2013b). 
Briefly, ECs were grown to confluence in gelatin-coated 96-well plates (BD biosciences, 
Bedford, MA, USA). EC monolayers were treated with UV-irradiated supernatant of mock-, 
FIPV-, or UV-inactivated FIPV-infected monocytes, heat-inactivated sera (1:4 final dilution) 
from FIP cats or healthy cats, recombinant feline TNF-α (1 ng/ml; R&D Systems, 
Minneapolis, MN, USA) or recombinant feline Il-1β (1 ng/ml; R&D systems) for 6 h (P-
selectin and E-selectin) or 12 h (VCAM-1). Next, ECs were washed once with RPMI and 
incubated for 1.5 h on ice with mouse mAbs against P-selectin, E-selectin, or VCAM-1 (AbD 
Serotec, Raleigh, NC, USA). After three washings, the EC monolayers were fixed with 1% 
PF. Bound primary antibodies were detected by a peroxidase-conjugated goat anti-mouse IgG 
(Molecular Probes, Eugene, Oregon, USA) for 1 h at RT. After a triple wash, a colorimetric 
reaction was performed using tetramethylbenzidine substrate solution (R&D systems). The 
color reaction was stopped after 15 min using 1 M H2SO4 and the absorbance was measured 
at 450 nm. Data are plotted as means ± standard deviation (SD) of three independent 
experiments performed in duplicate. 
4.2.3.7 Monocyte-endothelial adhesion assay 
Endothelial cells were grown to confluence in 16-well Lab-Tek II chamber slides (Thermo 
Scientific, Rochester, NY) and treated with UV-irradiated supernatant of mock-, FIPV-, or 
UV-inactivated FIPV-infected monocytes, TNF-α (1 ng/ml) or Il-1β (1 ng/ml) for 12 h at 
37°C, 5% CO2. After incubation, EC monolayers were washed once with RPMI and 5x10
4
 
MACS-purified monocytes in RPMI were added per well and co-incubated for 30 min at 
37°C. Non-adherent monocytes were removed by washing thrice with RPMI. Finally 4% PF 
was added for 10 min to fix monocytes to the endothelial monolayer. The cell nuclei were 
stained with Hoechst 33342 (Molecular Probes) and the chamber slides were mounted in 
glycerin/PBS (0.9:0.1, v/v) with 2.5% 1,4-diazabicyclo (2,2,2) and analyzed using 
fluorescence microscopy (Leica Microsystems DMRBE, Wetzlar, Germany). Monocytes were 
readily distinguishable from ECs by their smaller, denser, bean-shaped nuclei. The number of 
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adherent monocytes was determined for each treatment, taking the mean of adherent cells 
counted in ten randomly selected microscopic fields at 400x magnification. Three 
independent experiments were performed using culture fluids of monocytes from three 
different blood donors and MACS-purified monocytes from one donor and the results are 
plotted as mean ± standard deviation (SD) of the number of adherent monocytes per 
microscopic field. 
4.2.3.8 Statistic analysis 
Statistical analysis was carried out using the Mann-Whitney U test. Differences were 
considered significant if P ≤ 0.05. All statistical graphs and analyses were created with 
GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA).  
4.2.4  Results 
4.2.4.1 Induction of endothelial cell adhesion molecule expression by culture fluids 
 from FIPV-infected peripheral blood monocytes  
We examined the hypothesis that FIPV-infected monocytes might secrete factors which affect 
endothelial cell properties. Therefore, supernatants derived from FIPV- or mock-infected 
monocytes, cultured for 48 h, were added to feline venous EC cultures and incubated for 6 h 
(P- and E-selectin) or 12 h (VCAM-1) in order to examine the upregulation of the endothelial 
expression of cell adhesion molecules. In parallel, wells with ECs were mock-treated as 
negative control or treated with TNF-alpha and IL-1β as positive controls. As shown in Figure 
4.2.1, no induction of adhesion molecule expression was observed by culture supernatants 
from mock-infected monocytes when compared with the negative control. However, there 
were 49±3%, 89±8%, and 44±11% increases in the absorbance readings for P-selectin, E-
selectin, and VCAM-1, respectively, in ECs exposed to supernatants of FIPV-infected 
monocytes relative to supernatants from mock-infected monocytes and these differences 
reached statistical significance. Similar (P-selectin and VCAM-1) or higher (E-selectin) 
increases in surface expression were observed in the positive control wells, where ECs were 
treated with TNF-α or IL-1β, both in a concentration of 1 ng/ml. These data collectively 
demonstrate that culture fluid derived from FIPV-infected monocytes is capable of activating 
ECs to almost the same extent as known pro-inflammatory stimuli, like TNF-α and IL-1β.  
 
Chapter 4.2 
 
112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.1: Expression of the adhesion molecules P-selectin, E-selectin, and VCAM-1 in untreated venous 
ECs (control) and ECs exposed to supernatant from FIPV- or mock-infected monocytes, feline recombinant 
TNF-α or IL-1β (both 1 ng/ml). Data represent duplicate determinants from three independent experiments and 
are plotted as mean ± SD. Significant difference from the mock sample is indicated by * (P ≤ 0.05 by Mann-
Whitney U test).  
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4.2.4.2 Requirement for infectious virus 
To determine whether infectious virus was required for the induction of endothelial cell-
stimulating activity in monocytes, cells were inoculated with replication-competent FIPV or 
UV-inactivated FIPV. As depicted in Figure 4.2.1, endothelial cell-activated activity was only 
detected in the culture fluid supernatants from monocytes inoculated with infectious virus, 
suggesting that virus replication is required to induce the production of endothelial cell 
activating factor(s).  
4.2.4.3 Effect of sera from FIP patients on endothelial expression of adhesion molecules 
We investigated whether sera from cats with FIP differed in their capacity to activate ECs 
compared with that of healthy controls. Feline venous ECs were incubated with heat-
inactivated sera (1:4 final dilution) from healthy subjects (n=8) and FIP patients (n=7) and the 
surface expression of P-selectin, E-selectin, and VCAM-1 was determined by ELISA. No 
significant difference in surface expression of P-selectin (P = 0.7857), E-selectin (P = 
0.5608), or VCAM-1 (P = 0.4057) could be observed when EC monolayers were treated with 
sera of FIP patients compared with the expression induced by serum samples of healthy 
individuals (Figure 4.2.2). 
 
 
 
 
 
 
 
 
Figure 4.2.2: Differential effect of sera (1:4 final dilution) from healthy controls (n=8) and FIP patients (n=7) on 
the expression of P-selectin, E-selectin, and VCAM-1 on ECs. Data are plotted as mean ± SD. 
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4.2.4.4 Increased adhesion of naïve monocytes to endothelial cell cultures that are 
 pretreated with culture fluids from FIPV-infected peripheral blood monocytes  
We evaluated whether the FIPV-induced alteration in adhesion molecule expression also 
permitted an enhanced binding of uninfected monocytes to the activated endothelium. 
Monocytes were layered for 30 min onto EC monolayers that were pretreated for 12 h as 
described in the section of material and methods. Non-adherent cells were removed and the 
monocytes that remained on the surface of ECs were counted in 10 random microscopic fields 
for each well. Each experiment was performed in triplicate. Results are shown in Figure 4.2.3. 
Only small numbers of monocytes adhered to the negative control EC monolayers, cultured in 
growth medium.  
A similar low number of adherent monocytes were observed when EC cultures were 
pretreated with supernatant from mock-infected monocytes. In contrast, we saw a 4-fold (P = 
0.05) increase in adhesion of uninfected monocytes to the endothelial cell surface that was 
exposed for 12 h to culture fluids of FIPV-infected monocytes. An even more pronounced 
increase in monocyte adherence was observed in the positive control wells, where endothelial 
cells were pretreated with TNF-α (5-fold; P = 0.05) or Il-1β (8-fold; P = 0.05) . 
 
 
Figure 4.2.3: Adhesion of uninfected monocytes to untreated venous EC monolayers (control) or venous EC 
monolayers pretreated for 12 h with supernatant from FIPV- or mock-infected monocytes, feline recombinant 
TNF-α or Il-1β (both 1 ng/ml). Adhered monocytes were quantified by fluorescence microscopy, taking the 
mean of adherent cells counted in ten randomly selected microscopic fields (400x magnification). Three 
independent experiments were performed using MACS-purified monocytes from one donor and the results are 
plotted as mean ± SD of the number of adherent monocytes per microscopic field. Significant difference from 
the mock sample is indicated by * (P ≤ 0.05 by Mann-Whiney U test).  
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4.2.5  Discussion 
The complex pathogenesis of FIP remains a topic of considerable interest with current work 
focusing on the pathogenic mechanism underlying the development of the granulomatous 
vascular lesions. Data presented here demonstrate that transferable factors derived from 
FIPV-infected monocytes initiate EC activation, as shown by the increased expression of 
adhesion molecules on a feline venous EC line. The surface expression of both endothelial 
selectins, P-selectin and E-selectin, was significantly upregulated after 6 h of exposure to 
culture fluids of FIPV-infected monocytes. The selectins are known to mediate the initial 
interaction of leukocytes with the endothelium and although we did not assess leukocyte 
rolling, we hypothesize that the elevated expression of both selectins may be involved in the 
continued rolling of leukocytes in FIP-associated inflammation (Vestweber and Blanks, 
1999). VCAM-1 is a member of the immunoglobulin (Ig) supergene family and is involved in 
firm adherence of leukocytes to the endothelium. VCAM-1 is not present on resting ECs, but 
cytokines can elicit upregulation with peak expression after 12 h (Kelly et al., 2007). In our 
work, there was a baseline expression of VCAM-1 and marked upregulation of surface 
expression after exposure for 12 h to the supernatant of FIPV-infected monocytes. Another 
member of the Ig supergene family, ICAM-1, is also important in leukocyte adherence and is 
constitutively expressed at low levels on ECs, but is significantly upregulated following 
inflammatory stimulation (Kelly et al., 2007). However, as we previously observed a 
complete loss of both constitutive as well as inducible expression of ICAM-1 on the feline 
venous EC line, we were not able to assess the expression of ICAM-1 in our EC model 
system (Olyslaegers et al., 2013b). Yet, since elevated expression of ICAM-1 was observed in 
the vascular lesions of FIP cats, we expect that besides P-selectin, E-selecin and VCAM-1, 
ICAM-1 also plays an essential role in leukocyte extravasation during FIPV infection 
(Olyslaegers et al, 2014).  
In contrast to replication-competent virus, UV-inactivated virus was unable to induce such 
activity in monocytes, indicating that effective virus replication in these cells is a main 
determinant for the generation of endothelial cell-stimulating factors.  
The enhanced surface expression of adhesion molecules was directly related to enhanced 
binding of uninfected monocytes to feline venous ECs exposed for 12 h to supernatants of 
FIPV-infected monocytes. The increase in monocyte adhesion was more pronounced after 
pretreatment for 12 h (4-fold) than 6 h (1.7-fold; data not shown) and paralleled the time 
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required for maximum expression of VCAM-1, which mediates firm leukocyte adhesion to 
the endothelium. The coincidence of the increased adhesion of naïve monocytes to 
endothelium with the increased surface expression of adhesion molecules indicates the 
biological significance of the adhesion molecule expression.  
Although systemically elevated levels of pro-inflammatory cytokines, including TNF-α, Il-1 
and Il-6, have been reported in FIP cats, sera of FIP patients could not induce significant 
higher adhesion molecule expression on feline venous ECs than samples from healthy 
controls (Goitsuka et al., 1990; Kiss et al., 2004; Takano et al., 2009). These results are in 
agreement with our previous study in which the expression of vessel-associated adhesion 
molecules was quantitated immunohistochemically in specimens from FIP cats (Olyslaegers 
et al., 2014). Comparison between the expression of endothelial adhesion molecules in FIP 
lesions and in adjacent, unaffected tissues showed that the upregulation was limited to the 
vessels involved in the granulomas. Based on previous and present findings, we can conclude 
that contained EC activation with respect to adhesion molecule expression occurs in response 
to locally produced cytokines by virus-infected monocytes, creating a microenvironment that 
regulates local leukocyte trafficking despite the general activation of circulating leukocytes. 
In conclusion, we demonstrate that a major mechanism of leukocyte extravasation in FIP is 
the ability of virus-infected monocytes to induce adhesion molecule expression on ECs that 
allows adherence and subsequent transmigration of these monocytes through the EC layer.  In 
addition to this strategy serving as a mechanism for viral spread from the blood into the 
surrounding tissue, this pattern of adhesion molecule induction also facilitates the recruitment 
of naïve monocytes, providing a continuous inflow of susceptible cells for viral replication.  It 
was previously shown that leukocytes from FIP patients show signs of activation in the 
peripheral circulation concerning adhesion (Olyslaegers et al., 2013a). Therefore, it is very 
likely that besides monocytes, the activated ECs in conjunction with the primed leukocytes 
also promote the influx of other leukocyte subtypes. At this level, it might result not only in 
activation but also in damage of ECs, ultimately contributing to the vascular disease 
associated with FIPV infection. Our findings confirm once again the central role of activated 
monocytes in FIP vasculitis and strengthen the view that FIP is a monocyte-triggered systemic 
disease. Understanding the interactions between FIPV-infected monocytes and the 
endothelium not only gives key insights into the pathogenesis of FIPV-associated tissue 
injury, but may provide future strategies for therapeutic interventions.  
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5 
General discussion 
Feline Coronavirus (FCoV) is an important viral agent of felids that causes infections in 
domestic and wild cat populations worldwide. FCoVs present themselves in two different 
biotypes, the low- or avirulent viruses and the highly virulent ones. The former viruses cause 
intestinal infection with no or only mild clinical manifestations. These so-called feline enteric 
coronaviruses (FECVs) are the predominant biotype in the field. Cats infected with the 
virulent biotype, feline infectious peritonitis virus (FIPV), develop a progressive and usually 
fatal, systemic disease termed feline infectious peritonitis (FIP). FIP is represented by 
fibrinous to granulomatous serositis and disseminated granulomatous inflammatory lesions in 
multiple organs, often with effusions in body cavities. The cumulative damage of these FIP 
lesions irrevocably leads to multi-organ failure, ultimately resulting in death. Although 
research over the past 50 years is slowly shedding more light on the pathogenesis of this ever-
present feline disease, the picture is far from complete. In particular, studies characterizing the 
FIP lesions and identifying the pathogenic mechanism underlying their development are 
sparse.   
5.1 Development of FIP lesions: past and current theory 
Traditionally, FIP has been divided into two distinct clinical forms: an effusive (or “wet”) 
form and a non-effusive (or “dry”) form (Montali and Strandberg, 1972).  
In the past, the typical lesions associated with the wet form, polyserositis and generalized 
vasculitis, were considered to be induced by an Arthus reaction (Jaconse-Geels et al., 1982; 
Paltrinieri et al., 1998a; Pedersen and Boyle, 1980; Weiss and Scott, 1981). This local type III 
hypersensitivity reaction involves the in situ formation of antigen-antibody complexes. 
Intravascular and/or perivascular deposition of these circulating immune complexes (ICs) 
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subsequently activates complement, leading to increased vascular permeability and the 
chemotaxis of neutrophils. Next, the resulting endothelial injury further activates the 
coagulatory system. The outcome is a fibrinoid necrosis of the vessel wall with outpouring of 
plasma and disseminated intravascular coagulation (DIC)(Weiss et al., 1980; Weiss and Scott, 
1981).  
In contrast, the histopathological picture of the lesions in the dry form, mainly perivisceral 
granuloma’s, has led many authors to ascribe their development to a type IV hypersensitivity 
reaction (Paltrinieri et al., 1998a; Paltrinieri et al., 1998b; Weiss and Cox, 1988). This so-
called delayed hypersensitivity reaction involves a cell-mediated immune (CMI) response 
rather than the participation of antibodies (Abs). FCoV-infected monocytes enter tissues, 
where they can act as antigen presenting cells (APCs), displaying viral antigen bound to class 
II major histocompatibility complex (MHC II). CD4
+
 T-lymphocytes recognize this complex 
and the proliferation of these cells is stimulated by the APCs. Next, CD8
+ 
T-lymphocytes are 
attracted to the lesions leading to destruction of the target cells. As a consequence of this 
inflammatory reaction initiated by mononuclear leukocytes, typical granulomatous changes 
develop (Paltrinieri et al., 1998a; Paltrinieri et al., 1998b).  
The last decade, several studies appeared that questioned the involvement of both the 
hypersensitivity reaction III and IV in the development of FIP lesions. Berg et al. 
demonstrated that the histopathological pattern of the lesions was rather similar in the effusive 
and the non-effusive form of FIP (Berg et al., 2005). Hence, it was brought forward that the 
commonly used subdivision of “wet” and “dry” form was based more on a clinical 
presentation than on any morphological criteria. Kipar and co-workers also demonstrated that 
the morphology, cellular composition, and distribution of the vascular lesions in FIP differed 
significantly from any IC-mediated vasculitis. In addition, the lack of evidence for a direct 
attack on the vessel wall and the paucity of T-lymphocytes among the cellular infiltrate, on 
the other hand, differentiated FIP vasculitis from a cell-mediated vasculitis (Kipar et al., 
2005). Both Kipar et al. and Berg et al. established the heterogeneous nature of FIP lesions 
concerning cellular composition and expression of viral antigen. However, they both 
emphasized that one cell type stands out as being the key element in both the “wet” and “dry” 
forms of FIP: the macrophage. Therefore, the currently accepted theory states that in FIP, the 
vasculitis is initiated by activated and FCoV-infected, circulating monocytes. After infiltration 
of infected monocytes in the perivascular tissue, the infected monocytes and surrounding cells 
release numerous chemotactic and vasoactive factors. This leads to vasodilatation and 
increased vascular permeability and attraction of new monocytes to the area, which can be 
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infected in turn. The exaggerated extravasation is associated with enhanced local release of 
matix metalloproteinases B (MMP 9) leading to endothelial barrier dysfunction. The outcome 
of the inflammatory reaction is a characteristic phlebitis and periphlebitis which often cause 
the venules to leak large amounts of protein- and fibrin-rich fluid into the body cavity. The 
demonstration of FCoV antigen within intravascular monocytes and among macrophages in 
the granulomas supports the vision that FIPV-infected monocytes mediate the development of 
FIP lesions (Kipar et al., 2005; Rottier et al., 2005).  
Data generated in the present doctoral research support the theory that FIP is a monocyte-
triggered systemic disease and confirm the central role of activated, FIPV-infected monocytes 
in FIP vasculitis. 
5.2 Development of FIP lesions : new insights 
5.2.1 Expression of leukocyte-endothelial adhesion molecules in FIP 
The histologic picture of FIP vasculitis is characterized by extensive infiltration of leukocytes 
into parenchyma, particular in areas around small and medium-sized veins. As stated above, it 
is now well recognized that the development of granulomatous inflammatory processes and 
fatal FIP are the consequence of exaggerated leukocyte transmigration in the surrounding 
tissues. A crucial step in the extravasation process is the adherence of circulating leukocytes 
to vascular endothelial cells (ECs), which is mediated by adhesion molecules expressed on the 
surface of both participating cell types. Yet, despite their critical role in the pathological 
outcome of FIP, the expression of adhesion molecules and their endothelial ligands have not 
been well characterized in FIPV infection. Hence, in a first part of this research, focus was 
placed on determining the expression of adhesion molecules on leukocytes and ECs in FIP. 
5.2.1.1 Expression of leukocyte adhesion molecules in FIP (Chapter 3.1) 
We conducted a comparative analysis on the quantitative expression of adhesion molecules on 
the main leukocyte subpopulations in healthy controls and FIP cats. When analyzing the 
adhesion phenotype on circulating leukocytes it is important not to alter the surface 
expression during cell preparation procedures (Forsyth and Levinsky, 1990; Macey et al., 
1995). Therefore, the formaldehyde-based rapid leukocyte preparation technique was chosen 
to process feline whole blood samples. This technique is specifically designed to minimize ex 
vivo manipulations and subsequently to prevent procedure-related, artefactual changes in the 
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surface expression of function-associated antigens, like adhesion molecules (Hamblin et al., 
1992). In order to assess only the surface expression, the selection of a low concentration of 
paraformaldehyde (PF) and a short fixation time was crucial because the plasma membrane 
integrity decreased substantially with a prolonging fixation time and higher PF concentration, 
as indicated by vimentin staining (Macey and McCathy, 1993). Together with a thorough cell 
labeling and flow cytometric analysis, we believe that our results provide accurate 
information about the in vivo activation status of peripheral blood leukocytes in FIP.  
Histochemical and immunohistochemical characterization of the cellular composition of FIP 
lesions have revealed that macrophages are without question the most predominant cells in the 
inflammatory infiltrate (Berg et al., 2005; Kipar et al., 1998). The macrophages in the 
perivenous infiltrates can be identified as emigrated monocytes, since blood monocytes are 
the immediate progenitors of macrophages and a strong expression of the myeloid/histiocyte 
antigen, a marker for recently blood derived macrophages, was previously detected (Kipar et 
al., 2005). Hence, it was of great interest to gain more information on the adhesion profile of 
circulating monocytes in FIP cats. We demonstrated that the expression of CD11b and CD18, 
that combine to form the β2 integrin macrophage-1 antigen (Mac-1), was elevated on this 
population in FIP. This is in accordance with a study of Kipar et al. (2005) illustrating that 
monocytes/macrophages in vascular lesions exhibit strong expression of CD18, which was 
frequently more pronounced on the cell surface. Since the β1 integrin very late antigen-4 
(VLA-4) is critically involved in monocyte interaction with the endothelium, it was rather 
surprising that the expression level of the α4 subunit (CD49d) of this adhesion molecule was 
significantly lower on monocytes from FIP patients compared with healthy controls. Given 
that Mac-1/ICAM-1 and VLA-4/VCAM-1 represent alternative pathways for the 
transendothelial migration of monocytes, these results may suggest that monocyte 
extravasation in FIP largely depends on β2 integrin/ICAM-1 interaction. Alternatively, these 
findings may indicate that a considerable amount of monocytes, displaying a high density of 
VLA-4, already left the blood circulation, resulting in an absolute lower expression of this 
molecule on the circulating pool of monocytes. 
There is some disagreement about neutrophils in FIP lesions, particularly concerning their 
extent in the inflammatory cell infiltrates. According to Kipar et al. few neutrophils were 
found between macrophages in necrotizing lesions, but in general were rarely seen (Kipar et 
al., 1998). In contrast, there are several studies that claim the opposite. Takano et al. reported 
that the infiltration of large amounts of neutrophils into granulomatous lesions is a typical 
finding of FIP. Moreover, sustained production of neutrophil survival factors by FIPV-
General discussion 
 
125 
 
infected macrophages is sufficient for prolonged neutrophil survival and contributes to the 
development of granulomatous lesions (Takano et al., 2009b). Paltrinieri described that 
cytokines accelerate the migration of neutrophils to inflamed lesions, thereby extending the 
lifespan of circulating neutrophils. In the same study it was demonstrated that the apoptosis of 
neutrophils is delayed by cytokines, thus increasing their existence in lesions (Paltrinieri, 
2008). Finally, cytology of FIP effusion demonstrated that the cellular component mainly 
consist of neutrophils (91%), with the remainder cell fraction composed of macrophages (6%) 
and lymphocytes (3%) (Goitsuka et al., 1991). Nonetheless, in our study we showed that 
granulocytes of FIP cats displayed a significantly increased expression of the α chain of Mac-
1 (CD11b) and the fluorescence associated with the expression of its β2 chain (CD18) was 
also higher compared with controls, though not significantly. So whether or not neutrophils 
are present in large amounts in the granulomatous vasculitis, our results confirm that they at 
least have the capacity to infiltrate the lesions. On top, the light scattergrams of leukocytes 
from the FIP cats included in our study revealed a clear neutrophilia which is a frequent, 
though nonspecific, hematologic finding in FIP cats (Paltrinieri et al., 1998a). Takano et al. 
stated that neutrophilia in FIP cats is likely associated with the infiltration of neutrophils into 
granulomatous lesions (Takano et al., 2009b). 
In our study, circulating B-lymphocytes from FIP patients exhibited higher expression of both 
the β1 integrin VLA-4 and the β2 integrin lymphocyte function-associated antigen (LFA-1; 
CD11a/CD18). This implies that B-lymphocytes can infiltrate the FIP lesions by interacting 
with both ICAM-1 and VCAM-1 expressed on the endothelium. Our findings are consistent 
with the immunohistochemical findings of Kipar et al. and Berg et al., who both showed that 
B-lymphocytes represent the majority of lymphocytes in granulomatous FIP lesions (Berg et 
al., 2005; Kipar et al., 1998). Particularly in lesions without extended necrosis, B-
lymphocytes gradually form a broad band between granulomas and unaltered tissue and 
progressively infiltrate granulomas, hence replacing macrophages. Once in the lesions, B-
lymphocytes seem to develop into plasma-cells bearing FCoV-specific Abs, which may play 
an important role in the maintenance of inflammatory processes in FIP (Kipar et al., 2005). A 
study from Takano et al. suggested that virus-infected macrophages overproduce B-
lymphocyte differentiation/survival factors, and these factors act on B-lymphoyctes and 
promote their maturation into plasma cells in FIPV-infected cats (Takano et al., 2009a). 
Moreover, increased levels of interleukin (IL)-6, a cytokine that functions as regulator of B-
lymphocyte proliferation and differentiation and as inhibitor of apoptosis of these cells, have 
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been reported in ascites and culture supernatant of peritoneal exudative cells from FIP cats 
(Goitsuka et al., 1990a). 
Immunohistochemical analysis of FIP vasculitis demonstrates only a small to moderate 
number of T-lymphocytes, scattered throughout the lesions (Berg et al., 2005; Kipar et al., 
1998). The elevated expression of LFA-1 on T-lymphocytes of FIP patients, recorded in our 
study, suggests that their minority in the cellular infiltrate is not caused by an inability of 
these cells to extravasate. Actually, we assume that this is rather a consequence of an overt T-
cell depletion that is well described in FIP. This is also confirmed in our study by the 
FSC/SSC profiles of peripheral blood leukocytes from FIP patients that illustrated clear 
lymphopenia. Since FIPV does not replicate in peripheral blood lymphocytes, apoptosis of T-
lymphocytes is regarded as a “bystander” effect induced by TNF-α that is produced by FIPV-
infected macrophages (Takano et al., 2007). 
Adhesion molecule expression can be used as an index of the adhesive function and 
consequently the state of activation of the circulating leukocytes in vivo. Therefore, we can 
conclude from our results that leukocytes from FIP cats show signs of activation in the 
peripheral circulation. It is very likely that the priming of blood leukocytes in FIP is one of 
the mechanisms behind the excessive recruitment and accumulation of immune cells resulting 
in granuloma formation and ultimately contributing indisputably to the pathogenesis of FIP. 
5.2.1.2 Expression of endothelial adhesion molecules in FIP (Chapter 3.2) 
The in situ expression of P-selectin, E-selectin, intercellular adhesion molecule (ICAM)-1, 
and vascular cell adhesion molecule (VCAM)-1 was quantified in specimens from FIP cats 
and compared with that of healthy subjects. As the renal cortex and the intestinal wall are 
commonly affected by FIP lesions, these tissues were selected for sampling. From the 
immunohistochemical analysis emerged that the endothelial expression of all four adhesion 
molecules was elevated in FIP. As the molecules analyzed in this study promote the 
attachment of diverse leukocyte subsets to the endothelium, their upregulation is related to the 
recruitment of the characteristic cell infiltrate that typify this disease.  
The first step of extravasation, the reversible tethering and rolling interaction, is mediated by 
members of the selectin family. The expression of both endothelial selectins, P-selectin and E-
selectin, were significantly upregulated in the granulomatous vascular lesions. However, in 
our previous study no significant difference was recorded in the expression level of their 
ligand, sialyl Lewis X (sLex), on any leukocyte population from patients compared with 
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controls. This might be explained by the fact that leukocyte adhesion molecule expression 
was only measured on circulating leukocytes, whereas the expression of endothelial adhesion 
molecules was assessed within the FIP lesions. Therefore, it is likely that the systemic 
changes in adhesion molecule expression differ from the modifications that occur in response 
to locally produced mediators, like cytokines, at the inflammatory site. Indeed, IFN-γ has 
been found to be upregulated within lesions, but downregulated in blood of cats with FIP, 
indicating that the cytokine profile in blood seems to differ significantly from that in the 
tissues (Kiss et al., 2004). In addition to IFN-γ, high levels of TNF-α and Il-1β are measured 
at the site of FIP lesions that may exert a local effect, when cells pass through inflammatory 
sites (Berg et al., 2005; Kipar et al., 2005).  
In a further step of the adhesion cascade, firm leukocyte arrest on the endothelium is mediated 
by members of the immunoglobulin (Ig) supergene family, expressed on ECs, and their 
counter structures on leukocytes, the integrins. Both members of the Ig supergene family, 
ICAM-1 and VCAM-1, displayed an elevated expression on the endothelial lining of the 
blood vessels involved in the FIP granulomas. ICAM-1 interacts with both β2 integrins LFA-1 
and Mac-1 that were upregulated on myeloid cells and lymphocytes in FIP cats, respectively. 
VCAM-1 interacts with VLA-4, a β1 integrin significantly elevated on B-lymphocytes in FIP 
patients. Such tight binding is a direct prerequisite of the transmigration of the leukocytes to 
neighboring tissues. Consequently, the upregulation of these vascular adhesion molecules is 
expected to be responsible for the recruiment and retention of inflammatory cells which typify 
the lesions. Inflammatory lesions in FIP are dominated by monocytes/macrophages 
intermingled with a few neutrophils and B- and T-lymphocytes. Since all vessel-associated 
adhesion molecules are present and all circulating leukocyte subsets show elevated expression 
of their specific counter ligands, we assume that other factors, in addition to adhesion 
molecules, are involved in this selective cell recruitment process. It is also possible that the 
kinetics of expression and the avidity of these adhesion molecules on both endothelium and 
leukocytes, in concert with chemotactic stimuli influence the number and types of 
inflammatory cells at sites of infection.  
Despite overwhelming systemic disease, FIP lesions are typically restricted to small and 
medium-sized veins and are predominantly distributed in selected organs, such as the kidneys 
and intestines (Kipar et al., 2005). Given the strategic location of the endothelium, at the 
interface between circulating leukocytes and extravascular tissue, we reasoned that a 
contained upregulation of vascular adhesion molecules is responsible for the localized 
recruitment and retention of the characteristic FIP infiltrate. Hence, it was examined whether 
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EC activation occurs only locally or also systemically, by comparing the expression of the 
endothelial adhesion molecules in affected and adjacent, non-affected tissues from FIP 
patients. From this comparison we learned that the upregulation was indeed limited to the 
vessels involved in the granulomas. This explains why lesions are not found uniformly 
throughout the body, despite the general activation of circulating leukocytes. Our findings 
concur with a study of Kipar et al., who reported a generalized activation of ECs during the 
course of monocyte-associated viraemia and granulomatous vasculitis in FIP (Kipar et al., 
2005). This was based on the observation of an intense MHC II upregulation and activated 
morphology in venous and, to a lesser extent, arterial ECs, independent of inflammatory 
lesions in the respective vessels. This discrepancy might suggest that the expression of MHC 
II is regulated differently than that of endothelial adhesion molecules. The wide distribution 
of endothelial MHC II expression and the restricted expression of adhesion molecules indicate 
that the former is induced by a systemic cytokine effect, whereas the latter is controlled by a 
local cytokine effect. Indeed, as already noted above, cytokine profile in the blood circulation 
seems to differ significantly from that at sites of inflammation. Consequently, FIP lesions can 
be considered as a micro-environment created by locally produced cytokines that exert their 
function in a paracrine fashion.  
In conclusion, locally activated ECs in association with primed leukocytes can explain the 
perpetuated, enhanced influx of leukocytes, promoting local vasculopathy and ultimately 
contributing to tissue damage, as seen in FIP.  
5.2.2 Elucidation of pathogenic mechanism in FIP 
In the first part of the present thesis, we thoroughly analyzed adhesion molecule expression on 
both leukocytes and ECs in FIP. This descriptive approach was necessary for the next part of 
our research, where we aimed to gain more insights in the sequence of events involved in the 
development of FIP vasculitis. Accordingly, in the second part of this thesis, we attempted to 
unravel the pathogenic mechanism underlying the endothelial activation in FIP lesions.  
5.2.2.1 Representative in vitro model system (Chapter 4.1) 
As the endothelium is actively involved in FIP vasculitis, the in vitro culture of feline vascular 
ECs is an indispensable tool to further elucidate the mechanism of pathological deterioration 
in FIP. Freshly isolated cells are well differentiated and basically represent the in vivo 
situation. However, since primary cells reach replicative senescence after a limited number of 
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population doublings, frequent re-establishment of fresh cell cultures is inevitable. This is a 
time consuming process, which can also add significant variation from one preparation to 
another. To address these limitations for continuous long-term studies and enhance the level 
of standardization, we generated continuous EC lines from the primary feline EC cultures 
isolated from the aorta and vena cava. The ideal immortalized cells are cells that are not only 
capable of extended proliferation, but also possess a similar phenotype as the primary cells. 
However, rapid cell proliferation and a differentiated state are often mutually exclusive. 
Extensive characterization demonstrated that both EC lines constitute a relevant model for 
addressing specific issues of endothelial cell biology, as they closely resembled the phenotype 
of the original primary cells and exhibited specific EC functions.  
In our research, we aimed to investigate the leukocyte-endothelium interaction in FIP, with 
emphasis on the expression of adhesion molecules. Hence, it was crucial to select the EC line 
that could recapitulate its regulatory function during inflammation, in particular the capacity 
to modulate its surface expression of adhesion molecules in response to cytokines. The 
venous immortalized ECs were proven to retain their typical immunologic activity as TNF-α 
could induce E-selectin and VCAM-1 expression in a dose-dependent manner. In contrast, the 
aortic immortalized ECs exhibited a high constitutive surface expression of VCAM-1 that was 
not further induced upon cytokine-activation. This observation motivated us to perform the 
further in vitro experiments with the venous EC line.  
5.2.2.2 The infected monocyte in FIP (Chapter 4.2) 
FIPV-infected macrophages, omnipresent in granulomatous lesions, play a dominant role in 
bringing about the typical immunopathological damage in various organs. The capacity to 
replicate effectively and sustainably in macrophages and their progenitors, the monocytes, 
appears to be an essential in the transition from FECV to FIPV (Dewerchin et al., 2005; 
Rottier et al., 2005; Stoddart and Scott, 1989). Although, FECV preferentially replicates in 
mature intestinal epithelial cells, PCR results in healthy cats showed that FECVs can also be 
detected in blood monocytes and phagocyte-rich organs during the course of natural infection 
(Gunn-Moore et al., 1998; Herrewegh et al., 1995; Meli et al., 2004). Accordingly, monocyte-
associated viraemia can be regarded as a general feature of FCoV infection in cats regardless 
of the development of FIP. However, when FECV reaches the blood circulation, the low 
production of progeny virus and the lack of sustainability results only in a short-term and low-
grade monocyte-associated viraemia (Dewerchin et al., 2005; Stoddart and Scott, 1989). In 
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contrast, during the development of FIP lesions, cats undergo at least intermittent to high-
level, monocyte-associated viraemia (Kipar et al., 2005). This indicates that quantitative 
differences regarding the degree of monocyte infection occur during the transition from FCoV 
infection without disease to the development of FIP. Moreover, it is now well established that 
not only the extent of infection, but also the viral effect on monocytes/macrophages is 
important for the development of FIP. Goitsuka et al. demonstrated that peritoneal exudate 
cells (PECs) recovered from FIP ascitis release a significant level of mouse thymocyte 
proliferating factors in the culture supernatant. As the release was independent of LPS 
stimulation, this strongly indicates the activated status of the PECs (Goitsuka et al., 1987). 
Likewise, quantitative PCR analysis by Berg et al. revealed an increase of IFN-γ mRNA 
levels within the inflammatory lesions, suggestive for the local activation of macrophages 
(Berg et al., 2005). Kipar et al. provided further evidence for the activation of monocytes as 
her study demonstrated that both intravascular and emigrated monocytes/macrophages 
expressed high surface expression of CD18 and were often positive for IL-1β and TNF-α 
(Kipar et al., 2005). Another study of Kipar et al. indicated that FCoV-infected cats which do 
not develop FIP are able to mount an effective FCoV-specific immune response and can avoid 
excessive macrophage activation and subsequently FIP, possibly by upregulation of IL-10 
production (Kipar et al., 2006). Taken together, the activation of monocytes/macrophages 
may therefore represent a hallmark of FIP-inducing FCoVs.  
The generally accepted view that FIPV infection leads to the activation of its host cell, 
suggests that infected monocytes/macrophages secrete mediators that subsequently can 
activate other cells in a paracrine fashion. Data presented in chapter 4.2 support this 
hypothesis, demonstrating that transferable factors derived from FIPV-infected monocytes 
initiate EC activation, as shown by the increased expression of P-selecin, E-selectin, and 
VCAM-1 on the feline venous EC line. As we previously observed a complete loss of both 
constitutive and inducible expression of ICAM-1 on the feline venous EC line, we were not 
able to assess the expression of ICAM-1 in our EC model system (Olyslaegers et al., 2013b). 
Yet, since elevated expression of ICAM-1 was observed in the vascular lesions of FIP cats, 
we expect that besides P-selectin, E-selecin and VCAM-1, ICAM-1 also plays an essential 
role in leukocyte extravasation during FIPV infection. The enhanced surface expression of 
adhesion molecules was directly related to enhanced binding of uninfected monocytes to 
feline venous ECs pretreated with supernatants of FIPV-infected monocytes.  
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Although systemically elevated levels of pro-inflammatory cytokines, including TNF-α, IL-1 
and IL-6, have been reported in FIP cats, sera of FIP patients could not induce significant 
higher adhesion molecule expression on feline venous ECs than samples from healthy 
controls (Goitsuka et al., 1990b; Kiss et al., 2004; Takano et al., 2009b). These results are in 
agreement with our previous study, in which we demonstrated that the enhanced expression of 
the vessel-associated adhesion molecules is limited to the vessels involved in the granulomas. 
Based on previous and present findings, we can conclude that contained EC activation with 
respect to adhesion molecule expression occurs in response to locally produced cytokines by 
virus-infected monocytes, creating a microenvironment that regulates local leukocyte 
trafficking despite the general activation of circulating leukocytes. 
Our findings support the notion that soluble factors are released from FIPV-infected 
monocytes/macrophages that can activate ECs in a paracrine fashion. However, based on our 
results we cannot pinpoint the specific inflammatory mediator(s) derived from the FIPV-
infected monocytes that contribute to the EC activation. TNF-α and IL-1β are known to be 
one of the most potent EC activating factors secreted by monocytes. In vitro studies have 
shown that FIPV-infected monocytes overexpress TNF-α and IL-1β (Dean et al., 2003; Kipar 
et al., 2005). Both cytokines have a variety of activities relevant to producing vascular 
abnormalities. The cytokines interact with specific endothelial cell receptors triggering 
increased endothelial permeability and loss of anticoagulant activity (Dinarello, 1991). In 
addition, TNF-α is known to be a potent inducer of IL-6 that in turn mediates increased 
endothelial cell permeability (Jirik et al., 1989; Maruo et al., 1992). Furthermore, a recent 
study provided evidence that vascular endothelial growth vactor (VEGF) is produced by 
FIPV-infected monocytes/macrophages and increases both the vascular permeability and the 
amounts of effusion in cats with FIP and VEGF production is increased by IL-6 (Feurino et 
al., 2007; Takano et al., 2011a). Nonetheless, since neutralizing Abs against feline TNF-α and 
IL-1β are not available we can only assume a role of these pro-inflammatory cytokines in 
mediating the endothelial cell activation during the course of FIP.  
In conclusion, we demonstrate that a major mechanism of leukocyte extravasation in FIP is 
the ability of virus-infected monocytes to activate the (initially) naïve endothelium. It was 
shown that FIPV infection of monocytes induces the generation of soluble mediators, which 
in turn enhance surface expression of vessel-associated adhesion molecules required for the 
initial tethering and subsequent firm adhesion of the leukocytes to the endothelium. This can 
facilitate the binding and penetration of virus-infected monocytes through the endothelium, 
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allowing viral dissemination throughout the body. In addition, our results prove that the 
upregulation of endothelial adhesion molecules also promotes the adhesion of uninfected 
monocytes to the endothelium, providing a continuous inflow of susceptible cells for viral 
replication. As we showed that leukocytes from FIP patients show signs of activation in the 
peripheral circulation concerning adhesion (Olyslaegers et al., 2013a). It is very likely that 
besides monocytes, the activated ECs in conjunction with the primed leukocytes also promote 
the influx of other leukocyte subtypes. At this level, it might result not only in activation but 
also in damage of ECs. Furthermore, activated ECs, in turn, can stimulate the adherent cells in 
a contact-dependent manner and produce a wide variety of inflammatory and immune 
modulatory mediators. The subsequent consequence of EC activation and downstream 
cascade of inflammatory cytokine production is a secondary wave of leukocyte recruitment 
that can result in the amplification of the inflammatory vascular injury and aggravation of the 
FIP pathology.  
These data confirm once again the central role of activated monocytes in FIP vasculitis and 
strengthen the view that FIP is as a monocyte-triggered systemic disease. Understanding the 
interactions between FIPV-infected monocytes and the endothelium not only gives key 
insights into the pathogenesis of FIPV-associated tissue injury, but may provide future 
strategies for therapeutic interventions.  
5.3 Location of FIP lesions: a hypothesis 
FIP lesions are typically confined to small and medium-sized veins, primarily located in 
leptomeninges, renal cortex, eyes and, less frequently, in lungs and liver. In chapter 3.2 we 
showed that the enhanced expression of endothelial adhesion molecules is limited to the 
vessels involved in the granulomas. This can explain why lesions are not found uniformly 
throughout the body, despite the general leukocyte activation. However, it does not clarify the 
characteristic location of FIP lesions. Hypothetically, the existence of different subsets within 
the feline monocyte population together with a difference in susceptibility for FIPV infection 
might account for this distinctive distribution of granulomas.  
The term “monocyte” implies a single, homogenous population of cells with uniform 
physiology. However, it is now largely accepted that heterogeneity exists among blood 
monocytes, concerning their function and degree of maturation/activation. In humans, the 
differential expression of CD14 and CD16 was traced initially to define 2 major subsets in the 
peripheral blood: the so-called “classical’ CD14+CD16- monocytes, typically representing up 
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to 95% of the monocytes in a healthy individual, and the ‘non-classical’ CD14lowCD16+ 
monocytes, comprising the remaining fraction of the monocytes (Tacke and Randolph, 2006). 
The homologues of these two major monocyte subsets were already identified in nonhuman 
primates, mouse, rat, and pigs (Gordon and Taylor, 2005). Therefore, it is very likely that this 
dichotomy in the monocyte population is conserved in other mammalian species, including 
cats. Both subsets differ in expression of adhesion molecules and chemokine receptors, which 
suggest different modes of tissue trafficking. Indeed, it is reported that monocytes that show 
constitutive trafficking into healthy tissues belong to a different group than monocytes that 
home only to inflamed tissues (Auffray et al., 2009; Muller, 2001). The former subset serves 
as a precursor for resident myeloid cells in non-inflamed tissues including skin, liver, lung, 
brain, and spleen. Additionally, this subset may be further divided into subpopulations that 
specifically replenish tissue macrophages in the distinct compartments. Hence, when leaving 
the bone marrow these monocytes are already primed to enter certain tissues under steady 
state conditions (Geissmann et al., 2003; Tacke and Randolph, 2006).  
The distinct sets of adhesion molecules and chemokine receptors on the monocyte subsets 
might result not only in different migration patterns, but can confer differential susceptibility 
to infections. This was already reported for human immunodeficiency virus (HIV)-1, as it was 
shown that the minor CD14
low
/CD16
+
 monocyte subpopulation is preferentially susceptible to 
HIV-1 infection and consequently constitute a continuing source of viral persistence (Ellery et 
al., 2007). Because very few monocytes harbor FIPV in vitro and in vivo, this raises the 
possibility of the existence of a monocyte subset that is more permissive for FIPV infection. 
Since this subset is likely to be predetermined to home to specific tissues, the FIPV-infected 
monocytes are targeted to specific venules. Hijacking the physiological mechanisms of 
replenishment of the resident tissue macrophages by circulating monocytes, promotes viral 
seeding and establishes local vascular inflammation at these sites through trafficking of 
infected monocytes from the circulation. After monocytes enter tissue, they differentiate into 
macrophages, which increase their ability to support virus replication. Subsequently, the 
infected and activated macrophages release chemotactic mediators in the perivascular space 
that recruit additional monocytes from the periphery, amplifying the cascade finally resulting 
in granuloma formation. Additonally, as affected animals have lesions at various stages of 
development and FIP vasculitis appears to be associated with high-level, monocyte-associated 
viremia, it is likely that cats undergo recurrent bouts of monocyte-associated viremia with 
development of new lesions in each viremic phase (Gunn-Moore et al., 1998; Kipar et al., 
2005).  
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5.4 The main conclusions drawn from this thesis 
 The formaldehyde-based rapid leukocyte preparation technique was applied on feline 
whole blood samples, allowing the analysis of the true state of adhesion molecule 
expression on the surface of peripheral blood leukocytes in FIP.  
 Leukocytes from FIP patients show signs of systemic activation, as reflected by an 
increased surface expression of adhesion molecules. More specific, granulocytes and 
monocytes of FIP cats display more Mac-1 and circulating FIP lymphocytes (B- and T-
cells) express higher densities of LFA-1 than control subjects. In addition, the expression 
of VLA-4 is elevated on B-lymphocytes from FIP patients. 
 The surface expression of the endothelial cell adhesion molecules, P-selectin, E-selectin, 
ICAM-1, and VCAM-1, is upregulated in FIP. 
 The enhanced expression of the vessel-associated adhesion molecules is limited to the 
vessels involved in the granulomatous vascular lesions. 
 Two novel immortalized feline endothelial cell lines were established from primary feline 
EC cultures isolated from aorta and vena cava. As both EC lines retained much of the 
phenotypic characteristics of normal ECs and the capacity to recapitulate endothelial cell 
functions, they provide consistent model systems for the study of the vascular 
endothelium. 
 As the venous immortalized ECs were proven to retain their typical immunologic activity, 
these cells were used to investigate the leukocyte-endothelium interaction during FIPV 
infection.  
 Monocytes infected with replication-competent FIPV are able to generate soluble 
mediators which can activate venous ECs in a paracrine fashion, as reflected by enhanced 
surface expression of the endothelial adhesion molecules P-selectin, E-selectin, and 
VCAM-1. 
 The enhanced surface expression of adhesion molecules permits an increased adhesion of 
naive monocytes to feline venous ECs that were pretreated with supernatants of FIPV-
infected monocytes.  
 FIP patient’s sera did not display an EC activating effect, suggesting a local action of the 
mediators only at the site of infection. 
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Figure 5.1: Development of FIP lesions, a hypothetical model. (A) FIPV infection of the monocyte activates the 
host cell to release cytokines, which act in an autocrine and paracrine fashion. (B) In response to the cytokine 
stimulation, adhesion molecules, that support leukocyte rolling, firm adhesion, and transmigration, are elevated 
on both the monocyte and endothelial cells. (C) After transmigration, the infected monocyte differentiates into a 
macrophage, which implies a higher capacity to support viral replication and subsequently more release of pro-
inflammatory cytokines and also chemokines. (D) More adhesion molecules are expressed at the endothelial 
surface and additional leukocytes, including neutrophils, T-lymphocytes, B-lymphocytes, and monocytes, are 
recruited. (E) Exuberant leukocyte trafficking through the endothelium takes place at the site of infection. (F) 
The infiltrated cells pack together to form a perivascular granuloma, the hallmark lesion of FIP. In case of the 
effusive form of FIP, the endothelial barrier integrity is lost, resulting in the leakage of protein-rich fluid, 
effusion, from the blood into body cavities. 
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6 
Summary - samenvatting 
6.1 Summary 
Feline infectious peritonitis (FIP) is a highly lethal, systemic disease in domestic and wild 
cats, caused by a Feline Coronavirus (FCoV). Chapter 1 summarizes the current literature on 
feline coronaviruses. FIP pathology is typically characterized by multifocal granulomatous 
vascular lesions in several vital organs, often with protein-rich effusions in body cavities. The 
pathogenic mechanism underlying these hallmark lesions is complex with many unresolved 
issues relating to the role of leukocyte extravasation during feline infectious peritonitis virus 
(FIPV)-infection. Therefore, the general goal of this doctoral research, formulated in Chapter 
2, was (1) to identify the adhesion molecules that mediate the leukocyte interaction with 
vascular endothelial cells and (2) to elucidate the mechanism responsible for the exaggerated 
leukocyte extravasation in FIP. 
Chapter 3 bundles the research results addressing the first aim of the thesis; assessment of the 
expression and distribution of leukocyte adhesion molecules and their endothelial ligands 
during FIPV infection. In Chapter 3.1, it was investigated if the surface expression of 
adhesion molecules on peripheral blood leukocytes is altered in FIP. In a cross-sectional study 
of 15 FIPV-infected cats and 12 healthy controls, the expression level of the leukocyte 
principal adhesion molecules involved in leukocyte transmigration (CD15s, CD11a, CD11b, 
CD18, CD49d and CD54) was quantified on the predominant peripheral leukocyte 
populations by flow cytometry. Great care was taken at the level of patient selection, 
leukocyte preparation, cell labeling and flow cytometric analysis to reflect the activation 
status of peripheral leukocytes in vivo as accurate as possible. Leukocytes were prepared by 
the formaldehyde-based rapid leukocyte preparation technique to minimize the degree of cell 
manipulation and thereby avoiding ex vivo alterations in cell surface marker expression. 
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Striking differences in light scattergrams of leukocytes from healthy and FIP cats were noted. 
Most likely, this can be ascribed to FIP hematology that often reveals neutrophilia together 
with lymphopenia. Using the mean fluorescence intensity (MFI) parameter, significant 
alterations in the expression of integrins were demonstrated on peripheral blood leukocytes 
from FIP patients compared with healthy controls. More specific, T-and B-lymphocytes from 
FIP patients expressed significantly higher densities of the β2 integrin lymphocyte function-
associated antigen-1 (LFA-1; CD11a/CD18). In addition, the expression of the α4 subunit 
(CD49d) of the β1 integrin very late antigen (VLA)-4, was significantly elevated on B-
lymphocytes from FIP patients. The latter is consistent with the immunohistochemical 
findings of FIP lesions showing that B-cells and plasma-cells progressively infiltrate 
granulomas. The expression of both CD11b and CD18, that combine to form the β2 integrin 
membrane associated complement receptor (Mac)-1, was significantly elevated on monocytes, 
whereas the density of CD49d was significantly reduced on this leukocyte population in FIP. 
This might indicate that monocyte extravasation in FIP is largely beta2 integrin-depended. 
Granulocytes of FIP cats displayed a significantly increased expression of the α chain of Mac-
1 (CD11b) and the fluorescence associated with the expression of its β chain (CD18) was also 
higher compared with controls, though not significantly. Due to their key role in firm 
leukocyte adherence, increased numbers of integrins may predispose leukocytes to augmented 
adhesion. Our findings suggest that leukocytes from FIP patients show signs of systemic 
activation in the peripheral circulation, which might play a considerable role in the excessive 
recruitment and accumulation of immune cells resulting in granuloma formation and 
ultimately contributing to the pathogenesis of FIP disease. In Chapter 3.2, we aimed to 
determine whether endothelial cells (ECs) in FIP patients are activated to increase their 
adhesiveness to leukocytes, as reflected by elevated surface expression of adhesion molecules. 
A study was designed to quantify and compare the in situ expression of P-selectin, E-selectin, 
intercellular adhesion molecule (ICAM)-1, and vascular cell adhesion molecule (VCAM)-1 
on ECs at sites of FIP lesions versus normal tissue, using immunohistochemistry. The surface 
expression of all four adhesion molecules was significantly upregulated on ECs in FIPV-
infected tissues versus samples of healthy controls, providing further support for a prominent 
role of leukocyte extravasation in the development of FIP lesions. In addition, we tested 
whether EC activation in FIP occurs locally or systemically. Comparison between the 
expression of the vessel-associated adhesion molecules in FIP lesions and in adjacent, 
unaffected tissues, showed that this upregulation was limited to the vessels involved in the 
granulomas, explaining the specific location of FIP lesions despite general activation of 
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circulating leukocytes. In conclusion, locally activated ECs in association with primed 
leukocytes might explain the perpetuated, upregulated influx of leukocytes, promoting 
vasculopathy and ultimately contributing to tissue damage, as seen in FIP.   
Chapter 4 deals with the elucidation of the pathogenic mechanism underlying the endothelial 
activation in FIP lesions. For this purpose the set up of a representative in vitro model system 
was required. Chapter 4.1 details the methodology for the isolation and culture of feline 
endothelial cells from aorta and vena cava. The use of these primary ECs was confined by 
their inherently short replicative life span and their fastidious culture requirements. These 
limitations and the need for consistent material throughout long-term studies have prompted 
us to undertake the immortalization of these primary cells to generate immortalized EC lines. 
The transformation of the primary EC cultures was established by sequential lentiviral 
transduction with simian virus 40 large T (SV40LT) antigen and the catalytic subunit of 
human telomerase (hTERT). Before utilizing the novel EC lines as substitutes for primary 
ECs in vitro, it remained to be demonstrated that the immortalized cells retained much of the 
normal physiology of ECs. To this end, phenotypical and functional assays were carried out to 
directly compare the transformed cells with their parental cells. Established cell lines 
exhibited several inherent endothelial properties, including typical cobblestone morphology, 
binding of endothelial cell-specific lectins and internalization of acetylated low-density 
lipoprotein. In addition, the immortalization did not affect the functional phenotype as 
demonstrated by their capacity to rapidly form cord-like structures on matrigel and to express 
cell adhesion molecules following cytokine stimulation. The ready availability of well-
characterized feline endothelial cell lines with a known and constant functional profile will 
enable a greater understanding of fundamental mechanisms underlying the FIP pathogenesis. 
Furthermore, the use of cell lines is an effective implementation of the 3-R principles 
formulated by Russel and Burch. In Chapter 4.2, we examined the hypothesis that feline 
infectious peritonitis virus (FIPV)-infected peripheral blood monocytes might generate 
soluble mediators which affects endothelial cell properties. It was demonstrated that 
transferable factors derived from FIPV-infected monocytes initiate EC activation, as shown 
by the increased expression of adhesion molecules P-selectin, E-selectin, and VCAM-1 in the 
previously generated feline venous EC line. Culture fluids of monocytes inoculated with UV-
inactivated FIPV did not increase endothelial expression of these adhesion molecules, 
suggesting that effective virus replication is required to induce the production of endothelial 
cell-activating factor(s). Next, we evaluated whether the FIPV-induced alteration in adhesion 
molecule expression also permitted an enhanced binding of uninfected monocytes to the 
Chapter 6 
 
142 
 
activated endothelium. Adhesion assays demonstrated an increased adhesion of naive 
monocytes to ECs treated with culture fluids from FIPV-infected monocytes versus mock-
infected monocytes, indicating the biological significance of the adhesion molecule 
expression. Finally, we investigated whether sera from cats with FIP differed in their capacity 
to activate ECs compared with that of healthy controls. No significant difference in surface 
expression could be observed, suggesting that inflammatory mediators released by FIPV-
infected monocytes act only locally at the site of infection. In conclusion, these data strongly 
suggest that the mechanism for FIPV entry into the tissue is a consequence of the ability of 
virus-infected monocytes to induce adhesion molecule expression on ECs that allows 
adherence and subsequent transmigration of these monocytes through the EC layer. In 
addition to this strategy serving as a mechanism for viral spread from the blood into the 
surrounding tissue, this pattern of adhesion molecule induction also facilitates the recruitment 
of naive monocytes, ultimately promoting the vascular disease associated with FIPV 
infection. 
Chapter 5 provides a general discussion on the research data generated in this thesis. In a first 
part, the past and current theory on the development of the FIP lesions is discussed. Next, the 
focus is laid on the new insights in this matter obtained by our findings. In a final part, a 
hypothesis is provided to explain the specific location of FIP lesions. 
Several important conclusions can be drawn from this thesis: 
 The formaldehyde-based rapid leukocyte preparation technique was applied on feline 
whole blood samples, allowing the analysis of the true state of adhesion molecule 
expression on the surface of peripheral blood leukocytes in FIP.  
 Leukocytes from FIP patients show signs of systemic activation, as reflected by an 
increased surface expression of adhesion molecules. More specific, granulocytes and 
monocytes of FIP cats display more Mac-1 and circulating FIP lymphocytes (B- and T-
cells) express higher densities of LFA-1 than control subjects. In addition, the expression 
of VLA-4 is elevated on B-lymphocytes from FIP patients. 
 The surface expression of the endothelial cell adhesion molecules, P-selectin, E-selectin, 
ICAM-1, and VCAM-1, is upregulated in FIP. 
 The enhanced expression of the vessel-associated adhesion molecules is limited to the 
vessels involved in the granulomatous vascular lesions. 
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 Two novel immortalized feline endothelial cell lines were established from primary feline 
EC cultures isolated from aorta and vena cava. As both EC lines retained much of the 
phenotypic characteristics of normal ECs and the capacity to recapitulate endothelial cell 
functions, they provide consistent model systems for the study of the vascular 
endothelium. 
 As the venous immortalized ECs were proven to retain their typical immunologic activity, 
these cells were used to investigate the leukocyte-endothelium interaction in FIP.  
 Monocytes infected with replication-competent FIPV are able to generate soluble 
mediators which can activate venous ECs in a paracrine fashion, as reflected by enhanced 
surface expression of the endothelial adhesion molecules P-selectin, E-selectin, and 
VCAM-1. 
 The enhanced surface expression of adhesion molecules permits an increased adhesion of 
naive monocytes to feline venous ECs that were pretreated with supernatants of FIPV-
infected monocytes.  
 FIP patient’s sera did not display an EC activating effect, suggesting a local action of the 
mediators only at the site of infection.  
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6.2 Samenvatting 
Felien infectieuze peritonitis (FIP) is een progressieve, systemische ziekte in zowel 
gedomesticeerde als wilde katachtige met een vaak fatale afloop, veroorzaakt door het felien 
coronavirus (FCoV). Hoofdstuk 1 geeft een samenvatting van de huidige literatuur over de 
feliene coronavirussen. De pathologie geassocieerd met FIP is gekarakteriseerd door 
multifocale, granulomateuze, vasculaire laesies in verscheidene vitale organen, vaak gepaard 
met eiwitrijk vocht in de lichaamsholten. Het achterliggend pathogenetisch mechanisme van 
deze typische FIP letsels is complex met veel onwetendheid omtrent de rol van leukocyt 
extravasatie tijdens een infectie met het felien infectieuze peritonitis virus (FIPV). Vervolgens 
was de algemene doelstelling van dit doctoraatsonderzoek, geformuleerd in Hoofdstuk 2, (1) 
het identificeren van de adhesiemoleculen die de leukocyt interactie met het endotheel 
bewerkstelligen en (2) het mechanisme op helderen dat verantwoordelijk is voor de 
buitensporige leukocyt extravasatie in FIP.  
Hoofdstuk 3 bundelt de onderzoeksresultaten die de eerste doelstelling van de thesis 
behandelt; zijnde de analyse van de expressie en distributie van leukocyt adhesiemoleculen en 
hun corresponderende endotheliale liganden tijdens een FIPV infectie. In Hoofdstuk 3.1 werd 
nagegaan of de oppervlakte expressie van de adhesiemoleculen op perifere bloedleukocyten 
gewijzigd is in FIP. In een cross-sectioneel onderzoek van 15 FIP patiënten en 12 gezonde 
controles werd de expressie van de voornaamste adhesiemoleculen betrokken bij leukocyt 
transmigratie (CD15s, CD11a, CD11b, CD18, CD49d en CD54) gekwantificeerd op de 
belangrijkste leukocyt populaties met behulp van flowcytometrie. Om de in vivo activatie 
status van de leukocyten zo accuraat mogelijk weer te geven, werd veel aandacht geschonken 
aan de patiëntenselectie, de bewerking en de kleuring van de leukocyten en de 
flowcytometrische analyse. Leukocyten werden verwerkt volgens de snelle leukocyt 
bereidingstechniek op basis van formaldehyde. Dit om de manipulatie van de cellen te 
beperken zodat er geen ex vivo wijzigingen in de oppervlakte expressie van de celmerkers 
optreden. Duidelijke verschillen in de voorwaartse/zijwaartse lichtverstrooiing tussen de 
leukocyten van FIP katten en deze van de gezonde katten werden opgemerkt. Waarschijnlijk 
kan dit worden toegeschreven aan de FIP hematologie dat vaak een neutrofilie gepaard met 
een lymfopenie vertoont. Aan de hand van de parameter gemiddelde fluorescentie intensiteit 
(MFI) werden significante verschillen gedetecteerd in de expressie van integrins op 
leukocyten van FIP patiënten en deze van gezonde controles. T- en B-lymfocyten van FIP 
patiënten vertoonde een hogere expressie van lymfocyt functie-geassocieerd antigen-1 (LFA-
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1; CD11a/CD18) dat behoort tot de β2 integrins. Daarnaast was de expressie van de α4 subunit 
(CD49d) van het erg laat antigen (VLA)-4, deel uitmakend van de β1 integrins, duidelijk 
verhoogd op B-lymfocyten van FIP patiënten. Dit laatste is consistent met de 
immunohistochemische bevinding van FIP laesies die duidelijk demonstreren dat B-
lymfocyten en plasmacellen progressief infiltreren in de granulomas. De expressie van zowel 
CD11b en CD18, die samen de membraan geassocieerde complement receptor (Mac)-1 
vormen (een β2 integrin), was significant opgereguleerd op FIP monocyten, terwijl de 
dichtheid van CD49d duidelijk gedaald was op deze populatie in FIP. Dit kan betekenen dat 
monocyt extravasatie in FIP grotendeels β2 integrin-afhankelijk is. Granulocyten van FIP 
katten vertoonden een duidelijk verhoogde expressie van de α keten van Mac-1 (CD11b) en 
de fluorescentie geassocieerd met de expressie van zijn β keten (CD18) was eveneens 
verhoogd vergeleken met de controle, doch niet statistisch significant. Gezien hun sleutelrol 
in de leukocyt adhesie, kan een verhoogd aantal integrins de leukocyten predisponeren tot 
verhoogde adhesie. Onze bevindingen suggereren dat leukocyten van FIP patiënten in de 
perifere circulatie tekenen vertonen van systemische activatie, dewelke waarschijnlijk een 
aanzienlijke rol speelt in de overmatige rekrutering en accumulatie van immuuncellen. Dit 
leidt tot granuloomvorming en draagt finaal bij tot de pathogenese van FIP. In Hoofdstuk 3.2 
werd nagegaan of endotheelcellen (ECs) in FIP patiënten geactiveerd zijn en aldus een 
verhoogde expressie vertonen van adhesiemoleculen waardoor meer leukocyten kunnen 
vasthechten. Met behulp van immunocytochemistry werd de in situ expressie van P-selectin, 
E-selectin, intercellulair adhesiemolecule (ICAM)-1, en vasculair cel adhesiemolecule 
(VCAM)-1 op ECs  in FIP laesies gekwantificeerd en vergeleken met de endotheliale 
expressie in gezond weefsel. De oppervlakte expressie van de vier adhesiemoleculen was 
significant opgereguleerd op ECs in FIPV-geïnfecteerd weefsel versus stalen van gezonde 
controles. Deze resultaten bekrachtigen de rol van leukocyt extravasatie in de ontwikkeling 
van FIP laesies. Bovendien werd gekeken of deze EC activatie in FIP enkel lokaal of ook 
systemisch plaatsvindt. Vergelijking van de expressie van de adhesiemoleculen in FIP laesies 
en dat in aanliggend, onaangetast weefsel gaf aan dat de opregulatie beperkt was tot 
bloedvaten betrokken in de granulomen. Dit verklaart de specifieke locatie van FIP laesies 
ondanks de algemene activatie van de circulerende leukocyten. Ter conclusie, lokaal 
geactiveerde ECs samen met geactiveerde leukocyten bieden een mogelijke verklaring voor 
de verhoogde influx van leukocyten die leidt tot vasculopathie en uiteindelijk bijdraagt tot de 
aanzienlijke weefselschade die wordt waargenomen in FIP. 
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Hoofdstuk 4 behandelt de opheldering van het onderliggend pathogenetisch mechanisme van 
de endotheel activatie in FIP laesies. Voor dit doeleinde was de opstelling van een 
representatief in vitro model noodzakelijk. Hoofdstuk 4.1 documenteert de methodologie van 
de isolatie en cultivatie van feliene endotheelcellen afkomstig van de aorta en de vena cava. 
Het gebruik van primaire ECs is echter gelimiteerd door hun inherente korte replicatieve 
levensduur en hun zeer selectieve cultuurbenodigdheden. Deze beperkingen samen met de 
nood aan consistent celmateriaal tijdens lange termijn studies heeft ons aangezet tot de 
immortalisatie van deze primaire cellen ten einde continue endotheelcellijnen te genereren. 
De transformatie van de primaire EC culturen werd verkregen door de sequentiële lentivirale 
transductie met het simian virus 40 large T (SV40LT) antigen en de katalytische subunit van 
het humane telomerase (hTERT). Alvorens de nieuwe cellijnen konden worden aangewend 
als substituut voor de primaire ECs in vitro studies, moest worden aangetoond dat de 
geïmmortaliseerde cellen zo veel mogelijk van de normale fysiologie van ECs hadden 
behouden. Hiervoor werden zowel fenotypische als functionele testen uitgevoerd om de 
getransformeerde cellen direct te vergelijken met de parentale cellen. De cellijnen vertoonde 
meerdere eigenschappen inherent voor endotheelcellen waaronder de typische morfologie, 
binding van endotheelcel-specifieke lectines en internalisatie van geacetyleerd laag-densiteit 
lipoproteïnen. Daarenboven werd het functionele fenotype niet aangetast door het 
immortalisatieproces, aangetoond door hun capaciteit om snel buisvormige structuren te 
vormen op matrigel en adhesiemoleculen tot expressie te brengen na cytokine stimulatie. De 
beschikbaarheid van goed gekarakteriseerde feliene endotheelcellijnen met een gekend en 
constant functioneel profiel zal een grotere kennis van de fundamentele mechanismes in de 
FIP pathogenese mogelijk maken. Bovendien is het gebruik van cellijnen een effectieve 
implementatie van het 3-V principe geformuleerd door Russel en Burch. In hoofdstuk 4.2 
werd onderzocht of FIPV-geïnfecteerde monocyten in staat zijn om oplosbare mediators te 
produceren die de eigenschappen van het endotheel kunnen aantasten. Er werd aangetoond dat 
transferabele factoren, afkomstig van FIPV-geïnfecteerde monocyten, EC activatie initiëren. 
Deze activatie is weerspiegeld door de verhoogde expressie van de adhesiemoleculen P-
selectin, E-selectin, en VCAM-1 in de felien veneuze endotheelcellijn. Cultuurvloeistoffen 
van monocyten, geïnoculeerd met ultraviolet (UV)-geïnactiveerd FIPV, waren niet in staat de 
endotheliale expressie van deze adhesiemoleculen te verhogen. Dit suggereert dat effectieve 
virusreplicatie noodzakelijk is om de productie van EC-activerende factoren te induceren. 
Vervolgens werd er geëvalueerd of de FIPV-geïnduceerde verhoging in de expressie van 
adhesiemoleculen een verhoogde binding van niet-geïnfecteerde monocyten aan het 
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geactiveerde endotheel toeliet. Adhesietesten demonstreerde een verhoogde adhesie van 
naïeve monocyten aan ECs behandeld met cultuurvloeistof van FIPV-geïnfecteerde 
monocyten versus mock-geïnfecteerde monocyten. Dit geeft de biologische significantie van 
de expressie van de adhesiemoleculen aan. Finaal werd onderzocht of sera van FIP katten 
verschillen in hun vermogen om ECs te activeren vergeleken met dat van gezonde controles. 
Geen significant verschil in oppervlakte expressie werd bemerkt wat doet vermoeden dat 
ontstekingsmediatoren vrijgesteld door FIPV-geïnfecteerde monocyten enkel lokaal, ter 
hoogte van de infectieplaats, inwerken. Ter conclusie, deze data zijn een sterke aanwijzing dat 
het mechanisme voor FIPV intrede in het weefsel een gevolg is van het vermogen van virus-
geïnfecteerde monocyten om de expressie van adhesiemoleculen op het oppervlak van ECs te 
induceren, wat de adhesie en vervolgens de transmigratie van deze monocyten toelaat 
doorheen het endothelium.  Naast virale spreiding van het bloed naar het omliggend weefsel 
promoot de verhoogde expressie van adhesiemoleculen de rekrutering van naïeve monocyten 
wat uiteindelijk resulteert in de vasculaire ziekte geassocieerd met FIPV infectie.  
Hoofdstuk 5 voorziet de algemene discussie van de onderzoeksdata gecreëerd in deze thesis.  
In een eerste deel wordt de oude en de nieuwe theorie over de ontwikkeling van FIP laesies 
uiteengezet. Vervolgens wordt de focus gelegd op de nieuwe inzichten hierover, verkregen 
door onze eigen onderzoeksresultaten. Finaal wordt een hypothese aangeleverd die de 
specifieke locatie van FIP laesies tracht te verklaren. 
De hoofdbesluiten van deze thesis zijn: 
 Bloedstalen van katten werden verwerkt volgens de snelle leukocyt bereidingstechniek op 
basis van formaldehyde. Deze methode laat toe om de werkelijke expressie van 
adhesiemoleculen op het oppervlak van perifere bloedleukocyten in FIP te analyseren. 
 Leukocyten van FIP katten vertonen tekenen van systemische activatie weerspiegeld door 
een verhoogde oppervlakte expressie van adhesiemoleculen. Meer specifiek, granulocyten 
en monocyten van FIP katten dragen meer Mac-1 op hun oppervlak en circulerende FIP 
lymfocyten (B- en T-cellen) vertonen een hogere expressie van LFA-1 dan gezonde 
controle katten. Bovendien is de expressie van VLA-4 verhoogd op B-lymfocyten 
afkomstig van FIP katten.  
 De oppervlakte expressie van de endotheliale adhesiemoleculen P-selectin, E-selectin, 
ICAM-1 en VCAM-1 zijn opgereguleerd in FIP. 
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 De verhoogde expressie van de endotheliale adhesiemoleculen is beperkt tot de 
bloedvaten die betrokken zijn in de granulomateuze vasculaire laesies.  
 Twee nieuwe feliene geïmmortaliseerde cellijnen werden gegenereerd van primaire EC 
culturen, geïsoleerd van de aorta en vena cava van katten. Gezien beide cellijnen de 
fenotypische karakteristieken van normale endotheelcellen grotendeels behouden en 
bovendien in staat zijn om EC functies uit te voeren, leveren deze cellijnen betrouwbare in 
vitro modellen voor de studie van het vasculair endothelium.  
 De veneuze endotheelcellijn was in staat om zijn typische immunologische activiteit uit te 
voeren en werd daardoor geselecteerd om de leukocyt-endotheel interactie tijdens een 
FIPV-infectie te onderzoeken.  
 Monocyten geïnfecteerd met replicatie-competent FIPV zijn in staat om oplosbare 
mediatoren te produceren, dewelke op een paracriene manier veneuze ECs activeren. De 
EC activatie wordt weerspiegeld door een verhoogde oppervlakte expressie van 
endotheliale adhesiemoleculen P-selectin, E-selectin en VCAM-1. 
 De toename in oppervlakte expressie van adhesiemoleculen laat een verhoogde adhesie 
toe van naïeve monocyten op veneuze ECs die zijn voorbehandeld met supernatants van 
FIPV-geïnfecteerde monocyten.   
 Sera van FIP katten vertoont geen EC activerend effect, wat suggereert dat de oplosbare 
mediatoren enkel lokaal, ter hoogte van de infectieplaats, inwerken.  
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